Recombinant_JJ murine_JJ and_CC human_JJ TCF-1_NN recognized_NN the_DT same_JJ sequence_NN motif_NN in_IN the_DT CD3-epsilon_NN enhancer_NN as_IN judged_NN by_IN gel_NN retardation_NN and_CC methylation_NN interference_NN assays_NNS ._JJ
p50B_NN is_VBZ able_JJ to_TO form_NN heteromeric_NN kappa_NN B-binding_JJ complexes_NNS with_IN RelB_JJ ,_, as_IN well_RB as_IN with_IN p65_NN and_CC p50_NN ,_, the_DT two_CD subunits_NNS of_IN NF-kappa_NN B_NN ._NN
The_DT constitutively_RB active_JJ type_NN of_IN the_DT CN_NN A_NN subunit_NN ,_, which_WDT lacks_NN the_DT auto-inhibitory_NN and_CC calmodulin-binding_NN domains_NN ,_, acts_NN in_IN synergy_NN with_IN PMA_NN to_TO activate_VB transcription_NN from_IN the_DT GM-CSF_NN promoter_NN ._NN
This_DT high-affinity_JJ site_NN has_VBZ been_VBN conserved_VBN in_IN the_DT promoters_NNS of_IN both_DT human_JJ and_CC mouse_NN CD19_NN genes_NNS and_CC was_VBD furthermore_JJ shown_VBN to_TO confer_VB B-cell_NN specificity_NNS to_TO a_DT beta-globin_NN reporter_NN gene_NN in_IN transient_NN transfection_NN experiments_NN ._NN
N-acetyl-L-cysteine_NN NP_NN ,_, a_DT well_RB characterized_VBN antioxidant_NN which_WDT counteracts_NN the_DT effects_NNS of_IN reactive_NN oxygen_NN intermediates_NN ROI_NN in_IN living_NN cells_NNS ,_, prevented_VBD the_DT activation_NN of_IN NF-kappa_NN B_NN by_IN H2O2_NN ._NN
Total_TO RNA_NN isolated_VBN from_IN the_DT index_JJ subject_NN mononuclear_JJ leukocytes_NNS was_VBD used_VBN to_TO produce_VB first_JJ strand_NN hGR_NN cDNAs_NN ,_, and_CC the_DT entire_JJ hGR_NN cDNA_NN was_VBD amplified_VBN in_IN segments_NN and_CC sequenced_NN ._NN
The_DT eukaryotic_JJ transcription_NN factor_NN nuclear_JJ factor-kappa_NN B_NN NF-kappa_NN B_NN participates_NNS in_IN many_JJ parts_NNS of_IN the_DT genetic_JJ program_NN mediating_VBG T_NN lymphocyte_NN activation_NN and_CC growth_NN ._NN
We_PRP have_VBP cloned_JJ the_DT latent_NN membrane_NNS protein_NN 1_NN LMP1_NN homologs_NN from_IN the_DT simian_JJ EBV_NN naturally_NN infecting_NN baboons_NN cercopithicine_NN herpesvirus_NN 12_NN ,_, herpesvirus_NN papio_NNS and_CC rhesus_NN monkeys_NN cercopithicine_NN herpesvirus_NN 15_NN for_IN a_DT comparative_JJ study_NN with_IN the_DT human_JJ EBV_NN oncogene_NN ._NN
To_TO clarify_VB the_DT molecular_JJ mechanisms_NNS involved_VBN in_IN the_DT developmental_NN control_NN of_IN hemoglobin-encoding_JJ genes_NNS we_PRP have_VBP been_VBN studying_VBN the_DT expression_NN of_IN these_DT genes_NNS in_IN human_JJ cells_NNS in_IN continuous_NN culture_NN ._NN
We_PRP conclude_VBP that_IN the_DT serum_NN response_NN of_IN the_DT human_JJ TSP_NN 1_CD gene_NN requires_VBZ the_DT coordinated_JJ function_NN of_IN an_DT SRE-_NN and_CC NF-Y-binding_NN site_NN ._NN
It_PRP is_VBZ concluded_VBN that_IN adenovirus_NN may_MD be_VB one_CD cause_VBN of_IN persistent_JJ or_CC recurrent_JJ inflammatory_JJ arthritis_NN ._NN
To_TO further_JJ define_NN the_DT effects_NNS of_IN dexamethasone_NN at_IN the_DT molecular_JJ level_NN ,_, we_PRP prepared_VBP a_DT series_NN of_IN deleted_NN c-jun_NN promoter_NN fragments_NN linked_NNS to_TO the_DT chloramphenicol_NN acetyltransferase_NN CAT_NN gene_NN ._NN
In_IN nuclear_JJ extracts_NNS from_IN monocytes_NNS or_CC macrophages_JJ ,_, induction_NN of_IN NF-KB_NN occurred_VBZ only_RB if_IN the_DT cells_NNS were_VBD previously_RB infected_VBN with_IN HIV-1_NN ._NN
Mutations_JJ of_IN the_DT CRE_JJ site_NN that_WDT result_VBZ in_IN loss_NN of_IN CREB_JJ binding_NN also_RB lead_VBD to_TO loss_NN of_IN functional_JJ activity_NN of_IN the_DT bcl-2_NN promoter_NN in_IN transient-transfection_NN assays_NNS ._JJ
In_IN line_NN with_IN this_DT conclusion_NN ,_, we_PRP show_VBP that_IN the_DT protein_NN ,_, a_DT transcriptional_JJ repressor_NN that_WDT inhibits_VBZ gpc91-phox_NN gene_NN expression_NN by_IN preventing_JJ NF-Y_NN binding_NN to_TO the_DT CAAT_NN box_NN ,_, is_VBZ absent_JJ in_IN monocytes_NNS ._NN
The_DT inhibition_NN of_IN HIV_NN infection_NN in_IN cells_NNS stably_RB expressing_VBG a_DT transdominant_NN Rev_NN protein_NN ,_, in_IN the_DT absence_NN of_IN any_NN deleterious_NN effect_NN on_IN T_NN cell_NN function_NN ,_, suggests_VBZ that_IN such_JJ a_DT strategy_NN could_MD provide_VB a_DT therapeutic_DT effect_NN in_IN the_DT T_NN lymphocytes_NNS of_IN acquired_JJ immunodeficiency_NN syndrome_NN patients_NNS ._JJ
Here_RB ,_, we_PRP show_VBP that_IN v-erbA_NN and_CC c-erbA_NN bind_VB directly_JJ to_TO sequences_NNS within_IN the_DT promoter_NN of_IN the_DT erythrocyte-specific_JJ carbonic_NN anhydrase_NN II_NN CAII_NN ,_, a_DT gene_NN transcription_NN is_VBZ efficiently_JJ suppressed_NN by_IN v-erbA_NN ._NN
The_DT nuclear_JJ factor_NN of_IN activated_VBN T_NN cells_NNS NF-AT_NN 3_NN is_VBZ an_DT inducible_JJ DNA-binding_JJ protein_NN that_WDT is_VBZ essential_JJ for_IN transcriptional_JJ induction_NN of_IN the_DT IL-2_NN gene_NN during_IN T_NN cell_NN activation_NN ._NN
In_IN contrast_NN to_TO the_DT type_NN I_NN receptor_NN ,_, the_DT type_NN II_CD IL-1R_NN has_VBZ a_DT small_NN cytoplasmic_JJ tail_NN ,_, and_CC it_PRP is_VBZ not_RB clear_JJ whether_IN this_DT receptor_NN is_VBZ a_DT signal-transducing_JJ or_CC a_DT regulatory_JJ molecule_NN ._NN
The_DT presence_JJ of_IN c-fos_NN had_VBD a_DT negative_JJ influence_NN on_IN GR_NN function_NN and_CC correlated_NN with_IN the_DT cell-specific_JJ synergistic_NN or_CC antagonistic_NN activity_NN of_IN Jun_NN with_IN respect_JJ to_TO GR_NN ;_NN high_JJ basal_JJ expression_NN of_IN c-fos_NN as_IN well_RB as_IN AP-1_NN DNA_NN binding_NN and_CC transcriptional_JJ activity_NN were_VBD observed_VBN in_IN HeLa_NN cells_NNS ,_, but_CC not_RB in_IN T_NN cells_NNS ._JJ
One_CD ,_, located_JJ at_IN -50_NN ,_, binds_VBZ members_NNS of_IN the_DT family_NN and_CC the_DT other_JJ ,_, located_JJ at_IN -20_NN ,_, binds_VBZ the_DT erythroid_JJ factor_NN GATA-1_NN ._NN
Although_IN sequences_NNS located_JJ between_IN -559_NN and_CC -88_NN of_IN the_DT zeta_NN 2_CD globin_JJ gene_NN were_VBD dispensable_JJ for_IN expression_NN on_IN enhancerless_NN plasmids_NNS ,_, they_DT were_VBD required_VBN for_IN the_DT HS-40_NN enhancer-mediated_NN activity_NN of_IN the_DT zeta_NN 2_CD globin_JJ promoter_NN ._NN
The_DT minimal_JJ region_NN of_IN the_DT human_JJ tumor_NN necrosis_NN factor_NN alpha_NN TNF-alpha_NN gene_NN promoter_NN necessary_JJ for_IN transcriptional_JJ induction_NN by_IN phorbol_NN esters_NNS PMA_NN in_IN human_JJ T_NN and_CC B_NN lymphocyte_NN cell_NN lines_NNS has_VBZ been_VBN localized_JJ between_IN -52_NN and_CC nucleotides_NN nt_NN relative_JJ to_TO the_DT gene_NN transcriptional_JJ start_NN site_NN ._NN
Glucocorticoids_NNS and_CC interferon-alpha_JJ in_IN the_DT acquired_JJ immunodeficiency_NN syndrome_NN ._NN
We_PRP tested_JJ the_DT ability_NN of_IN human_JJ TSP_NN 1-chloramphenicol_NN acetyltransferase_NN constructs_NN to_TO respond_NNS to_TO serum_NN in_IN stably_NN transfected_NN NIH-3T3_NN cells_NNS ._JJ
Involvement_IN of_IN mitogen-activated_NNS protein_NN kinase_NN pathways_NNS in_IN interleukin-8_JJ production_NN by_IN human_JJ monocytes_NNS and_CC polymorphonuclear_JJ cells_NNS stimulated_VBN with_IN lipopolysaccharide_NN or_CC Mycoplasma_NN fermentans_NN membrane_NNS lipoproteins_NNS ._NN
Nondividing_NN macrophages_NN from_IN normal_JJ individuals_NNS also_RB expressed_VBN 1,25-LRB-OH-RRB-2D3_NN receptor_NN RNA_NN ._NN
IFN-gamma_NN has_VBZ potent_JJ antiproliferative_NN and_CC apoptotic_NN effects_NNS in_IN T_NN cells_NNS that_WDT are_VBP important_JJ in_IN determining_NN T_NN cell_NN development_NN and_CC polarized_NN differentiation_NN ._NN
The_DT promoters_NNS and_CC enhancers_NN of_IN cell_NN type-specific_JJ genes_NNS are_VBP often_IN conserved_VBN in_IN evolution_NN ,_, and_CC hence_NN one_NNS might_MD expect_VB that_IN a_DT given_JJ enhancer_NN has_VBZ evolved_RB to_TO work_NN best_NN with_IN own_JJ promoter_NN ._NN
The_DT mechanism_NN of_IN action_NN of_IN DM_NN on_IN IL-2R_NN alpha_NN transcription_NN was_VBD examined_VBN by_IN determining_NN the_DT mRNA_NN levels_NNS of_IN the_DT p50_NN subunit_NN of_IN nuclear_JJ factor_NN kappa_NN B_NN NF-kappa_NN B_NN ,_, a_DT transcription_NN factor_NN that_WDT stimulates_VBZ IL-2R_NN alpha_NN gene_NN expression_NN ._NN
Phytohemagglutinin_NN stimulated_VBN lymphocytes_NNS derived_VBN from_IN DS_NN subjects_NNS showed_VBD a_DT statistically_NN significant_JJ diminished_NN proliferation_NN capacity_NN in_IN comparison_JJ with_IN lymphocytes_NNS derived_VBN from_IN NCL_NN and_CC healthy_NN individuals_NN ._NN
In_IN previous_JJ transfection_NN analyses_NNS using_VBG the_DT chloramphenicol_NN acetyltransferase_NN reporter_NN gene_NN system_NN ,_, we_PRP determined_VBD that_IN linker_NN substitution_NN LS_NN mutations_NNS between_IN -201_NN and_CC -130_NN relative_JJ to_TO the_DT transcription_NN start_NN site_NN of_IN the_DT human_JJ immunodeficiency_NN virus_NN type_NN 1_CD long_JJ terminal_JJ repeat_NN LTR_NN caused_VBN moderate_NN decreases_NN in_IN LTR_NN transcriptional_JJ activity_NN in_IN a_DT T-cell_NN line_NN S.L.Zeichner_NN ,_, J.Y.H._NN Kim_NN ,_, and_CC J.C.Alwine_NN ,_, J.Virol.65_NN :_: 2436-2444_NN ,_, 1991_NN ._NN
Inhibition_IN of_IN anti-CD3_NN monoclonal_NN antibody-induced_NN T-cell_NN proliferation_NN by_IN dexamethasone_NN ,_, isoproterenol_VBN ,_, or_CC prostaglandin_NN E2_NN either_CC alone_NN or_CC in_IN combination_NN ._NN
Additionally_JJ ,_, infected_JJ T_NN cells_NNS displayed_JJ lower_JJR levels_NNS of_IN CD45_NN on_IN surfaces_NN ._NN
Glucocorticoid_NN receptor_NN and_CC inhibition_NN of_IN 3-O-methyl-D-glucose_NN uptake_NN by_IN glucocorticoids_NNS in_IN peripheral_JJ blood_NN leukocytes_NNS from_IN normal_JJ humans_NNS :_: correlation_NN between_IN receptor_NN level_NN and_CC hormone_NN effect_NN in_IN vitro_FW ._NN
Epstein-Barr_JJ virus_NN nuclear_JJ antigen_NN 2_CD and_CC latent_NN membrane_NNS protein_NN independently_NN transactivate_NN p53_NN through_IN induction_NN of_IN NF-kappaB_NN activity_NN ._NN
The_DT T_NN lineage-specific_NN expression_NN and_CC the_DT affinity_NN for_IN functional_JJ motifs_NNS in_IN the_DT TCR-alpha_NN and_CC CD3-epsilon_NN enhancers_NN imply_NN an_DT important_JJ role_NN for_IN TCF-1_NN in_IN the_DT establishment_JJ of_IN the_DT mature_JJ T_NN cell_NN phenotype_NN ._NN
Cell_NN type-_NN and_CC stage-specific_NN expression_NN of_IN the_DT antigen_NN correlates_NN with_IN the_DT activity_NN of_IN a_DT diverged_JJ octamer_NN DNA_NN motif_NN present_JJ in_IN promoter_NN ._NN
We_PRP have_VBP located_JJ the_DT major_JJ positive_NN regulatory_JJ region_NN for_IN control_NN of_IN bcl-2_NN expression_NN in_IN B_NN cells_NNS in_IN the_DT region_NN ._NN
IL-10_NN profoundly_NNS inhibited_VBD release_NN of_IN IL-1beta_NN from_IN PBMC_NN stimulated_VBZ by_IN all_DT three_CD stimuli_NNS ._NN
Tat_NN ,_, a_DT potent_JJ activator_NN of_IN HIV-1_NN gene_NN expression_NN ,_, serves_NN to_TO greatly_NNS increase_NN the_DT rate_NN of_IN transcription_NN directed_VBZ by_IN the_DT viral_JJ promoter_NN ._NN
From_NN HeLa_NN cells_NNS ,_, two_CD major_JJ proteins_NNS of_IN 52_NN and_CC 45_NN kilodaltons_NNS kD_NN copurified_NN with_IN DNA_NN binding_NN activity_NN ,_, whereas_IN from_IN T-cells_NN ,_, four_VBN proteins_NNS --_NN a_DT major_JJ protein_NN of_IN 52_NN kD_NN and_CC three_CD minor_NN proteins_NNS of_IN 82_NN ,_, 67_NN ,_, and_CC 43-47_NN kD_NN --_NN were_VBD purified_VBN ._NN
Finally_NN ,_, we_PRP did_VBD not_RB observed_VBN either_CC up-regulation_NN or_CC antagonism_NN of_IN GcR_NN by_IN ketoconazole_NN treatment_NN ,_, at_IN the_DT time_NN that_WDT cortisol_NN levels_NNS of_IN patients_NNS with_IN Cushing_NN disease_NN were_VBD reduced_VBN ._NN
occurrence_VBZ is_VBZ considered_NN to_TO be_VB extremely_NN rare_NN ._NN
Within_NN this_DT region_NN ,_, we_PRP have_VBP identified_VBN several_JJ sequences_NNS that_WDT are_VBP implicated_JJ in_IN DNA_NN protein_NN interactions_NN as_IN shown_JJ in_IN DNAse_NN I_NN footprints_NN and_CC gel_NN mobility_NN shift_NN assays_NNS ._JJ
The_DT regulatory_JJ effect_NN of_IN insulin_NN on_IN the_DT specific_JJ binding_NN power_NN of_IN glucocorticoid_NN receptor_NN GR_NN of_IN human_JJ leukocytes_NNS was_VBD assessed_VBN by_IN the_DT unoccupied_JJ receptor_NN sites_NNS capable_JJ of_IN combining_NNS with_IN -LCB-3H-RCB-_NN labelled_NN dexamethasone_NN measured_NN at_IN 3_NN and_CC 24_NN h_NN after_IN incubation_NN with_IN various_JJ concentrations_NNS of_IN insulin_NN added_NN to_TO the_DT medium_NN ._NN
We_PRP suggest_VBP that_IN in_IN young_NN subjects_NNS Type_JJ II_NN receptors_NNS are_VBP initially_VBN up-regulated_VBN by_IN dexamethasone_NN ,_, and_CC then_RB down-regulated_JJ ,_, while_IN in_IN aged_NNS subjects_NNS an_DT up-regulation_NN can_MD not_RB be_VB achieved_VBN ,_, as_IN suggested_VBD by_IN the_DT higher_JJ values_NN of_IN plasma_NN cortisol_NN usually_NN found_VBN in_IN aging_NN subjects_NNS
This_DT function_NN has_VBZ been_VBN attributed_IN to_TO the_DT coordinated_NN binding_NN of_IN subunits_NNS of_IN NF-kappa_NN B_NN to_TO distinct_JJ regions_NNS of_IN the_DT promoter_NN elements_NNS of_IN numerous_NN genes_NNS ,_, including_VBG cytokines_NN ,_, growth_NN factor_NN receptors_NNS ,_, and_CC adhesion_NN molecules_NNS ._JJ
The_DT potential_JJ clinical_JJ usefulness_NN of_IN these_DT CL_NN assays_NNS was_VBD suggested_VBD by_IN the_DT ability_NN of_IN both_DT monocytes_NNS and_CC IFN-U937_NN cells_NNS to_TO respond_VB to_TO red_JJ cells_NNS ,_, platelets_NNS or_CC granulocytes_NNS sensitized_JJ with_IN sera_NN from_IN pregnant_JJ women_NN babies_NNS had_VBD either_CC haemolytic_JJ disease_NN of_IN the_DT newborn_JJ HDN_NN ,_, alloimmune_NN thrombocytopenia_CD or_CC alloimmune_DT neutropenia_JJ respectively_NN ._NN
These_DT findings_NN indicate_VBP that_IN corticosteroid_NN resistance_NN in_IN bronchial_JJ asthma_NN can_MD not_RB be_VB explained_VBN by_IN abnormalities_NNS in_IN corticosteroid_NN receptor_NN characteristics_NNS ._JJ
In_IN conclusion_NN ,_, E-LRB-gre-RRB-_NN motifs_NNS and_CC interacting_JJ basic_JJ helix-loop-helix_NN proteins_NNS are_VBP important_JJ determinants_JJ for_IN MLV_NNS transcriptional_JJ activity_NN in_IN lymphocytic_JJ cell_NN lines_NNS ._JJ
Characterization_NN of_IN a_DT new_JJ isoform_NN of_IN the_DT NFAT_NN nuclear_JJ factor_NN of_IN activated_VBN T_NN cells_NNS gene_NN family_NN member_NNS NFATc_NN published_NN erratum_NN appears_VBZ in_IN J_NN Biol_NN Chem_NN 1996_NN Dec_NN 27_NN ;_NN 271_NN 52_NN :_: 33705_NN
The_DT retinoblastoma_NN gene_NN product_NN Rb_NN is_VBZ a_DT nuclear_JJ phosphoprotein_NN that_WDT regulates_VBZ cell_NN cycle_NN progression_NN ._NN
Generation_NN of_IN dendritic_NN cells_NNS and_CC tartrate-resistant_NN acid_NN phosphatase-positive_NN osteoclast-like_NN multinucleated_JJ giant_NN cells_NNS from_IN human_JJ monocytes_NNS ._NN
To_TO correlate_NN changes_NN in_IN nuclear_JJ factor_NN binding_NN in_IN vitro_FW with_IN transcriptional_JJ activity_NN in_IN vivo_NN and_CC define_NN the_DT structural_JJ requirements_NN for_IN IL-2_NN promoter_NN repression_NN ,_, we_PRP used_VBN transient_NN DNA_NN transfections_NN ._NN
1,25-Dihydroxy_NN vitamin_NN D3_NN and_CC 12-O-tetradecanoyl_NN phorbol-13-acetate_NN synergistically_RB induce_VBD monocytic_JJ cell_NN differentiation_NN :_: FOS_NN and_CC RB_NN expression_NN ._NN
In_IN the_DT bone_JJ marrow_NN ,_, it_PRP is_VBZ preferentially_JJ expressed_VBN in_IN myeloid_JJ cells_NNS ._NN
TAR-independent_NN transactivation_NN by_IN Tat_NN in_IN cells_NNS derived_VBN from_IN the_DT CNS_NN :_: a_DT novel_JJ mechanism_NN of_IN HIV-1_NN gene_NN regulation_NN ._NN
Compared_JJ to_TO benign_VB tumor_NN or_CC mammary_NN reduction_NN test_NN material_NN the_DT eicosanoid_NN profile_NN of_IN tissue_NNS obtained_VBN from_IN malignant_NN mammary_NN tumors_NN showed_VBD important_JJ differences_JJ ._NN
Similar_RB effects_NNS were_VBD obtained_VBN for_IN the_DT c-fos_NN gene_NN ._NN
Of_NN the_DT 23_NN cases_NN ,_, 19_NN were_VBD classified_JJ as_IN NK-cell_NN and_CC 4_NN as_IN T-cell_NN tumours_NN ._NN
Therefore_RB ,_, the_DT successful_JJ generation_NN of_IN surrogate_NN receptors_NNS on_IN non-T_JJ cells_NNS is_VBZ not_RB associated_VBN with_IN more_RBR efficient_JJ TG_NN presentation_JJ of_IN T_NN cells_NNS ._JJ
The_DT IL-2_NN and_CC the_DT IL-2-R_NN alpha_NN genes_NNS are_VBP both_CC expressed_VBN transiently_RB in_IN normal_JJ T_NN lymphocytes_NNS after_IN Ag_NN or_CC mitogen_NN activation_NN ._NN
The_DT inhibition_NN of_IN c-fos_NN and_CC c-jun_NN expression_NN by_IN IL-4_NN in_IN LPS-treated_JJ cells_NNS was_VBD shown_VBN to_TO be_VB due_JJ to_TO a_DT lower_JJR transcription_NN rate_NN of_IN the_DT c-fos_NN and_CC c-jun_NN genes_NNS ._JJ
No_NN age-related_NN differences_NN were_VBD found_VBN in_IN the_DT expression_NN of_IN either_CC of_IN these_DT two_CD proto-oncogenes_NNS by_IN anti-CD2_JJ activated_VBN T_NN cells_NNS ._JJ
In_IN cotransfection_NN experiments_NNS we_PRP show_VBP that_IN all_DT the_DT isoforms_NNS are_VBP able_JJ to_TO activate_VB an_DT octamer_NN containing_VBG promoter_NN element_NN in_IN fibroblasts_NNS revealing_VBD an_DT unexpected_JJ functional_JJ redundancy_NN ._NN
In_IN situ_NN hybridizations_NN of_IN adult_NN murine_JJ tissues_NNS demonstrate_VBP Spi-B_NN mRNA_NN in_IN the_DT medulla_NN of_IN the_DT thymus_JJ ,_, the_DT white_NN pulp_NN of_IN the_DT spleen_JJ ,_, and_CC the_DT germinal_NN centers_NN of_IN lymph_JJ nodes_NN ._NN
All-trans_DT retinoic_JJ acid_NN RA_NN is_VBZ an_DT important_JJ morphogen_NN in_IN vertebrate_JJ development_NN ,_, a_DT normal_JJ constituent_NN in_IN human_JJ adult_NN blood_NN and_CC is_VBZ also_RB involved_VBN in_IN the_DT control_NN of_IN cell_NN growth_NN and_CC differentiation_NN in_IN acute_NN promyelocytic_NN leukemia_NN ._NN
Oct2_NN transactivation_NN from_IN a_DT remote_JJ enhancer_NN position_NN requires_VBZ a_DT B-cell-restricted_JJ activity_NN ._NN
Activation_NN of_IN human_JJ monocytic_JJ cells_NNS by_IN Treponema_FW pallidum_FW and_CC Borrelia_FW burgdorferi_FW lipoproteins_NNS and_CC synthetic_NN lipopeptides_NN proceeds_NN via_IN a_DT pathway_NN distinct_JJ from_IN that_IN of_IN lipopolysaccharide_NN but_CC involves_VBZ the_DT transcriptional_JJ activator_NN NF-kappa_NN B_NN ._NN
A_DT similar_JJ result_NN was_VBD obtained_VBN with_IN the_DT mature_JJ monocytic_JJ leukemia_NN cell_NN line_NN THP-1_NN ._NN
Cotransfection_JJ of_IN a_DT YB-1_NN expression_NN plasmid_NN increases_NN HTLV-I_NN basal_JJ transcription_NN approximately_RB 14-fold_JJ in_IN Jurkat_NN T_NN lymphocytes_NNS ._JJ
The_DT current_NN study_NN examined_VBD the_DT effects_NNS of_IN oxidative_JJ stress_NN on_IN transcriptional_JJ activities_NN mediated_VBN by_IN AP-1_NN and_CC the_DT nuclear_JJ factor_NN of_IN activated_VBN T_NN cells_NNS NF-AT_NN ._NN
A_DT novel_JJ T_NN cell-specific_JJ negative_JJ regulatory_JJ element_NN NRE_NN composed_NN of_IN two_CD protein-binding_NN sites_NNS were_VBD mapped_RB in_IN the_DT flanking_NN region_NN of_IN the_DT IL-4_NN gene_NN :_: -311CTCCCTTCT-303_NN NRE-I_NN and_CC -288CTTTTTGCTT-TGC-300_NN NRE-II_NN ._NN
Furthermore_RB ,_, JunD_NN is_VBZ shown_VBN to_TO activate_VB transcription_NN of_IN genes_NNS linked_VBG to_TO both_CC cAMP_NN and_CC phorbol_NN ester_NN response_NN elements_NNS in_IN a_DT protein_NN kinase_NN A-dependent_NN fashion_NN ,_, further_JJ blurring_NN the_DT distinction_JJ between_IN these_DT response_NN elements_NNS ._JJ
GCs_NN induce_VBZ apoptosis_NN in_IN neoplastic_JJ lymphoid_JJ cells_NNS ;_: and_CC ,_, defective_JJ apoptosis_NN is_VBZ implicated_VBN in_IN the_DT genesis_JJ of_IN chronic_NN lymphocytic_NN leukemia_NN CLL_NN ._NN
At_NN the_DT level_NN of_IN the_DT genomic_JJ TNF_NN gene_NN ,_, a_DT DNase_NN I_NN hypersensitive_NN site_NN is_VBZ detected_VBN within_IN the_DT TNF_NN promoter_NN between_IN -200_CD to_TO -100_NN bp_NN relative_JJ to_TO the_DT transcription_NN initiation_NN site_NN ._NN
Increased_IN expression_NN of_IN the_DT oncogene_NN in_IN breast_JJ cancer_NN correlates_NN with_IN decreased_NN estrogen_NN receptor_NN concentration_NN and_CC seems_NN to_TO be_VB an_DT important_JJ prognostic_NN factor_NN ._NN
Exposing_VBG HUVECs_NNS to_TO induces_VBZ an_DT increase_NN in_IN nuclear_JJ factor_NN kappaB_NN NF-kappaB_NN in_IN HUVEC_NNS nuclei_NNS within_IN 4_NN hours_NN ._NN
Within_NN this_DT region_NN ,_, we_PRP define_VBD a_DT minimal_JJ promoter_NN -62_NN to_TO that_IN displays_JJ erythroid-specific_JJ activity_NN and_CC contains_VBZ two_CD DNA_NN binding_NN sites_NNS ._JJ
This_DT indicates_JJ an_DT increase_NN in_IN either_CC episomal_NN DNA_NN or_CC concatameric_NN linear_NNS DNA_NN ._NN
In_IN T_NN cells_NNS ,_, HIV_NN transcription_NN is_VBZ poorly_JJ detected_NN in_IN vivo_NN ._NN
No_NN correlation_NN was_VBD observed_VBN between_IN c-myc_NN mRNA_NN and_CC B_NN lymphocyte_NN monoclonicity_NN or_CC lymphoma_NN ._NN
Electrophoretically_NN purified_VBN p50_NN alone_NN can_MD form_VBP a_DT protein-DNA_NN complex_NN ,_, but_CC in_IN the_DT mixture_NN ,_, p50_NN associates_VBN preferentially_JJ with_IN p65_NN to_TO form_VBP the_DT NF-GM2_NN complex_NN ._NN
NF-kB_NN is_VBZ a_DT eukaryotic_JJ transcription_NN regulatory_JJ factor_NN ._NN
Thus_RB ,_, the_DT estrogen_JJ receptor-related_NN protein_NN is_VBZ HSP27_NN ,_, and_CC the_DT three_CD major_JJ 29-kDa_NN proteins_NNS phosphorylated_NN in_IN thrombin-activated_CD platelets_NNS are_VBP forms_NNS of_IN HSP27_NN ._NN
The_DT BZLF1_NN protein_NN of_IN Epstein-Barr_JJ virus_NN EBV_NN is_VBZ a_DT key_JJ immediate-early_NN protein_NN which_WDT has_VBZ been_VBN shown_VBN to_TO disrupt_VB virus_NN latency_NN in_IN EBV-infected_NN B_NN cells_NNS ._JJ
In_IN addition_NN to_TO these_DT novel_JJ E2F_NN complexes_NNS ,_, three_CD distinct_JJ forms_NNS of_IN unbound_JJ free_JJ E2F_NN were_VBD resolved_VBN in_IN gel_NN shift_NN experiments_NN ._NN
Pb-induced_NN activation_NN of_IN NF-kappa_NN B_NN is_VBZ blocked_VBD by_IN antibodies_NN for_IN p65_NN and_CC p50_NN subunits_NNS but_CC not_RB cRel_NN ,_, indicating_VBG that_IN the_DT p65:p50_NN heterodimer_NN NF-kappa_NN B_NN is_VBZ involved_VBN ._NN
Basal_NN total_NN white_WDT blood_NN cell_NN and_CC granulocyte_NN counts_NN did_VBD not_RB appreciably_VB differ_JJ between_IN transgenic_JJ and_CC control_JJ mice_NNS ._NN
The_DT implications_NNS ,_, in_IN particular_JJ ,_, in_IN relation_JJ to_TO future_VB prognosis_NN of_IN the_DT patient_NN ,_, remain_NN obscure_NN ._NN
GR_NN was_VBD determined_VBN by_IN whole_NN cell_NN assay_NN with_IN 3H-Dex_NN ._NN
In_IN contrast_NN ,_, the_DT C26_NN element_NN itself_NN was_VBD profoundly_RB activated_VBN upon_IN stimulation_NN with_IN 12-O-tetradecanoylphorbol-13-acetate_JJ ._NN
Furthermore_RB ,_, an_DT antiserum_NN against_IN KBF1_NN identical_NN to_TO 50_NN kDa_NN NF-kappa_NN B_NN protein_NN reacted_NN with_IN the_DT p50_NN of_IN NF-GM2_NN ,_, indicating_VBG that_IN the_DT NF-GM2_NN polypeptide_NN can_MD not_RB be_VB immunologically_JJ differentiated_NN from_IN the_DT 50_NN kDa_NN subunit_NN of_IN NF-kappa_NN B_NN ._NN
The_DT difference_JJ in_IN signals_NNS transduced_NN through_IN sIgM_JJ and_CC sIgD_JJ in_IN B104_NN cells_NNS is_VBZ discussed_JJ ._NN
A_DT novel_JJ SP-1_NN site_NN in_IN the_DT human_JJ interleukin-1_NN beta_IN promoter_NN confers_VBZ preferential_JJ transcriptional_JJ activity_NN in_IN keratinocytes_NNS ._NN
This_DT common_JJ pathway_NN may_MD involve_VB reactive_NN oxygen_NN intermediates_NN ROI_NN as_IN messenger_NNS molecules_JJ ._NN
FK506_NN and_CC cyclosporin_NN A_NN block_NN translocation_NN of_IN the_DT cytoplasmic_JJ component_NN without_IN affecting_VBG synthesis_NN of_IN the_DT nuclear_JJ subunit_NN ._NN
The_DT molecular_JJ basis_JJ for_IN restricted_JJ cytokine_NN expression_NN by_IN T_NN helper_NN 1_NN Th1_NN and_CC T_NN helper_NN 2_CD Th2_JJ cells_NNS is_VBZ unclear_JJ ._NN
The_DT B_NN cell_NN NFAT_NN complex_NN ,_, however_NN ,_, was_VBD not_RB functional_JJ ,_, since_JJ it_PRP failed_VBD to_TO activate_NN transcription_NN from_IN an_DT NFAT-driven_NN chloramphenicol_NN acetyltransferase_NN CAT_NN construct_NN ._NN
HIV-1_NN can_MD also_RB establish_JJ a_DT latent_NN or_CC persistent_NN infection_NN in_IN some_DT T_NN cell_NN lines_NNS that_WDT show_VBP minimal_JJ constitutive_JJ virus_NN expression_NN ._NN
Data_NN obtained_VBN from_IN studies_NNS in_IN laboratories_NN demonstrate_VBP that_IN the_DT proteasome_NN plays_VBZ an_DT important_JJ role_NN in_IN the_DT inflammatory_JJ cascade_NN by_IN regulating_VBG the_DT activation_NN of_IN NF-kappa_NN B_NN ._NN
However_RB ,_, when_WRB HL60R_NN cells_NNS were_VBD transduced_VBN with_IN a_DT functional_JJ copy_NN of_IN the_DT RAR_NN alpha_NN gene_NN ,_, RA_NN induced_VBN a_DT 10-fold_JJ increase_NN in_IN E3_NN mRNA_NN levels_NNS ._JJ
In_IN six_NN cases_NN we_PRP determined_VBN MR_NN ,_, plasma_NN aldosterone_NN ,_, and_CC SPD_NN in_IN patients_NNS with_IN preeclampsia_JJ before_NN and_CC 3_NN months_NN after_IN delivery_NN ._NN
In_IN contrast_NN ,_, GATA-2_NN is_VBZ strongly_RB expressed_VBN in_IN both_CC most_RBS primitive_JJ and_CC committed_JJ progenitors_NNS cells_NNS ,_, whereas_IN GATA-3_NN is_VBZ mostly_VBN detected_VBN in_IN most_JJS primitive_JJ ones_NNS ._NN
Transcription_JJ of_IN the_DT hypersensitive_NN site_NN HS2_NN enhancer_NN in_IN erythroid_JJ cells_NNS ._NN
Inhibition_IN of_IN protein_NN phosphatases_NN by_IN okadaic_NN acid_NN induces_VBZ AP1_NN in_IN human_JJ T_NN cells_NNS ._JJ
Activated_NN T-lymphocytes_NN are_VBP found_VBN early_JJ in_IN atherosclerosis_NN lesions_NNS ,_, but_CC little_JJ is_VBZ known_VBN about_JJ role_NN ._NN
In_IN this_DT work_NN ,_, we_PRP report_NN that_IN these_DT anergic_JJ T_NN cells_NNS are_VBP defective_VBN in_IN ability_NN to_TO up-regulate_VB protein_NN binding_NN and_CC transactivation_NN at_IN two_CD critical_NNS IL-2_NN DNA_NN enhancer_NN elements_NNS :_: NF-AT_NN nuclear_JJ factor_NN of_IN activated_VBN T_NN cells_NNS ;_: a_DT sequence_NN that_WDT binds_VBZ a_DT heterotrimeric_JJ NFATp_NN ,_, Fos_NN ,_, and_CC Jun_NN protein_NN complex_NN and_CC Activator_NN Protein-1_NN AP-1_NN that_WDT binds_VBZ Fos_NN and_CC Jun_NN heterodimers_NN ._NN
Lymphocytes_NN activated_VBN with_IN the_DT OKT3_NN antibody_NN to_TO the_DT T-cell_NN antigen_NN receptor_NN expressed_VBD fewer_JJ binding_NN sites_NNS as_IN compared_VBN to_TO lymphocytes_NNS that_IN were_VBD activated_VBN by_IN the_DT polyclonal_JJ activator_NN phytohemagglutinin_NN PHA_NN ._NN
Using_NN a_DT structure-function_NN mutagenesis_NN approach_VBZ ,_, two_CD tyrosine_NN residues_JJ Tyr427_NN and_CC Tyr477_NN in_IN the_DT intracellular_JJ domain_NN of_IN the_DT murine_JJ IL-10_NN receptor_NN were_VBD found_VBN to_TO be_VB redundantly_NN required_VBN for_IN receptor_NN function_NN and_CC for_IN activation_NN of_IN Stat3_NN but_CC not_RB for_IN Stat1_NN or_CC Stat5_NN ._NN
Threonine_DT 78_NN lies_NN within_IN the_DT D-box_NN of_IN the_DT v-erb_NN A_NN protein_NN ,_, a_DT region_NN thought_DT to_TO mediate_NN receptor-receptor_NN dimerizations_NN ,_, and_CC is_VBZ not_RB in_IN physical_NN proximity_NN to_TO the_DT serine_NN at_IN position_NN 61_NN ._NN
Surprisingly_NN ,_, multimers_JJ of_IN kappa_NN 1_NN -_NN kappa_NN 3_NN can_MD confer_VB PMA_NN inducibility_VBN on_IN a_DT heterologous_JJ promoter_NN in_IN a_DT B_NN Raji_NN ,_, but_CC not_RB a_DT T_NN HUT78_NN cell_NN line_NN ._NN
Here_RB we_PRP report_NN that_IN LTB4_NN induces_VBZ synthesis_NN of_IN interleukin_NN IL_NN -6_NN by_IN human_JJ blood_NN monocytes_NNS through_IN transcriptional_JJ activation_NN of_IN the_DT IL-6_NN gene_NN ._NN
The_DT extent_NN to_TO which_WDT peptides_NN containing_VBG chemically_NN and_CC post-translationally_NN modified_NN amino_NN acid_NN side_NN chains_NN are_VBP recognized_VBN by_IN primed_JJ CTL_NN has_VBZ not_RB been_VBN clearly_RB defined_VBN ._NN
The_DT data_NNS also_RB indicate_VBP that_IN CD2_NN receptor_NN activation_NN and_CC phytohemagglutinin_NN plus_NN phorbol_NN 12-myristate_NN 13-acetate_NN stimulation_NN augment_NN T_NN cell_NN IL3_NN gene_NN expression_NN through_IN the_DT same_JJ cis-_JJ and_CC trans-activating_JJ signals_NN ._NN
A_DT comparison_JJ of_IN in_IN situ_NN hybridization_NN to_TO EBV_NN DNA_NN and_CC viral_JJ capsid_NN antigen_NN staining_NN with_IN BZ1_NN reactivity_NN suggested_VBD that_IN BZLF1_NN expression_NN precedes_JJ rampant_NN virus_NN replication_NN ._NN
Protein_NN kinase_NN C_NN activation_NN and_CC protooncogene_NN expression_NN in_IN of_IN human_JJ U-937_NN leukemia_NN cells_NNS ._JJ
Comparison_JJ of_IN the_DT sequences_NNS of_IN all_DT elements_NNS recognized_VBP by_IN TCF-1_NN defines_NN a_DT consensus_NN motif_NN C_NN A_NN A_NN G_NN ._NN
ABSTRACT_NN TRUNCATED_NN AT_NN 250_NN WORDS_NN
The_DT binding_NN affinity_NN was_VBD not_RB different_JJ between_IN patients_NNS and_CC controls_NNS ._NN
Eosinophils_NN play_VBZ an_DT important_JJ role_NN in_IN the_DT effector_JJ phase_NN of_IN allergic_DT inflammation_NN ._NN
The_DT numbers_NN of_IN leucocytic_JJ ER_NN were_VBD significantly_RB increased_VBN after_IN treatment_NN ._NN
Using_NN a_DT human_JJ TSH_NN receptor_NN TSH-R_NN cDNA_NN probe_NN ,_, we_PRP investigated_VBD TSH-R_NN transcript_NN levels_NNS in_IN 13_NN human_JJ thyroid_NN fragments_NN by_IN Northern_NN blot_NN analysis_NN ;_NN 7_NN Graves_NN disease_NN ,_, 2_CD Hashimoto_NN disease_NN ,_, 3_NN endemic_NN goiter_NN ,_, and_CC 1_CD healthy_NN thyroid_NNS gland_JJ were_VBD studied_VBN ._NN
Expression_NN was_VBD confirmed_VBN in_IN the_DT bone_JJ marrow_NN with_IN a_DT reverse_JJ transcription_NN PCR_NN assay_NN ._NN
Antiphosphotyrosine_NN immunoblots_NN of_IN whole_NN cell_NN lysates_NN prepared_JJ from_IN neutrophils_NNS show_VBP that_IN the_DT G-CSF_NN rapidly_NN induces_VBZ prominent_VBN tyrosine_NN phosphorylation_NN of_IN a_DT protein_NN of_IN a_DT relative_JJ molecular_JJ mass_NN of_IN 80_NN kDa_NN ._NN
Most_RB of_IN the_DT AP-1_NN activity_NN could_MD be_VB eliminated_NN when_WRB the_DT anti-AIM_NN mAb_NN was_VBD added_VBN to_TO the_DT culture_NN medium_NN in_IN the_DT presence_JJ of_IN cycloheximide_NN ,_, suggesting_VBG that_IN de_NN novo_JJ protein_NN synthesis_NN is_VBZ crucial_NN for_IN the_DT induction_NN of_IN AP-1-binding_NN activity_NN ._NN
In_IN vitro_FW effects_NNS of_IN aldosterone_NN on_IN the_DT intracellular_JJ concentrations_NN of_IN sodium_JJ ,_, potassium_JJ and_CC calcium_NN ,_, cell_NN volume_NN and_CC the_DT sodium-proton-antiport_NN have_VBP been_VBN described_VBN in_IN intact_NN human_JJ mononuclear_JJ leukocytes_NNS HML_NN ._NN
These_DT findings_NN suggest_VBP that_IN the_DT combination_NN of_IN p49_NN 100_NN and_CC p65_NN NF-kappa_NN B_NN can_MD act_VB in_IN concert_NN with_IN the_DT tat-I_NN gene_NN product_NN to_TO stimulate_VB the_DT synthesis_NN of_IN HIV_NN RNA_NN ._NN
IL4_NN and_CC IL13_NN receptors_NNS share_VBP the_DT gamma_NN c_NN chain_NN and_CC activate_NN STAT6_NN ,_, STAT3_NN and_CC STAT5_NN proteins_NNS in_IN normal_JJ human_JJ B_NN cells_NNS ._JJ
Primary_JJ lymphocyte_NN cultures_NNS showed_VBD partial_RB independence_VBN from_IN exogenous_JJ growth_NN stimuli_NNS and_CC increased_VBN resistance_NN to_TO low-serum_JJ apoptosis_NN ._NN
Retinoic_JJ acid_NN activates_VBZ interferon_NN regulatory_JJ factor-1_NN gene_NN expression_NN in_IN myeloid_JJ cells_NNS ._NN
BACKGROUND_JJ ._NN
We_PRP have_VBP tested_VBN a_DT variety_JJ of_IN Oct2_NN isoforms_NNS generated_VBN by_IN alternative_NN splicing_NN for_IN the_DT capability_JJ to_TO activate_VB an_DT octamer_NN enhancer_NN in_IN nonlymphoid_JJ cells_NNS and_CC a_DT B-cell_JJ line_NN ._NN
Furthermore_RB ,_, the_DT physical_JJ interaction_NN of_IN Tax_NN with_IN p100_NN leads_NN to_TO the_DT inhibition_NN of_IN Tax-induced_NN activation_NN of_IN the_DT HTLV-I_NN and_CC human_JJ immunodeficiency_NN virus_NN type_NN 1_CD long_JJ terminal_JJ repeats_NN ,_, reflecting_NN p100-mediated_NN cytoplasmic_JJ sequestration_NN of_IN the_DT normally_JJ nuclearly_NN expressed_VBN Tax_NN protein_NN ._NN
The_DT inhibitor_NN also_RB dramatically_NN inhibited_VBN monocyte_NN chemotactic_NN activity_NN of_IN and_CC MCP-1_NN production_NN by_IN the_DT cells_NNS ._NN
Spi-B_JJ and_CC PU.1_NN are_VBP hematopoietic-specific_JJ transcription_NN factors_NNS that_WDT constitute_VBP a_DT subfamily_NN of_IN the_DT Ets_NN family_NN of_IN DNA-binding_JJ proteins_NNS ._NN
We_PRP have_VBP investigated_VBN whether_IN a_DT palmitate_JJ conjugate_NN of_IN a_DT human_JJ monoclonal_NN antibody_NN specific_JJ for_IN thyroglobulin_DT TG_NN could_MD function_VB as_IN a_DT surrogate_NN TG_NN receptor_NN on_IN blood_NN mononuclear_JJ cells_NNS separated_NN into_NN fractions_NN enriched_NN for_IN T_NN cells_NNS or_CC depleted_JJ of_IN T_NN cells_NNS non-T_JJ cells_NNS ._NN
Phorbol_NN esters_NNS are_VBP required_VBN to_TO induce_VB cell-surface_JJ expression_NN as_IN well_RB as_IN for_IN triggering_NN the_DT proliferation_NN of_IN T_NN cells_NNS in_IN conjunction_NN with_IN anti-AIM_NN mAb_NN ._NN
The_DT affinity_NN of_IN the_DT BAT_NN box_NN binding_NN proteins_NNS for_IN the_DT BAT_NN box_NN was_VBD approximately_RB 25-fold_VB less_RBR than_IN for_IN the_DT octamer_NN sequence_NN and_CC the_DT BAT_NN box_NN binding_NN proteins_NNS dissociated_VBD from_IN the_DT BAT_NN box_NN 10-fold_CD more_RBR rapidly_JJ than_IN from_IN the_DT octamer_NN sequence_NN ._NN
Although_IN NFAT_NN has_VBZ been_VBN recently_VBN shown_VBN to_TO be_VB inducible_JJ in_IN several_JJ non-T_JJ immune_NN cells_NNS ,_, the_DT NFAT_NN gene_NN family_NN members_NNS characterized_VBN to_TO date_NNS have_VBP been_VBN isolated_VBN only_RB from_IN T_NN cells_NNS ._JJ
Induction_NN of_IN vascular_NN cell_NN adhesion_NN molecule-1_NN by_IN low-density_JJ lipoprotein_NNS ._NN
Thus_RB ,_, signaling_JJ in_IN NK3.3_NN cells_NNS is_VBZ not_RB always_VBN identical_NN with_IN that_IN in_IN primary_JJ NK_NN cells_NNS ._JJ
was_VBD found_VBN to_TO be_VB hyposialylated_NN ,_, bearing_VBG predominantly_JJ O-linked_NN monosaccharide_NN glycans_NN ,_, whereas_IN bore_NN complex_NN sialylated_NN tetra-_NN and_CC hexasaccharide_NN chains_NN ._NN
The_DT experiments_NNS in_IN this_DT report_NN show_VBP that_IN cysteine_NN or_CC N-acetylcysteine_NN NP_NN raise_NN the_DT intracellular_JJ glutathione_NN GSH_NN level_NN and_CC inhibit_VBP HIV-1_NN replication_NN in_IN persistently_JJ infected_NN Molt-4_NN and_CC U937_NN cells_NNS ._JJ
3_NN ._NN Initial_NN and_CC post-dexamethasone_NN in_IN vitro_FW fibroblast_NN binding_NN to_TO glucocorticoid_NN was_VBD not_RB different_JJ between_IN major_JJ depressive_NN disorder_NN and_CC non-depressed_JJ control_NN subjects_NNS ._JJ
Using_NN electrophoretic_JJ mobility_NN shift_NN assays_NNS ,_, we_PRP find_VBP that_IN TPCK_NN virtually_NN abolishes_NN to_TO less_NNS than_IN 1_CD the_DT levels_NNS of_IN NF-LRB-kappa-RRB-B_NN but_CC not_RB Oct-1_NN found_VBN in_IN nuclear_JJ and_CC whole_JJ cell_NN extracts_NNS of_IN activated_VBN T_NN cells_NNS ._JJ
In_IN this_DT report_NN ,_, we_PRP demonstrate_VBP that_IN the_DT corresponding_JJ mutations_NNS in_IN murine_JJ calcineurin_NN render_NN the_DT T_NN cell_NN receptor_NN signal_NN transduction_NN cascade_NN CsA_NN resistant_JJ in_IN human_JJ Jurkat_NN T_NN cells_NNS ._JJ
NF-ATn_NN is_VBZ a_DT ubiquitous_JJ protein_NN ,_, can_MD be_VB synthesized_NN in_IN response_NN to_TO PMA_NN ,_, and_CC has_VBZ many_JJ similarities_NNS to_TO AP-1_NN ._NN
The_DT functional_JJ domains_NN of_IN HS-40_NN were_VBD also_RB mapped_JJ ._NN
Measurement_NN of_IN GR_NN mRNA_NN turnover_NN in_IN 6TG1.1_NN cells_NNS treated_NN with_IN actinomycin-D_NN revealed_VBD a_DT half-life_NN of_IN 2.5_CD h_NN ,_, which_WDT was_VBD unaffected_JJ by_IN dexamethasone_NN treatment_NN ._NN
It_PRP is_VBZ very_RB likely_IN that_IN these_DT domains_JJ bind_NN megakaryocyte-specific_NN nuclear_JJ proteins_NNS acting_NN as_IN positive_JJ transcription_NN factors_NNS ._JJ
The_DT proband_NN had_VBD no_DT detectable_JJ DPD_NN activity_NN ._NN
The_DT proto-oncoprotein_NN c-Rel_NN is_VBZ a_DT member_NNS of_IN the_DT nuclear_JJ factor_NN kappa_NN B_NN transcription_NN factor_NN family_NN ,_, which_WDT includes_VBP the_DT p50_NN and_CC p65_NN subunits_NNS of_IN nuclear_JJ factor_NN kappa_NN B_NN ._NN
In_IN addition_NN ,_, the_DT product_NN of_IN the_DT proto-oncogene_NN c-rel_NN can_MD bind_VB to_TO similar_JJ DNA_NN motifs_NNS by_IN itself_NN or_CC as_IN a_DT heterodimer_NN with_IN p50_NN or_CC p65_NN ._NN
This_DT is_VBZ the_DT first_JJ documented_NN case_NN of_IN female_NN twins_NNS discordant_VBD for_IN Fabry_NN disease_NN ._NN
Treatment_NN of_IN chronically_NN HIV-infected_NN PBMC_NN with_IN anti-CD2_NN mAb_NN has_VBZ been_VBN shown_VBN to_TO induce_VB the_DT expression_NN of_IN infectious_JJ virus_NN from_IN these_DT cultures_NNS ._NN
Such_NN transcription_NN factors_NNS play_NNS a_DT key_JJ role_NN in_IN the_DT development_NN of_IN the_DT mature_JJ T-cell_NN phenotype_NN by_IN functioning_JJ as_IN master_NN regulators_NN of_IN T-cell_NN differentiation_NN ._NN
Characterization_NN of_IN the_DT human_JJ myeloid_JJ cell_NN nuclear_JJ differentiation_NN antigen_NN gene_NN promoter_NN ._NN
Increased_IN natural_NN killer_NN cell_NN activity_NN correlates_NN with_IN low_JJ or_CC negative_JJ expression_NN of_IN the_DT oncogene_NN in_IN patients_NNS with_IN breast_JJ cancer_NN ._NN
SRC-related_NN proto-oncogenes_NNS and_CC transcription_NN factors_NNS in_IN primary_JJ human_JJ T_NN cells_NNS :_: modulation_NN by_IN cyclosporin_NN A_NN and_CC FK506_NN ._NN
However_RB ,_, specific_JJ function_NN in_IN these_DT processes_NN has_VBZ not_RB been_VBN clearly_RB defined_VBN ._NN
The_DT involvement_JJ of_IN p21-LRB-ras-RRB-_NN in_IN the_DT regulation_NN of_IN calcium-dependent_JJ signals_NNS has_VBZ been_VBN suggested_VBD through_IN analysis_NN of_IN role_NN in_IN the_DT activation_NN of_IN NF-AT_NN ._NN
The_DT Thy-1_NN gene_NN promoter_NN resembles_NN a_DT housekeeping_NN promoter_NN in_IN that_IN it_PRP is_VBZ located_JJ within_IN a_DT methylation-free_JJ island_NN ,_, lacks_VBG a_DT canonical_JJ TATA_NN box_NN ,_, and_CC displays_JJ heterogeneity_NN in_IN the_DT termini_JJ of_IN the_DT mRNA_NN ._NN
Here_RB we_PRP demonstrate_VBP that_IN hexamethylene_NN bisacetamide_NN HMBA_NN induced_VBD K562_NN cells_NNS to_TO differentiate_VB along_NN a_DT third_DT pathway_NN ._NN
We_PRP have_VBP investigated_VBN the_DT constitutive_JJ and_CC inducible_JJ transcriptional_JJ activity_NN mediated_VBN by_IN five_NN kappa_NN B-related_JJ sequence_NN elements_NNS in_IN two_CD different_JJ cell_NN types_NNS ._JJ
However_RB ,_, X_NN failed_NN to_TO react_VB with_IN a_DT variety_NN of_IN antibodies_NNS against_IN Rb_NN or_CC p107_NN ,_, implicating_NN the_DT involvement_VBN of_IN an_DT E1A-binding_NN protein_NN other_JJ than_IN Rb_NN or_CC p107_NN ._NN
Nuclear_JJ factor_NN kappa_NN B_NN NF-kappa_NN B_NN ;_NN heterodimer_NN of_IN p50_NN and_CC p65_NN proteins_NNS have_VBP been_VBN suggested_VBD to_TO play_VB an_DT important_JJ role_NN in_IN gene_NN transcription_NN of_IN inflammatory_JJ mediators_NNS when_WRB monocytes_NNS are_VBP stimulated_VBN with_IN lipopolysaccharide_NN ._NN
The_DT latter_NN defect_NN may_MD provide_VB an_DT explanation_NN for_IN many_JJ of_IN the_DT XP_NN and_CC CS_JJ symptoms_NNS that_WDT are_VBP difficult_JJ to_TO rationalize_VB based_JJ solely_NN on_IN an_DT NER_NN defect_NN ._NN
Much_JJ attention_JJ has_VBZ recently_NN focused_NN on_IN the_DT observation_NNS that_IN UV_NN light_NN can_MD activate_VB the_DT long_JJ terminal_JJ repeat_NN LTR_NN of_IN the_DT human_JJ immunodeficiency_NN virus_NN HIV_NN ._NN
These_DT results_NNS indicate_VBP that_IN E3_NN is_VBZ a_DT hematopoietic-specific_JJ gene_NN that_WDT is_VBZ an_DT immediate_JJ target_NN for_IN the_DT activated_VBN RAR_NN alpha_NN during_IN myelopoiesis_NN ._NN
Structure-function_RB studies_NNS of_IN the_DT GATA-1_NN protein_NN could_MD be_VB greatly_NNS simplified_JJ and_CC a_DT larger_NN number_NN of_IN mutants_NNS studied_VBN ._NN
T_NN cell_NN proliferation_NN was_VBD induced_VBN by_IN three_CD peptides_NN ,_, P1_NN ,_, P4_NN ,_, and_CC P7_NN ,_, in_IN 71-100_NN of_IN the_DT donors_JJ tested_NN before_NN and_CC after_IN vaccination_NN using_VBG DC_NN as_IN APC_NN ._NN
We_PRP further_JJ demonstrate_VBP the_DT impact_JJ of_IN platelet-activating_NNS factor_NN binding_NN to_TO B_NN cells_NNS by_IN measuring_NN platelet-activating_NN factor_NN induced_VBD arachidonic_JJ acid_NN release_NN and_CC 5-hydroxyeicosatetraenoic_NN acid_NN production_NN ._NN
The_DT half-life_NN of_IN c-jun_NN mRNA_NN was_VBD similar_JJ 45-50_NN min_NN in_IN both_DT untreated_JJ and_CC okadaic_JJ acid-induced_NN cells_NNS ._JJ
In_IN contrast_NN ,_, there_DT was_VBD no_DT regulation_NN by_IN glucocorticoids_NNS of_IN either_CC the_DT CD8_NN or_CC CD4_NN antigens_NNS in_IN the_DT leukemic_JJ clone_NN CEM_NN C1_NN ._NN
Rhom-2_NN mRNA_NN is_VBZ expressed_VBN in_IN early_JJ mouse_NN development_NN in_IN central_JJ nervous_NNS system_NN ,_, lung_NN ,_, kidney_NN ,_, liver_NN ,_, and_CC spleen_NN but_CC only_RB very_RB low_JJ levels_NNS occur_VBZ in_IN thymus_JJ ._NN
In_IN 1991_NN ,_, we_PRP demonstrated_VBD ,_, using_VBG electrophoretic_JJ mobility_NN shift_NN assays_NNS ,_, that_IN 3_NN different_JJ factors_NNS termed_VBN B1_NN ,_, B2_NN and_CC B3_NN with_IN affinity_NN for_IN the_DT KB-enhancer_NN target_NN sequence_NN were_VBD specifically_RB detected_VBN in_IN nuclear_JJ extracts_NNS from_IN HIV1-infected_NN monocytes_NNS and_CC macrophages_JJ ._NN
In_IN this_DT study_NN ,_, we_PRP demonstrate_VBP that_IN HTLV-I_NN Tax_NN can_MD physically_NN associate_VBN with_IN p100_NN ,_, the_DT product_NN of_IN the_DT Rel-related_NN NF-kappa_NN B2_NN gene_NN ,_, both_CC in_IN transfected_NN cells_NNS and_CC in_IN HTLV-I-infected_NN leukemic_JJ T-cell_NN lines_NNS ._JJ
Estrogen_NN receptor_NN positive_JJ :_NN MCF-7_NN and_CC negative_JJ ER-_NN :_: MDA-MB-231_NN human_JJ breast_NN cancer_MD cell_NN lines_NNS were_VBD utilized_NN to_TO evaluate_VB the_DT effects_NNS of_IN tamoxifen_NN TAM_NN and_CC estradiol_NN E2_NN on_IN modulation_NN of_IN breast_JJ cancer_NN target_NN susceptibility_NN to_TO lysis_NN by_IN lymphokine-activated_JJ killer_NN LAK_NN cells_NNS ._JJ
Thus_RB ,_, autoreactive_JJ T-cells_NN identify_NN a_DT novel_JJ antigen_NN ,_, p38_NN jun-B_NN ,_, in_IN IDDM_NN and_CC appear_VBP to_TO indicate_VBP subjects_NNS at_IN risk_NN for_IN the_DT development_NN of_IN clinical_JJ disease_NN ._NN
Results_NN of_IN preliminary_JJ studies_NNS ,_, many_JJ of_IN which_WDT were_VBD conducted_NN by_IN Dr._NN Dezube_NN ,_, suggest_VBG that_IN use_NN of_IN this_DT agent_NN in_IN combination_NN with_IN antiretroviral_NN compounds_NNS may_MD prove_VB useful_NN in_IN the_DT treatment_NN of_IN patients_NNS with_IN HIV-1_NN infection_NN
However_RB ,_, activation_NN of_IN the_DT T_NN cell_NN lines_NNS leading_VBG to_TO enhanced_NN HIV-1_NN replication_NN can_MD be_VB induced_VBN by_IN antigens_JJ ,_, mitogens_NNS ,_, and_CC cytokines_NN tumor_NN necrosis_NN factor_NN alpha_NN TNF-alpha_NN ,_, interleukin_NN 1_CD ,_, and_CC interleukin-2_NN ._NN
Cell_NN activation_NN resulted_VBD in_IN a_DT delayed_NN induction_NN of_IN STAT_NN DNA-binding_JJ activity_NN ,_, which_WDT was_VBD sustained_JJ for_IN several_JJ days_NN ,_, was_VBD composed_JJ predominantly_JJ of_IN Stat1_NN and_CC Stat3_NN ,_, and_CC was_VBD blocked_VBD by_IN cycloheximide_NN and_CC actinomycin_NN D_NN ._NN
Glucocorticoid-mediated_NN inhibition_NN of_IN RANTES_NN expression_NN in_IN human_JJ T_NN lymphocytes_NNS ._JJ
Jurkat_NN cells_NNS were_VBD transfected_VBN with_IN plasmids_NNS containing_VBG either_CC the_DT intact_JJ IL-2_NN promoter_NN or_CC AP-1_NN ,_, NF-AT_NN ,_, and_CC NF-kB_NN motifs_NNS ._JJ
The_DT presence_JJ of_IN an_DT AP-1_NN protein_NN in_IN the_DT NF-AT_NN protein_NN complex_NN may_MD regulate_VB NF-AT-binding_NN activity_NN through_IN protein-protein_NN interaction_NN ._NN
Estrogens_NN and_CC anti-estrogens_NN enhance_NN the_DT number_NN of_IN immunoglobulin_NN Ig_NN -secreting_NN cells_NNS in_IN pokeweed_JJ mitogen_NNS PWM_NN -stimulated_NN lymphocyte_NN cultures_NNS ._JJ
First_NN ,_, Tax_NN was_VBD found_VBN to_TO interact_VBP with_IN the_DT 35-kDa_NN alpha_NN subunit_NN of_IN TFIIA_NN in_IN the_DT yeast_JJ two-hybrid_NN interaction_NN system_NN ._NN
The_DT results_NNS are_VBP discussed_RB in_IN the_DT context_NN of_IN a_DT model_NN relating_NN the_DT two_CD nuclear_JJ NF-AT_NN complexes_NNS to_TO NF-ATp_NN ._NN
Here_RB we_PRP report_NN that_IN tepoxalin_NN selectively_NN inhibits_VBZ intercellular_JJ adhesion_NN molecule-1_NN ICAM-1_NN ,_, CD54_NN dependent_JJ adhesion_NN of_IN polymorphonuclear_JJ cells_NNS to_TO IL-1_NN activated_VBN human_JJ umbilical_JJ vein_NN endothelial_JJ cells_NNS ._NN
Therefore_RB oxygen_JJ therapy_NN is_VBZ helpful_NN in_IN raising_NN the_DT activity_NN of_IN glucocorticoid_NN receptors_NNS and_CC controlling_NNS the_DT development_NN of_IN the_DT disease_NN ._NN
Acquired_NN immunodeficiency_NN syndrome_NN AIDS_NN results_NNS from_IN infection_NN with_IN a_DT human_JJ immunodeficiency_NN virus_NN HIV_NN ._NN
In_IN this_DT study_NN we_PRP analyzed_VBD the_DT T_NN cell_NN receptor_NN TcR_NN delta_NN transcripts_NNS expressed_VBN by_IN cells_NNS and_CC we_PRP investigated_VBN whether_IN these_DT cells_NNS expressed_VBN the_DT hGATA-3_JJ T_NN cell_NN transcription_NN factor_NN and_CC the_DT recombination-activating_NN gene_NN RAG_NN -1_NN ._NN
The_DT first_JJ objective_NN of_IN this_DT study_NN was_VBD to_TO determine_VB whether_IN human_JJ DC_NN mediate_NN in_IN vitro_FW sensitization_JJ of_IN naive_NN T_NN cells_NNS to_TO epitopes_NN of_IN the_DT immediate_JJ early_JJ 62_NN IE62_NN protein_NN of_IN varicella_JJ zoster_NN virus_NN VZV_NN ._NN
Here_RB we_PRP show_VBP that_IN phorbol_NN ester_NN treatment_NN also_RB abolishes_JJ induction_NN of_IN chloramphenicol_NN acetyltransferase_NN activity_NN in_IN Ar-5_NN cells_NNS transfected_VBN with_IN a_DT plasmid_NN containing_VBG the_DT IL-2_NN promoter_NN linked_NNS to_TO this_DT reporter_NN gene_NN ._NN
IL-12_NN is_VBZ a_DT powerful_JJ skewer_NN of_IN T_NN cell_NN responses_NNS toward_IN the_DT Th1_NN phenotype_NN by_IN inducing_VBG IFN-gamma_NN production_NN in_IN naive_NN Th_NN cells_NNS ._JJ
Using_NN this_DT assay_NN ,_, we_PRP have_VBP detected_VBN NF_NN kappa_NN B_NN in_IN extracts_NNS of_IN nuclei_NNS from_IN normal_JJ human_JJ monocytes_NNS ._NN
These_DT data_NNS support_VBP the_DT view_NN of_IN an_DT impaired_JJ ligand-induced_NN plasticity_NN of_IN glucocorticoid_NN receptor_NN regulation_NN rather_NN than_IN the_DT hypothesis_NN of_IN decreased_NN glucocorticoid_NN receptor_NN numbers_NN during_IN depression_JJ ._NN
The_DT emergence_NN of_IN nuclear_JJ binding_NN proteins_NNS was_VBD investigated_VBN using_VBG interleukin-2_NN sequence_NN specific_JJ oligonucleotide_NN probes_NN in_IN the_DT electrophoretic_JJ mobility_NN shift_NN assay_NN ._NN
We_PRP demonstrated_VBD that_IN CMV_NN infection_NN increased_VBD both_CC IL-6_NN protein_NN and_CC mRNA_NN in_IN peripheral_JJ blood_NN mononuclear_JJ cells_NNS ._NN
Naive_NN T_NN lymphocytes_NNS are_VBP more_RBR sensitive_JJ to_TO oxidative_JJ stress-induced_NN signals_NNS than_IN memory_NNS cells_NNS ._NN
Selective_JJ effects_NNS of_IN DNA_NN damaging_NN agents_NNS on_IN HIV_NN long_JJ terminal_JJ repeat_NN activation_NN and_CC virus_NN replication_NN in_IN vitro_FW ._NN
We_PRP have_VBP now_RB examined_VBN expression_NN of_IN the_DT mouse_NN E2A_NN gene_NN at_IN the_DT protein_NN level_NN using_VBG polyclonal_NN antisera_NN directed_VBZ against_IN distinct_JJ portions_NN of_IN the_DT E2A_NN protein_NN to_TO probe_NN blots_NN of_IN cellular_JJ extracts_NNS ._NN
In_IN contrast_NN ,_, TGF-beta_NN had_NNS only_RB minimal_JJ effects_NNS on_IN two_CD other_JJ B_NN cell_NN membrane_NNS proteins_NNS ,_, HLA-DR_NN and_CC CD20_NN ._NN
Concomitant_JJ stimulation_NN by_IN VitD3_NN inhibited_VBD the_DT RA-stimulated_NN formation_NN of_IN RAR_NN heterodimers_NN ,_, favoring_NN binding_NN to_TO the_DT RARE_NN ._NN
Since_JJ recent_NN studies_NNS have_VBP shown_VBN that_IN lipopolysaccharide-induced_NN tyrosine_NN kinase_NN activation_NN is_VBZ not_RB required_VBN for_IN NFkappaB_NN nuclear_JJ translocation_NN ,_, we_PRP sought_NN to_TO determine_VB whether_IN NFkappaB_NN translocated_NN in_IN the_DT absence_NN of_IN tyrosine_NN kinase_NN activity_NN was_VBD active_JJ in_IN stimulating_NNS transcription_NN ._NN
Although_IN both_CC viruses_RB establish_JJ latency_NN in_IN quiescent_JJ human-peripheral-blood_JJ T_NN cells_NNS ,_, the_DT asymptomatic_JJ phase_NN of_IN HIV-2_NN infection_NN may_MD be_VB more_RBR prolonged_JJ than_IN that_IN of_IN HIV-1_NN ._NN
These_DT results_NNS show_VBP that_IN ,_, physiologically_JJ ,_, high_JJ levels_NNS of_IN nuclear_JJ of_IN p50_NN ,_, p52_NN and_CC RelB_NN are_VBP restricted_JJ to_TO accessory_JJ cells_NNS of_IN the_DT immune_JJ system_NN ,_, which_WDT include_VBP FDC_NN in_IN GC_NN ,_, and_CC DC_NN and_CC macrophages_NN in_IN the_DT T_NN cell_NN zone_NN ,_, that_IN specialized_JJ scavenger_NN macrophages_NN from_IN GC_NN do_NN not_RB have_VBP detectable_JJ levels_NNS of_IN p52_NN and_CC RelB_NN ,_, whereas_IN macrophages_JJ from_IN the_DT T_NN cell_NN area_VBP ,_, known_VBN to_TO present_JJ the_DT antigen_NN to_TO T_NN cells_NNS ,_, do_JJ have_VBP both_CC nuclear_JJ p52_NN and_CC RelB_NN ,_, and_CC that_IN in_IN the_DT T_NN cell_NN zone_NN ,_, p52_NN and_CC RelB_NN are_VBP located_JJ in_IN nuclei_NNS of_IN both_DT ,_, or_CC both_CC ,_, cells_NNS APC_NN ,_, whereas_IN p50_NN is_VBZ restricted_JJ to_TO CD1a-_NN and_CC CD68-_NN APC_NN ._NN
Functional_JJ interaction_NN between_IN the_DT two_CD zinc_NN finger_NN domains_NNS of_IN the_DT v-erb_NN A_NN oncoprotein_NN ._NN
Susceptibility_NN of_IN these_DT transformed_NN cell_NN lines_NNS to_TO NK_NN cells_NNS was_VBD determined_VBN by_IN cytolytic_JJ assays_NNS ._NN
This_DT is_VBZ most_RBS likely_IN due_JJ to_TO the_DT presence_JJ of_IN the_DT lymphoid-specific_JJ OTF-2_NN factor_NN ._NN
v-erbA_NN overexpression_NN is_VBZ required_VBN to_TO extinguish_VB c-erbA_NN function_NN in_IN erythroid_JJ cell_NN differentiation_NN and_CC regulation_NN of_IN the_DT erbA_JJ target_NN gene_NN CAII_NN ._NN
Sterol_NN dependent_JJ LDL-receptor_NN gene_NN transcription_NN in_IN lymphocytes_NNS from_IN normal_JJ and_CC CML_NN patients_NNS ._JJ
Purified_NN NF-kB_NN is_VBZ also_RB able_JJ to_TO bind_VB to_TO the_DT TCEd_NN ,_, but_CC TCF-1_NN binds_VBZ stronger_JJR than_IN NF-kB_NN to_TO TCEd_NN DNA_NN ._NN
Cytomegalovirus_NN modulates_VBZ interleukin-6_JJ gene_NN expression_NN ._NN
The_DT results_NNS of_IN the_DT present_JJ study_NN demonstrate_VBP that_IN dysfunction_NN of_IN these_DT genes_NNS also_RB occurs_VBZ during_IN recurrence_NN of_IN glial_JJ tumors_NNS that_WDT were_VBD highly_JJ malignant_NN at_IN first_JJ presentation_JJ ._NN
2_CD ._NN These_DT two_CD types_NNS of_IN estrogen_JJ binding_NN sites_NNS existed_VBP in_IN human_JJ peripheral_JJ blood_NN monocytes_NNS ._JJ
The_DT GCR_NN binding_NN affinity_NN for_IN budesonide_NN was_VBD significantly_RB higher_JJ in_IN both_CC groups_NNS i.e._NN ,_, lower_JJR dissociation_NN constant_NN than_IN that_IN obtained_VBN for_IN dexamethasone_NN ._NN
Further_RB deletional_NN and_CC alanine_NN mutagenesis_NN analyses_NNS and_CC comparison_NNS with_IN TRAF_NN binding_NN sequences_NNS in_IN CD40_NN ,_, in_IN CD30_NN ,_, and_CC in_IN the_DT LMP1_NN of_IN other_JJ lymphycryptoviruses_NN provide_NN the_DT first_JJ evidence_NN that_WDT is_VBZ a_DT core_NN TRAF_NN binding_NN motif_NN ._NN
The_DT hepatitis_NN B_NN virus_NN genome_NN encodes_VBZ a_DT transcriptional_JJ transactivator_NN protein_NN designated_NN HBxAg_NN ._NN
Differences_NN in_IN pre-_JJ and_CC postoperative_JJ values_NN of_IN cancer_NN patients_NNS were_VBD seen_JJ in_IN plasma_NN RIA_NN values_NN :_: PGE2_NN and_CC 6-k-PGF1_NN alpha_NN were_VBD significantly_RB higher_JJ preoperatively_JJ when_WRB compared_VBN with_IN postoperatively_JJ ,_, however_NN ,_, such_JJ differences_NN were_VBD seen_JJ in_IN the_DT control_NN groups_NNS as_IN well_RB ._NN
The_DT purified_VBN NF-GM2_NN activated_VBN in_IN vitro_FW transcription_NN from_IN the_DT kappa_NN B_NN enhancer_NN ,_, while_IN it_PRP failed_VBD to_TO stimulate_VB transcription_NN from_IN the_DT GM-CSF_NN promoter_NN harboring_NN the_DT GM2_NN sequence_NN ._NN
NF-E1_NN is_VBZ encoded_VBN by_IN the_DT same_JJ gene_NN as_IN the_DT YY-1_NN protein_NN ,_, which_WDT binds_VBZ to_TO the_DT adeno-associated_NN virus_NN P5_NN promoter_NN ._NN
Circadian_NN rhythm_NN in_IN glucocorticoid_NN receptor_NN GR_NN was_VBD studied_VBN in_IN the_DT rat_NN liver_NN and_CC human_JJ peripheral_JJ leukocytes_NNS ._NN
Starting_NN with_IN a_DT replication-incompetent_NN molecular_JJ clone_NN of_IN human_JJ immunodeficiency_NN virus_NN type_NN 1_CD ,_, lacking_VBG all_DT the_DT NF-kappa_NN B_NN and_CC Sp1_NN binding_NN sites_NNS present_JJ in_IN the_DT native_NN long_JJ terminal_JJ repeat_NN LTR_NN ,_, proviruses_NN containing_VBG reconstructed_NN LTRs_NN with_IN individual_JJ or_CC combinations_JJ of_IN NF-kappa_NN B_NN and_CC Sp1_NN elements_NNS were_VBD generated_VBN and_CC evaluated_VBD for_IN capacity_NN to_TO produce_NNS virus_NN progeny_NN following_VBG transfection-cocultivation_NN ._NN
In_IN preincubated_JJ cells_NNS ,_, the_DT cycloheximide_NN response_NN is_VBZ decreased_VBN ,_, especially_JJ in_IN the_DT case_NN of_IN FOSB_NN ._NN
Native_NN PTF_NN beta_IN ,_, in_IN either_CC protein_NN fractions_NN or_CC a_DT PTF-Oct-1-DNA_NN complex_NN ,_, can_MD be_VB recognized_NN by_IN polyclonal_JJ antibodies_NNS raised_NN against_IN recombinant_NN PTF_NN beta_NN ._NN
For_NN all_DT other_JJ arginine_NN mutations_NNS ,_, no_DT differences_JJ in_IN affinity_VBG were_VBD detectable_JJ ._NN
If_NN GATA-1-_NN -red_NN cells_NNS were_VBD available_JJ ,_, the_DT analyses_NNS would_VBP involve_VBN the_DT actual_JJ transcription_NN of_IN or_CC chromatin_NN structure_NN surrounding_NN the_DT globin_NN genes_NNS ._JJ
These_DT results_NNS indicate_VBP that_IN activation_NN of_IN c-fos_NN is_VBZ involved_VBN in_IN IL_NN 6-induced_NN differentiation_NN of_IN SKW_NN 6.4_NN cells_NNS into_IN IgM-secreting_NN cells_NNS ._JJ
Here_RB we_PRP report_NN that_IN both_DT IL-4_NN and_CC IL-13_NN share_NN signaling_NN events_NNS in_IN human_JJ colon_NN carcinoma_NNS cell_NN lines_NNS HT-29_NN and_CC WiDr_NN ._NN
First_NN ,_, it_PRP gives_NN no_DT information_NN on_IN memory_NNS to_TO lytic_JJ cycle_NN antigens_NNS ;_: second_JJ ,_, it_PRP preferentially_VBP amplifies_VBN the_DT dominant_JJ components_NNS of_IN latent_NN antigen-specific_NN memory_NNS at_IN the_DT expense_NN of_IN key_JJ subdominant_NN reactivities_NN ._NN
Transfection_JJ of_IN an_DT AP-2_NN expression_NN construct_NN into_NN T-lymphocytes_NN activated_VBN gene_NN expression_NN from_IN the_DT HTLV-I_NN LTR_NN ._NN
The_DT kinetics_NN of_IN expression_NN of_IN the_DT two_CD genes_NNS were_VBD also_RB slightly_RB different_JJ ,_, with_IN c-fos_NN mRNA_NN reaching_NN a_DT peak_NN at_IN 15_NN min_NN after_IN stimulation_NN and_CC c-jun_NN at_IN 30_CD min_NN ._NN
c-myc_NN protooncogene_NN is_VBZ implicated_VBN in_IN the_DT pathogenesis_NN of_IN B_NN cell_NN lymphoid_JJ malignancies_NN and_CC high_JJ levels_NNS of_IN c-myc_NN mRNA_NN expression_NN are_VBP observed_VBN in_IN activated_VBN blood_NN mononuclear_JJ cells_NNS ._NN
Lymphocyte_NN glucocorticoid_NN receptor_NN number_NN in_IN posttraumatic_JJ stress_NN disorder_NN ._NN
Differential_JJ autoregulation_NN of_IN glucocorticoid_NN receptor_NN expression_NN in_IN human_JJ T-_NN and_CC B-cell_NN lines_NNS ._JJ
However_RB ,_, inhibition_NN of_IN HIV-1_NN replication_NN appears_VBZ not_RB to_TO be_VB directly_RB correlated_NN with_IN GSH_NN levels_NNS ._JJ
In_IN 19_NN patients_NNS with_IN a_DT malignant_JJ breast_NN tumor_NN ,_, tumor_NN tissue_NNS and_CC blood_NN were_VBD taken_VBN to_TO determine_VB the_DT eicosanoid_NN profile_NN and_CC platelet_NN aggregation_NN ._NN
G0S24_NN is_VBZ a_DT member_NNS of_IN a_DT set_JJ of_IN genes_NNS putative_JJ switch_NN regulatory_JJ genes_NNS that_WDT are_VBP expressed_VBN transiently_RB within_IN 1-2_NN hr_NN of_IN the_DT addition_NN of_IN lectin_NN or_CC cycloheximide_NN to_TO human_JJ blood_NN mononuclear_JJ cells_NNS ._NN
We_PRP report_NN on_IN the_DT CTL_NN recognition_NN of_IN a_DT MHC_NN class_NN I-restricted_NN peptide_NN containing_VBG a_DT cyclized_JJ asparagine_NN succinimide_JJ residue_NN ._NN
Since_JJ induction_NN of_IN the_DT IL-2_NN receptor_NN alpha_NN subunit_NN is_VBZ a_DT hallmark_NN of_IN lymphocyte_NN activation_NN ,_, we_PRP suggest_VBP that_IN p21ras_NN naturally_NN triggers_NN B_NN cell_NN activation_NN ._NN
Regulation_NN of_IN glucocorticoid_NN receptor_NN GR_NN expression_NN by_IN cognate_JJ ligand_NN was_VBD examined_VBN in_IN the_DT glucocorticoid-sensitive_JJ human_JJ leukemic_NN T-cell_NN line_NN 6TG1.1_NN and_CC in_IN the_DT human_JJ B-cell_NN line_NN IM-9_NN ._NN
Induced_NN myeloid_JJ differentiation_NN of_IN K562_NN cells_NNS with_IN downregulation_NN of_IN erythroid_JJ and_CC megakaryocytic_JJ transcription_NN factors_NNS :_: a_DT novel_JJ experimental_NN model_NN for_IN hemopoietic_JJ lineage_NN restriction_NN ._NN
corresponding_VBG plasma_NN cortisol_NN levels_NNS were_VBD assessed_VBN ._NN
Changes_NN in_IN leucocytic_JJ estrogen_NN receptor_NN levels_NNS in_IN patients_NNS with_IN gynecomastia_NN
Egr-1_NN mRNA_NN expression_NN induced_VBD by_IN sIgM-_JJ and_CC sIgD-crosslinking_JJ was_VBD inhibited_VBN by_IN H7_NN ,_, erbstatin_NN and_CC genistein_NN ,_, but_CC not_RB by_IN HA1004_NN ._NN
Low-density_NN lipoprotein_NN LDL_NN is_VBZ a_DT well-established_RB risk_NN factor_NN for_IN atherosclerosis_NN ._NN
Activation_NN of_IN T_NN cells_NNS by_IN antigen_NN ,_, lectin_NN ,_, or_CC a_DT combination_NN of_IN phorbol-12-myristate_NN acetate_NN PMA_NN and_CC calcium_NN ionophore_NN A23187_NN leads_NN to_TO the_DT induction_NN of_IN genes_NNS for_IN a_DT set_NN of_IN lymphokines_JJ ,_, including_VBG granulocyte-macrophage_JJ colony-stimulating_JJ factor_NN GM-CSF_NN ._NN
We_PRP have_VBP found_VBN that_IN the_DT basic_JJ domains_NN of_IN all_DT the_DT myogenic_NN factors_NNS remain_RB unaltered_JJ in_IN rhabdomyosarcomas_NN ._NN
The_DT mechanism_NN by_IN which_WDT NF-ATc_NN enters_JJ the_DT nucleus_NN is_VBZ unknown_JJ ,_, and_CC although_IN it_PRP appears_VBZ to_TO require_VB calcineurin_NN ,_, NF-ATc_NN has_VBZ not_RB yet_JJ been_VBN shown_VBN to_TO be_VB an_DT in_IN vivo_NN substrate_NNS of_IN calcineurin_NN ._NN
A_DT 2-4-fold_NN increase_NN in_IN IFN-beta_NN promoter_NN transcription_NN was_VBD observed_VBN in_IN Sendai_NN virus_NN induced_VBD extracts_VBN ,_, and_CC deletion_NN of_IN PRDI_NN and_CC PRDII_NN elements_NNS decreased_VBN this_DT induced_VBN level_NN of_IN transcription_NN ._NN
Deletion_NN of_IN all_DT the_DT Sp_JJ 1-binding_NN sites_NNS from_IN the_DT enhancer_NN reduces_NN transcription_NN by_IN 80-90_NN in_IN HeLa_NN ,_, as_IN well_RB as_IN in_IN BJA-B_NN cells_NNS ,_, whereas_IN the_DT removal_JJ of_IN the_DT octamer-binding_JJ site_NN reduces_NN transcription_NN to_TO levels_NNS below_VBN detection_VBN in_IN both_CC cell_NN types_NNS ._JJ
Basophils_JJ express_NN GATA-2_NN and_CC GATA-3_NN ._NN
To_TO further_JJ characterize_NN the_DT protein-DNA_NN interactions_NN mediating_NN IFN-beta_NN induction_NN ,_, positive_JJ regulatory_JJ domain_NN PRD_NN II_NN binding_NN proteins_NNS were_VBD purified_VBN from_IN phorbol_NN ester_NN induced_VBD Jurkat_NN T-cells_NN and_CC from_IN IFN_NN primed_JJ ,_, acid_NN treated_NN HeLa_NN S3_NN cells_NNS ._JJ
We_PRP show_VBP that_IN the_DT ability_NN to_TO detect_VB NF-ATp_NN in_IN a_DT gel_NN shift_NN assay_NN ,_, which_WDT is_VBZ essential_NN for_IN purification_JJ and_CC biochemical_JJ studies_NNS of_IN this_DT protein_NN ,_, is_VBZ strikingly_RB dependent_JJ on_IN the_DT precise_JJ sequence_NN of_IN the_DT NF-AT_NN oligonucleotide_NN used_NN as_IN the_DT labeled_NN probe_NN ._NN
We_PRP ,_, therefore_RB ,_, examined_VBN glucocorticoid_NN receptor_NN characteristics_NNS on_IN mononuclear_JJ leukocytes_NNS by_IN measuring_NN -LCB-3H-RCB-dexamethasone_NN binding_NN and_CC the_DT effect_NN of_IN dexamethasone_NN on_IN -LCB-3H-RCB-thymidine_NN incorporation_NN ,_, which_WDT is_VBZ one_CD of_IN the_DT effects_NNS of_IN glucocorticoid_NN receptor_NN activation_NN ._NN
The_DT resultant_JJ primer_JJ products_NNS are_VBP analysed_VBN by_IN denaturing_NN polyacrylamide_NN gel_NN electrophoresis_NN and_CC autoradiography_NN ._NN
We_PRP previously_RB reported_VBN the_DT purification_JJ of_IN human_JJ PTF_NN ,_, a_DT complex_NN of_IN four_JJ subunits_NNS ,_, and_CC the_DT molecular_JJ cloning_NN and_CC characterization_NN of_IN PTF_NN gamma_NN and_CC delta_NN subunits_NNS ._JJ
One_CD of_IN the_DT major_JJ objectives_NN in_IN the_DT study_NN of_IN thrombogenesis_CD is_VBZ to_TO determine_VB the_DT mechanisms_NNS by_IN which_WDT a_DT hematopoietic_JJ progenitor_NN is_VBZ activated_VBN and_CC committed_JJ to_TO the_DT megakaryocytic_JJ lineage_NN ._NN
The_DT anaphylatoxin_NN C3a_NN has_VBZ been_VBN reported_VBN to_TO have_VB immunomodulatory_NN effects_NNS on_IN a_DT number_NN of_IN different_JJ cell_NN types_NNS ._JJ
One_CD HIV-1_NN variant_NNS was_VBD detected_VBN containing_VBG an_DT additional_NN binding_NN site_NN for_IN the_DT transcription_NN factor_NN Sp1_NN ._NN
The_DT microA_NNS motif_NN was_VBD required_VBN for_IN microB-dependent_NN enhancer_NN activity_NN ,_, which_WDT suggests_VBZ that_IN a_DT minimal_JJ B_NN cell-specific_JJ enhancer_NN is_VBZ composed_JJ of_IN both_CC the_DT PU.1_NN and_CC Ets-1_NN binding_NN sites_NNS ._JJ
Characterization_NN of_IN Grb2-binding_NN proteins_NNS in_IN human_JJ platelets_NNS activated_VBN by_IN Fc_NN gamma_NN RIIA_NN cross-linking_NN ._NN
RESULTS_NN ._NN
Propylthiouracil_NN 50_NN did_VBD not_RB affect_VBN the_DT action_JJ of_IN T3SO4_NN ,_, suggesting_VBG that_IN deiodination_NN was_VBD not_RB important_JJ for_IN this_DT activity_NN of_IN T3SO4_NN ._NN
CsA_NN and_CC FK506_NN associate_VBN with_IN intracellular_JJ binding_NN proteins_NNS i.e._JJ ,_, CsA_NN with_IN cyclophilin_NN A_NN and_CC FK506_NN with_IN FKBP12_NN to_TO form_VBP complexes_NNS that_IN suppress_NN the_DT immune_JJ system_NN by_IN preventing_JJ activation_NN of_IN T_NN cells_NNS in_IN response_NN to_TO antigen_NN presentation_NN ._NN
The_DT response_NN to_TO antigen_NN proceeds_NN at_IN the_DT T_NN helper_NN cell_NN level_NN through_IN two_CD independent_NN forms_NNS of_IN cellular_JJ collaboration_NN ,_, contact_NN and_CC lymphokine_NN ._NN
The_DT increased_VBN levels_NNS of_IN these_DT proteins_NNS correlated_JJ with_IN increases_VBG in_IN the_DT amounts_NN of_IN mRNAs_NNS during_IN LPS_NN activation_NN of_IN THP-1_NN cells_NNS ._JJ
The_DT amplified_VBN product_NN showed_VBD an_DT identical_NN nucleotide_NN sequence_NN to_TO the_DT DNA-binding_JJ domain_NN of_IN the_DT human_JJ intestinal_NN receptor_NN ._NN
Therefore_RB the_DT rel-related_NN 65-kD_NN protein_NN may_MD represent_VB the_DT p65_NN subunit_NN of_IN the_DT active_JJ NF-kappa_NN B_NN transcription_NN factor_NN complex_NN ._NN
The_DT KBF1_NN factor_NN ,_, which_WDT binds_VBZ to_TO the_DT enhancer_NN A_NN located_JJ in_IN the_DT promoter_NN of_IN the_DT mouse_NN MHC_NN class_NN I_NN gene_NN H-2Kb_NN ,_, is_VBZ indistinguishable_VBN from_IN the_DT p50_NN DNA_NN binding_NN subunit_NN of_IN the_DT transcription_NN factor_NN NF-kappa_NN B_NN ,_, which_WDT regulates_VBZ a_DT series_JJ of_IN genes_NNS involved_VBN in_IN immune_JJ and_CC inflammatory_JJ responses_NNS ._NN
The_DT tumors_NN showed_VBD high_JJ radiosensitivity_NN ._NN
To_TO address_NN possible_NN mechanisms_NNS that_WDT could_MD explain_VB this_DT selective_NN activity_NN of_IN c-ErbB_NN ,_, we_PRP analyzed_VBD the_DT ability_NN of_IN these_DT receptors_NNS to_TO activate_VB the_DT different_JJ members_NNS of_IN the_DT Stat_NN transcription_NN factor_NN family_NN ._NN
The_DT effect_NN of_IN toremifene_JJ therapy_NN on_IN serum_NN immunoglobulin_NN levels_NNS in_IN breast_JJ cancer_NN ._NN
Despite_NN the_DT widespread_JJ use_NN of_IN glucocorticoids_NNS in_IN the_DT treatment_NN of_IN diseases_JJ characterized_NN by_IN inflammation_NN ,_, the_DT molecular_JJ mechanism_NN s_NN by_IN which_WDT these_DT hormones_NN exert_VBD this_DT beneficial_JJ effect_NN in_IN patients_NNS with_IN asthma_NN remains_NN to_TO be_VB elucidated_VBN ._NN
Acetylsalicylic_NN acid_NN and_CC sodium_NN salicylate_NN inhibit_VBP LPS-induced_JJ NF-kappa_NN nuclear_JJ translocation_NN ,_, and_CC synthesis_NN of_IN tissue_NNS factor_NN TF_NN and_CC tumor_NN necrosis_NN factor_NN alfa_NN TNF-alpha_NN in_IN human_JJ monocytes_NNS ._NN
Thus_RB ,_, there_DT was_VBD a_DT statistically_NN significant_JJ correlation_NN of_IN cytolytic_JJ effector_NNS cell_NN function_NN with_IN expression_NN of_IN the_DT tumor_NN P_NN 0.003_CD ,_, and_CC overexpression_NN correlated_NN with_IN a_DT negative_JJ estrogen_NN receptor_NN status_NN P_NN 0.005_NN ._NN
Tissue-specific_NN expression_NN of_IN the_DT platelet_NN GPIIb_NN gene_NN ._NN
Furthermore_RB ,_, the_DT significance_JJ of_IN the_DT present_JJ study_NN is_VBZ that_IN the_DT T_NN cells_NNS ,_, not_RB the_DT antigen-presenting_NN cells_NNS ,_, are_VBP likely_IN to_TO be_VB the_DT limiting_NN element_NN in_IN the_DT T_NN cell_NN proliferative_NN response_NN to_TO TG_NN and_CC other_JJ thyroid_NN autoantigens_NN ._NN
GM2_NN defines_NN a_DT binding_NN site_NN for_IN protein_NN s_NN binding_NN is_VBZ inducible_JJ by_IN PMA_NN ._NN
Consistent_JJ with_IN these_DT results_NNS ,_, quantitative_JJ DNase_NN footprinting_NN of_IN the_DT TNF-alpha_NN promoter_NN using_VBG increasing_VBG amounts_IN of_IN recombinant_NN NFATp_NN demonstrated_VBD that_IN the_DT -76_NN site_NN binds_VBZ to_TO NFATp_NN with_IN a_DT higher_JJ affinity_NN than_IN the_DT kappa_NN 3_NN site_NN ._NN
To_TO confirm_VB the_DT physiological_JJ relevance_NN of_IN these_DT findings_NN ,_, we_PRP carried_NNS out_NN in_IN vivo_NN footprinting_NN experiments_NNS which_WDT showed_VBD that_IN stimulation_NN of_IN IL-2R_NN alpha_NN expression_NN correlated_NN with_IN occupancy_NN of_IN the_DT GASd_NN element_NN ._NN
ORF1_JJ consists_NN of_IN 240_NN bp_NN that_IN would_NN encode_NN 80_NN amino_NN acids_NN ,_, while_IN the_DT major_JJ ORF2_NN consists_NN of_IN 648_NN bp_NN capable_JJ of_IN coding_VBG for_IN 216_NN amino_NN acids_NN ._NN
Two_CD different_JJ strains_NN of_IN HHV-6_NN ,_, GS_NN and_CC Z29_NN ,_, transactivated_VBN the_DT HIV_NN promoter_NN ._NN
In_IN S107_NN cells_NNS stably_VBP transfected_VBN with_IN relB_NN genes_NNS ,_, stimulation_NN of_IN nuclear_JJ RelB_NN translocation_NN by_IN CD40_NN was_VBD observed_VBN ._NN
These_DT studies_NNS ,_, the_DT first_JJ to_TO demonstrate_VB induction_NN of_IN LT_NN promoter_NN activity_NN over_NN basal_JJ levels_NNS ,_, indicate_VBP that_IN HTLV-I_NN tax_NN causes_VBZ low-level_JJ activation_NN of_IN both_DT endogenous_JJ LT_NN and_CC the_DT LT_NN promoter_NN ,_, at_IN least_VBG in_IN part_NNS through_IN activation_NN of_IN NF-kappa_NN B_NN ._NN
Transcription_JJ factor_NN NF-kappa_NN B_NN is_VBZ generally_JJ localized_JJ to_TO the_DT cytoplasm_NN by_IN inhibitor_NN I_NN kappa_NN B_NN ._NN
The_DT fact_NN that_WDT BCL-6_NN rearrangements_RB identify_VBD biologically_JJ and_CC clinically_JJ distinct_JJ subsets_NNS of_IN DLCL_NN suggests_VBZ that_IN these_DT lesions_NNS may_MD be_VB useful_NN as_IN markers_NNS in_IN selection_NN of_IN differential_JJ therapeutic_NN strategies_NN based_JJ on_IN different_JJ risk_NN groups_NNS ._JJ
Neither_CC IL-10_NN nor_CC IL-4_NN inhibited_VBD LPS-induced_JJ NF-kappa_NN B_NN binding_NN activity_NN ._NN
The_DT study_NN of_IN human_JJ disorders_NN known_VBN as_IN premature_JJ aging_NN syndromes_NN may_MD provide_VB insight_NN into_IN the_DT mechanisms_NNS of_IN cellular_JJ senescence_NN ._NN
T_NN cell_NN blasts_NNS treated_NN with_IN PMA_NN are_VBP now_RB responsive_JJ to_TO IFN-gamma_NN ._NN
The_DT current_NN work_NN describes_NN the_DT regulation_NN of_IN TNF_NN in_IN human_JJ myelomonocytic_NN cell_NN lines_NNS after_IN PMA_NN stimulation_NN ._NN
This_DT probe_NN was_VBD used_VBN to_TO identify_VBN a_DT rel-related_JJ complementary_NN DNA_NN that_WDT hybridized_NN to_TO a_DT 2.6-kilobase_NN messenger_NN RNA_NN present_JJ in_IN human_JJ T_NN and_CC B_NN lymphocytes_NNS ._JJ
Analysis_NN of_IN the_DT ligand-binding_NN domain_NN of_IN human_JJ retinoic_NN acid_NN receptor_NN alpha_NN by_IN site-directed_NN mutagenesis_NN ._NN
The_DT presence_JJ of_IN mRNA_NN for_IN these_DT proteins_NNS in_IN eosinophils_NN and_CC basophils_JJ suggests_VBZ that_IN gene_NN transcription_NN in_IN these_DT lineages_NNS may_MD be_VB regulated_VBN by_IN GATA-binding_NN proteins_NNS ._JJ
Furthermore_RB ,_, 68_NN triple-labellings_NN with_IN mAbs_JJ were_VBD performed_JJ on_IN the_DT cells_NNS of_IN each_DT volunteer_NN to_TO possibly_JJ generate_NN further_JJ hypotheses_NN ._NN
To_TO determine_VB the_DT role_NN of_IN AP-2_NN in_IN the_DT regulation_NN of_IN the_DT HTLV-I_NN LTR_NN gene_NN expression_NN ,_, we_PRP used_VBN an_DT AP-2_NN cDNA_NN in_IN DNA_NN binding_NN and_CC transient_NN expression_NN assays_NNS ._JJ
We_PRP therefore_RB determined_VBN whether_IN corticosteroids_NN suppress_NN inflammation_NN by_IN inhibiting_VBG endothelial_JJ expression_NN of_IN adhesion_NN molecules_NNS for_IN neutrophils_NNS polymorphonuclear_JJ leukocytes_NNS ._NN
Transcription_JJ factor_NN AP-2_NN activates_VBZ gene_NN expression_NN of_IN HTLV-I_NN ._NN
Currently_NN available_JJ data_NNS indicate_VBP that_IN erythroid_JJ and_CC megakaryocytic_JJ differentiation_NN pathways_NNS are_VBP closely_RB related_JJ to_TO each_DT other_JJ ,_, and_CC there_NN may_MD exist_VB progenitor_NN cells_NNS common_JJ to_TO those_DT two_CD lineages_NNS may_MD exist_VB ._NN
The_DT present_JJ studies_NNS have_VBP examined_VBN the_DT effects_NNS of_IN M-CSF_NN on_IN potential_JJ signaling_NN pathways_NNS involving_VBN expression_NN of_IN the_DT jun_NN and_CC fos_NN early_JJ response_NN genes_NNS ._JJ
Inhibition_IN of_IN HIV-1_NN replication_NN and_CC NF-kappa_NN B_NN activity_NN by_IN cysteine_NN and_CC cysteine_NN derivatives_NN ._NN
Further_RB evidence_NN that_IN the_DT action_NN of_IN dexamethasone_NN was_VBD mediated_VBN through_IN ligation_NN of_IN corticosteroid_NN receptors_NNS human_JJ glucocorticoid_NN receptors_NNS hGRs_JJ was_VBD provided_VBN by_IN experiments_NN utilizing_NN the_DT steroid_JJ antagonist_NN RU-486_NN ._NN
The_DT c-Jun_NN delta-domain_NN inhibits_VBZ neuroendocrine_JJ promoter_NN activity_NN in_IN a_DT DNA_NN sequence-_NN and_CC pituitary-specific_NN manner_NN ._NN
One_CD of_IN these_DT activities_NN was_VBD found_VBN to_TO be_VB a_DT novel_JJ ,_, less_RBR abundant_JJ ,_, Rb-E2F_NN complex_NN ._NN
Granulocyte-macrophage_NN colony-stimulating_JJ factor_NN GM-CSF_NN induces_VBZ immediate_JJ effects_NNS in_IN monocytes_NNS by_IN activation_NN of_IN the_DT Janus_NN kinase_NN JAK2_NN and_CC STAT_NN transcription_NN factor_NN STAT5_NN pathway_NN ._NN
This_DT yields_NN a_DT fusion_JJ transcript_NN ,_, ,_, a_DT transcription_NN factor_NN with_IN reported_NN dominant_NN negative_JJ functions_NN in_IN the_DT absence_NN of_IN hormone_NN ._NN
Polymyxin_NN B_NN abrogated_NN only_RB the_DT response_NN to_TO LPS_NN ._NN
It_PRP has_VBZ been_VBN thought_VBN that_IN the_DT virally_RB induced_VBN inhibition_NN of_IN IFN-MCP_NN is_VBZ secondary_JJ to_TO the_DT shutdown_NN of_IN cellular_JJ macromolecular_NN synthesis_NN that_IN accompanies_NN cytopathic_NN virus_NN infections_NN ._NN
Phorbol_NN activation_NN was_VBD positively_JJ modulated_NN by_IN influx_NN while_IN TNF_NN alpha_NN activation_NN was_VBD not_RB ._VBN
In_IN this_DT report_NN ,_, we_PRP demonstrate_VBP that_IN the_DT supernatant_NN from_IN activated_VBN T-lymphocytes_NNS is_VBZ able_JJ to_TO induce_VB the_DT transcription_NN of_IN a_DT potent_JJ cytokine_NN ,_, TGF-beta_NN 2_CD in_IN glial_JJ cells_NNS ._NN
In_IN comparison_NN to_TO K562_NN ,_, nucleated_NN erythroblasts_NNS from_IN adult_NN human_JJ bone_NN marrow_NN exhibited_NN a_DT similar_JJ but_CC nonidentical_JJ pattern_NN of_IN nuclear_JJ factor_NN binding_NN in_IN vivo_NN at_IN the_DT HS-40_NN region_NN ._NN
Thus_RB ,_, tyrosine_NN phosphorylation_NN is_VBZ an_DT important_JJ and_CC perhaps_JJ mandatory_NN proximal_NN step_NN in_IN the_DT activation_NN of_IN the_DT protein_NN kinase_NN C_NN signaling_NN cascade_NN in_IN human_JJ B-lymphocyte_NN precursors_JJ ._NN
Spi-B_JJ expression_NN is_VBZ very_RB abundant_JJ in_IN B_NN cells_NNS and_CC both_CC Spi-B_NN mRNA_NN and_CC protein_NN are_VBP detected_VBN in_IN some_DT T_NN cells_NNS ._JJ
The_DT multimerized_JJ recognition_NN motif_NN of_IN TCF-1_NN constituted_NN a_DT T_NN cell-specific_JJ enhancer_NN ._NN
expression_NN remained_RB very_RB low_JJ in_IN nuclei_NNS of_IN HIV1-infected_NN macrophages_NN ._NN
However_RB ,_, most_RBS attention_JJ has_VBZ been_VBN focused_VBN on_IN lipopolysaccharide_NN LPS_NN ._NN
Using_NN deletion_NN mutants_NNS ,_, the_DT downstream_JJ parathyroid_JJ hormone-related_NN protein_NN PTHrP_NN promoter_NN is_VBZ shown_VBN to_TO be_VB responsive_JJ to_TO both_DT HTLV-I_NN and_CC HTLV-II_NN Tax_NN as_IN well_RB as_IN the_DT proto-oncogene_NN ._NN
In_IN directing_JJ the_DT synthesis_NN of_IN RNA_NN through_IN the_DT intervening_JJ DNA_NN and_CC the_DT gene_NN by_IN a_DT tracking_NN and_CC transcription_NN mechanism_NN ,_, the_DT HS2_NN enhancer_NN may_MD i_VB open_JJ up_NN the_DT chromatin_NN structure_NN of_IN a_DT gene_NN domain_NN and_CC ii_NN deliver_NN enhancer_NN binding_NN proteins_NNS to_TO the_DT promoter_NN sequence_NN where_WRB they_DT may_MD stimulate_RB the_DT transcription_NN of_IN the_DT gene_NN at_IN the_DT cap_JJ site_NN ._NN
TCR_JJ signaling_NN was_VBD triggered_JJ by_IN treating_NN Jurkat_NN T_NN cells_NNS with_IN PHA_NN or_CC anti-CD3_NN Abs_NN ,_, and_CC NF-kappaB_NN activation_NN was_VBD monitored_JJ by_IN electrophoretic_JJ mobility_NN shift_NN assays_NNS by_IN kappaB-dependent_NN reporter_NN assays_NNS ._JJ
Other_JJ cellular_JJ parameters_NNS ,_, such_JJ as_IN glycosidase_NN activities_NN ,_, cytokine_NN release_NN ,_, and_CC filament_NN expression_NN ,_, returned_NN to_TO levels_NNS similar_JJ to_TO that_DT observed_NN in_IN uninduced_JJ cells_NNS ._NN
These_DT results_NNS indicate_VBP that_IN defective_JJ recruitment_NN of_IN NF-kappa_NN B_NN may_MD underlie_VB Nef_NN negative_JJ transcriptional_JJ effects_NNS on_IN the_DT HIV-1_NN and_CC interleukin_NN 2_CD promoters_NNS ._NN
The_DT reaction_NN is_VBZ enhanced_VBN by_IN incubation_VBG of_IN the_DT tumor_NN cells_NNS for_IN 30_CD min_NN at_IN 37_NN degrees_NN C_NN prior_JJ to_TO fixation_NN ._NN
In_IN addition_NN ,_, this_DT proliferative_NN parameter_JJ maintained_NN prognostic_NN significance_NN when_WRB the_DT patients_NNS were_VBD stratified_RB according_VBN to_TO lymph_JJ node_JJ involvement_NN ,_, menopausal_NN status_NN ,_, and_CC nuclear_JJ estrogen_NN receptor_NN content_NN ._NN
Alteration_RB of_IN structural_NN order_NN of_IN human_JJ erythrocyte_JJ ghost_NN membrane_NNS by_IN glucocorticoids_NNS and_CC the_DT influence_JJ of_IN the_DT glucocorticoid_NN receptor_NN antagonist_NN RU_NN 486_NN ._NN
Nuclear_JJ factor_NN of_IN activated_VBN T_NN cells_NNS NF-AT_NN is_VBZ a_DT transcriptional_JJ activator_NN involved_VBN in_IN the_DT induction_NN of_IN IL-2_NN gene_NN expression_NN ._NN
Activated_NN viral_JJ gene_NN expression_NN associated_JJ with_IN phenotypic_NN conversion_NN of_IN group_NN I_NN cell_NN lines_NNS in_IN to_TO group_NN II_NN or_CC III_NN restores_NN the_DT Egr-1_NN gene_NN expression_NN ._NN
We_PRP also_RB show_VBP that_IN platelet-activating_JJ factor_NN from_IN 10-LRB--12-RRB-_CD to_TO 10-LRB--6-RRB-_CD M_NN induced_VBD rapid_JJ and_CC significant_JJ elevation_NN in_IN intracellular_JJ calcium_NN levels_NNS ,_, whereas_IN lyso-platelet-activating_NN factor_NN was_VBD again_RB ineffective_VBN ._NN
The_DT HTLV-I_NN LTR_NN contains_VBZ three_CD conserved_VBN regulatory_JJ elements_NNS known_VBN as_IN 21_NN base_JJ pair_NN repeats_NN which_WDT are_VBP required_VBN for_IN stimulation_NN of_IN gene_NN expression_NN by_IN the_DT transactivator_NN protein_NN tax_NN ._NN
The_DT BAT_NN box_NN and_CC Oct-2_NN were_VBD also_RB implicated_VBN in_IN the_DT induction_NN of_IN CD20_NN in_IN the_DT pre-B_JJ cell_NN line_NN ,_, PB-697_NN ,_, via_IN phorbol_NN esters_NNS ._JJ
The_DT nature_NN of_IN the_DT nuclear_JJ factors_NNS involved_VBN in_IN regulation_NN of_IN these_DT cytokine_NN genes_NNS is_VBZ still_RB unknown_JJ ._NN
Chlorinated_NN dibenzo-p-dioxins_JJ and_CC dibenzofurans_JJ and_CC the_DT human_JJ immune_NN system_NN ._NN
The_DT human_JJ T-cell_NN leukemia_NN virus_NN type_NN 1_CD posttranscriptional_JJ trans-activator_NN Rex_NN contains_VBZ a_DT nuclear_JJ export_NN signal_NN ._NN
We_PRP have_VBP examined_VBN the_DT effects_NNS of_IN RA_NN on_IN normal_JJ hematopoiesis_NN by_IN using_VBG early_JJ hematopoietic_JJ progenitor_NN cells_NNS HPC_VBP stringently_RB purified_VBN from_IN adult_NN peripheral_JJ blood_NN ._NN
ROI_NN appear_VBZ to_TO serve_JJ as_IN messengers_NNS mediating_VBG directly_JJ or_CC indirectly_JJ the_DT release_NN of_IN the_DT inhibitory_JJ subunit_NN I_NN kappa_NN B_NN from_IN NF-kappa_NN B_NN ._NN
We_PRP have_VBP studied_VBN the_DT impact_JJ of_IN gangliosides_NN on_IN the_DT expression_NN of_IN TNF_NN in_IN blood_NN monocytes_NNS and_CC in_IN the_DT monocytic_JJ cell_NN line_NNS Mono_VBG Mac_NN 6_NN ._NN
Rather_RB ,_, tyrosine_NN phosphorylation_NN was_VBD shown_VBN to_TO be_VB directly_RB involved_VBN in_IN mediating_VBG CD40-dependent_NN signals_NN ._NN
In_IN addition_NN ,_, p65_NN gave_NN per_IN se_JJ ,_, with_IN low_JJ affinity_NN ,_, a_DT protein-DNA_NN complex_NN that_WDT migrated_MD more_RBR slowly_NN than_IN native_NN NF-GM2_NN complex_NN ._NN
After_NN T_NN cell_NN activation_NN ,_, the_DT phosphorylation_NN of_IN Rb_NN results_VBZ in_IN the_DT release_NN of_IN Elf-1_NN ,_, which_WDT is_VBZ correlated_NN temporally_NN with_IN the_DT activation_NN of_IN Elf-1-mediated_NN transcription_NN ._NN
The_DT numbers_NN and_CC binding_NN affinities_NNS of_IN these_DT receptors_NNS could_MD not_RB account_NN for_IN the_DT observed_VBN difference_NN in_IN the_DT susceptibility_JJ of_IN these_DT cells_NNS to_TO functional_JJ inhibition_NN by_IN dexamethasone_NN in_IN vitro_FW ._NN
During_NN embryogenesis_NN ,_, the_DT BSAP_NN gene_NN is_VBZ transiently_RB expressed_VBN in_IN the_DT mesencephalon_NN and_CC spinal_NN cord_NN with_IN a_DT spatial_JJ and_CC temporal_JJ expression_NN pattern_NN that_WDT is_VBZ distinct_JJ from_IN that_IN of_IN other_JJ Pax_NN genes_NNS in_IN the_DT developing_NN central_JJ nervous_NN system_NN CNS_NN ._NN
Recombinant_JJ NFAT1_NN NFATp_NN is_VBZ regulated_VBN by_IN calcineurin_NN in_IN T_NN cells_NNS and_CC mediates_VBZ transcription_NN of_IN several_JJ cytokine_NN genes_NNS ._JJ
The_DT transcription_NN factor_NN HIV-TF1_NN ,_, which_WDT binds_VBZ to_TO a_DT region_NN about_NN 60_CD bp_NN upstream_JJ from_IN the_DT enhancer_NN of_IN the_DT human_JJ immunodeficiency_NN virus-1_NN HIV-1_NN ,_, was_VBD purified_VBN from_IN human_JJ B_NN cells_NNS ._JJ
In_IN addition_NN ,_, we_PRP observed_VBD cell_NN type-specific_JJ permissiveness_NN to_TO replication_NN of_IN some_DT mutant_JJ viruses_NN ._NN
In_IN human_JJ monocytes_NNS ,_, the_DT inhibitors_NNS of_IN these_DT phosphatases_NN ,_, okadaic_NN acid_NN and_CC calyculin_NN A_NN ,_, were_VBD found_VBN to_TO increase_NN the_DT mRNA_NN accumulation_NN and_CC cytokine_NN production_NN of_IN interleukin-1_NN beta_IN and_CC interleukin-1_NN alpha_NN ._NN
Transcription_JJ of_IN the_DT human_JJ immunodeficiency_NN virus_NN type-1_NN HIV-1_NN genome_NN is_VBZ regulated_VBN in_IN part_JJ by_IN cellular_JJ factors_NNS and_CC is_VBZ stimulated_VBN by_IN activation_NN of_IN latently_NN infected_NN T_NN cells_NNS ._JJ
Tumor_NN samples_NN ,_, obtained_VBN from_IN 129_NN patients_NNS who_IN underwent_JJ surgery_NN between_IN January_NN 1987_NN and_CC December_NN 1988_NN ,_, were_VBD processed_NN for_IN staining_NN by_IN an_DT immunohistochemical_JJ procedure_NN avidin-biotin_NN complex_NN ._NN
Induction_NN by_IN hemin_NN increases_NN ,_, while_IN induction_NN with_IN 12-O-tetradecanoylphorbol-13-acetate_JJ TPA_NN represses_NN ,_, erythroid-specific_JJ gene_NN expression_NN in_IN the_DT human_JJ cell_NN line_NNS K562_NN ._NN
Nasal_NN NK-_NN and_CC T-cell_NN lymphomas_NN share_NN the_DT same_JJ type_NN of_IN Epstein-Barr_JJ virus_NN latency_NN as_IN nasopharyngeal_JJ carcinoma_NN and_CC Hodgkin_NN disease_NN ._NN
Since_JJ C3a_NN has_VBZ been_VBN shown_VBN to_TO induce_VB PGE2_NN production_NN by_IN monocytes_NNS ,_, and_CC PGE2_NN has_VBZ been_VBN shown_VBN to_TO influence_VB cytokine_NN production_NN ,_, we_PRP investigated_VBD the_DT potential_JJ role_NN of_IN PGE2_NN in_IN C3a-mediated_NN enhancement_NN of_IN LPS-_NN and_CC IL-1beta-induced_NN IL-6_NN production_NN ._NN
Furthermore_RB both_CC childrens_NN T_NN cells_NNS were_VBD unable_VBN to_TO produce_VB the_DT cytokines_JJ IL-2_NN ,_, interferon-gamma_NN IFN-gamma_NN ,_, IL-4_NN and_CC tumor_NN necrosis_NN factor-alpha_NN TNF-alpha_NN ._NN
Prostaglandin_NN E2_NN induction_NN of_IN binding_NN activity_NN to_TO CRE_JJ and_CC AP-2_NN elements_NNS in_IN human_JJ T_NN lymphocytes_NNS ._JJ
Targeted_NN degradation_NN of_IN c-Fos_NN ,_, but_CC not_RB v-Fos_JJ ,_, by_IN a_DT phosphorylation-dependent_NN signal_NN on_IN c-Jun_NN ._NN
These_DT studies_NNS suggest_VBP that_IN interaction_NN of_IN CD2_NN with_IN natural_NN ligand_NN ,_, LFA-3_NN ,_, may_MD play_NN a_DT role_NN in_IN regulation_NN of_IN HIV_NN expression_NN ._NN
In_IN all_PDT subjects_NNS ,_, in_IN addition_NN ,_, lymphocyte_NN subsets_NNS were_VBD determined_VBN as_IN an_DT index_JJ of_IN corticosteroid_NN action_NN ._NN
Primer_JJ extension_NN and_CC nuclease_NN S1_NN protection_NN analysis_NN revealed_VBD two_CD major_JJ transcription_NN initiation_NN sites_NNS ._JJ
The_DT data_NNS obtained_VBN demonstrate_VBP that_IN phorbol_NN ionophore_NN A23187_NN combination_NN induced_VBD a_DT clearly_JJ higher_NN nuclear_JJ translocation_NN of_IN NF-kappa_NN B_NN in_IN neonatal_JJ than_IN adult_NN T_NN cells_NNS ._JJ
The_DT restricted_JJ pattern_NN of_IN SCL_NN protein_NN synthesis_NN is_VBZ consistent_RB with_IN the_DT restricted_JJ expression_NN of_IN SCL_NN mRNA_NN documented_NN previously_RB ._VBD
The_DT pAT_NN 133_NN gene_NN is_VBZ immediately_JJ induced_VBN ,_, with_IN FOS-like_NN kinetics_NN ,_, in_IN human_JJ T_NN cells_NNS and_CC in_IN fibroblasts_NN ._NN
BZLF_NN 1_CD ,_, transiently_RB expressed_VBN in_IN R7-57_NN reporter_NN cells_NNS ,_, was_VBD the_DT only_RB EBV_NN trans-activator_NN found_VBN ,_, sufficient_JJ in_IN inducing_VBG the_DT viral_JJ lytic_NN cycle_NN ._NN
Taken_VBN together_RB ,_, the_DT findings_NN of_IN the_DT present_JJ study_NN are_VBP consistent_VBN with_IN a_DT role_NN for_IN NF-kappaB_NN in_IN the_DT development_NN of_IN tolerance_NN with_IN respect_JJ to_TO PMN_NN adhesion_NN ,_, perhaps_RB by_IN transcriptional_JJ regulation_NN of_IN GTP-cyclohydrolase_NN ._NN
Oligonucleotide_JJ primers_JJ based_NNS on_IN the_DT murine_JJ sequence_NN were_VBD used_VBN to_TO construct_VB a_DT quantitative_JJ reverse_NN transcription-PCR_NN assay_NN for_IN gene_NN expression_NN ._NN
Exposure_NN of_IN certain_JJ cell_NN types_NNS to_TO bacterial_NNS lipopolysaccharide_NN LPS_NN leads_NN to_TO activation_NN of_IN nuclear_JJ factor_NN kappa_NN B_NN NF-kappa_NN B_NN ,_, an_DT inducible_JJ transcription_NN factor_NN ._NN
The_DT NK-kappa_NN B_NN transcription_NN factor_NN complex_NN is_VBZ sequestered_JJ in_IN the_DT cytoplasm_NN by_IN the_DT inhibitory_JJ protein_NN I_NN kappa_NN B-alpha_NN MAD-3_NN ._NN
TRAF3_NN is_VBZ a_DT negative_JJ modulator_NN of_IN LMP1-LRB-1-231-RRB--mediated_NN NF-kappaB_NN activation_NN ._NN
Sodium_JJ dodecyl_NN sulfate-polyacrylamide_NN gel_NN electrophoresis_NN showed_VBD significant_JJ aldosterone_NN binding_NN at_IN a_DT molecular_JJ weight_NN of_IN approximately_JJ 50000_NN Dalton_NN which_WDT was_VBD absent_JJ with_IN 1_CD microM_NNS cold_JJ aldosterone_NN ,_, but_CC not_RB cortisol_NN in_IN the_DT binding_NN media_NN ._NN
We_PRP show_VBP here_RB that_IN in_IN circulating_JJ monocytes_NNS ,_, NF-Y_NN binding_NN activity_NN is_VBZ not_RB detected_VBN on_IN the_DT CCAAT_NN motif_NN present_JJ in_IN the_DT promoters_NNS of_IN genes_NNS such_JJ as_IN major_JJ histocompatibility_NN complex_NN MHC_NN class_NN II_CD ,_, gp91-phox_NN ,_, mig_NN ,_, and_CC fibronectin_NN ,_, whereas_IN during_IN macrophage_NN differentiation_NN ,_, a_DT progressive_JJ increase_NN in_IN NF-Y_NN binding_NN activity_NN is_VBZ observed_VBN on_IN these_DT promoters_NNS ._NN
TSC2_NN is_VBZ a_DT gene_NN on_IN chromosome_NN 16p13.3_NN associated_JJ with_IN the_DT autosomal_JJ dominant_NN neurocutaneous_NNS disorder_JJ ,_, tuberous_JJ sclerosis_NN complex_NN TSC_NN ._NN
In_IN this_DT study_NN ,_, we_PRP have_VBP attempted_IN to_TO determine_VB whether_IN c-fos_NN expression_NN is_VBZ induced_VBN by_IN radiotherapy_NN in_IN human_JJ squamous_NN cell_NN carcinomas_NN of_IN the_DT head_NN and_CC neck_NN and_CC to_TO establish_JJ a_DT possible_JJ correlation_NN between_IN c-fos_NN expression_NN and_CC the_DT therapeutic_DT effects_NNS of_IN radiation_NN therapy_NN ._NN
Both_NN TCDD_NN and_CC estradiol_NN induce_VBD extrathymic_VBN T-cell_NN differentiation_NN in_IN the_DT liver_NN ._NN
In_IN this_DT work_NN ,_, we_PRP show_VBP that_IN human_JJ peripheral_JJ blood_NN T_NN cells_NNS that_WDT are_VBP stimulated_VBN through_IN the_DT TCR_NN and_CC expanded_NN with_IN IL-2_NN are_VBP unresponsive_JJ to_TO IFN-gamma_NN ,_, as_IN determined_VBN by_IN a_DT lack_NN of_IN activation_NN of_IN jak_NN kinases_NN and_CC the_DT transcription_NN factor_NN ,_, STAT1-LRB-alpha-RRB-_NN ,_, a_DT signal_NN transducer_NN and_CC activator_NN of_IN transcription_NN ._NN
Despite_NN this_DT lower_JJR affinity_NN ,_, a_DT trimer_JJ of_IN the_DT BAT_NN box_NN sequence_NN was_VBD as_IN efficiently_NN transactivated_NN by_IN an_DT Oct-2_NN expression_NN vector_NN as_IN was_VBD a_DT trimer_JJ of_IN the_DT octamer_NN sequence_NN in_IN HeLa_NN cells_NNS ._JJ
These_DT associations_NNS were_VBD found_VBN to_TO be_VB statistically_NN significant_JJ ._NN
We_PRP previously_RB reported_VBN that_IN human_JJ umbilical_JJ vein_NN EC_NN provide_NN costimulatory_NN signals_NNS to_TO PHA-stimulated_JJ PBL_NN via_IN CD2:lymphocyte_NN function-associated_NN Ag-3_NN and_CC an_DT unidentified_JJ ligand_NN pair_NNS ,_, resulting_JJ in_IN a_DT three-_CD to_TO eight-fold_NN enhancement_NN of_IN IL-2_NN production_NN ._NN
These_DT findings_NN are_VBP consistent_VBN with_IN a_DT model_NN for_IN Rex-mediated_JJ trans-activation_NN in_IN which_WDT Rex-viral_NN mRNA_NN complexes_NNS are_VBP targeted_VBN for_IN nuclear_JJ export_NN by_IN the_DT direct_JJ action_NN of_IN the_DT activation_NN domain_NN ._NN
The_DT mean_NN concentrations_NN necessary_JJ to_TO cause_VBN 50_NN inhibition_NN of_IN lymphocyte_NN proliferation_NN IC50s_NN for_IN the_DT steroid-sensitive_JJ group_NN ranged_NN from_IN 2_CD x_NN 10-LRB--10-RRB-_NN for_IN budesonide_NN to_TO 7_NNS x_NN 10-LRB--8-RRB-_NN for_IN hydrocortisone_NN ,_, whereas_IN the_DT mean_NN IC50s_NN for_IN the_DT steroid-resistant_JJ group_NN ranged_NN from_IN approximately_RB 2_CD x_NN 10-LRB--8-RRB-_NN for_IN budesonide_NN to_TO greater_NNS than_IN 10-LRB--6-RRB-_CD for_IN hydrocortisone_NN ._NN
These_DT findings_NN may_MD help_NN in_IN understanding_JJ the_DT pathogenesis_NN of_IN the_DT immunodeficiency_NN that_WDT occurs_VBZ with_IN mutations_NNS of_IN JAK3_NN and_CC may_MD suggest_VBP a_DT mechanism_NN for_IN the_DT pleiotropic_JJ effects_NNS of_IN IL-4_NN ._NN
results_NNS indicate_VBP that_IN the_DT AP-1_NN site_NN at_IN -150_NN bp_NN represents_NN a_DT major_JJ ,_, if_IN not_RB the_DT only_RB ,_, site_NN of_IN PKC_NN responsiveness_NN in_IN the_DT IL-2_NN promoter_NN ._NN
Role_NN of_IN AP-1-_NN and_CC octamer-binding_NN proteins_NNS in_IN control_NN of_IN IL3_NN gene_NN expression_NN ._NN
Glutathione-S-transferase_NN GST_NN -Grb2_NN fusion_NN proteins_NNS have_VBP been_VBN used_VBN to_TO identify_VB the_DT potential_JJ role_NN of_IN Grb2-binding_NN proteins_NNS in_IN platelet_NN activation_NN by_IN the_DT platelet_NN low-affinity_JJ IgG_NN receptor_NN ,_, Fc_NN gamma_NN RIIA_NN ._NN
We_PRP conclude_VBP that_IN a_DT different_JJ set_NN of_IN proteins_NNS recognize_NN IL-2_NN and_CC IL-4_NN genes_NNS ._JJ
Since_JJ T_NN cells_NNS normally_RB express_VBP Bcl-2_NN and_CC Bcl-xL_NN following_VBG activation_NN ,_, inability_NN to_TO block_VB Fas-mediated_JJ apoptosis_NN may_MD allow_VB for_IN the_DT elimination_NN of_IN self-reactive_JJ cells_NNS and_CC the_DT appropriate_JJ regulation_NN of_IN immune_JJ responses_NNS ._NN
Association_NN of_IN the_DT newly_JJ synthesized_NN I_NN kappa_NN B_NN alpha_NN with_IN p65_NN restores_NN intracellular_JJ inhibition_NN of_IN NF-kappa_NN B_NN DNA_NN binding_NN activity_NN and_CC prolongs_NN the_DT survival_NN of_IN this_DT labile_NN inhibitor_NN ._NN
Calcium_NN dependent_JJ activation_NN of_IN the_DT NF-AT_NN transcription_NN factor_NN by_IN p59fyn_NN ._NN
Here_RB we_PRP demonstrate_VBP complete_JJ correlation_JJ between_IN the_DT expression_NN pattern_NN of_IN the_DT CD19_NN gene_NN and_CC the_DT B-cell-specific_NN transcription_NN factor_NN BSAP_NN in_IN a_DT large_NN panel_JJ of_IN B-lymphoid_NN cell_NN lines_NNS ._JJ
TSH-R_NN expression_NN levels_NNS were_VBD variable_JJ ,_, but_CC displayed_JJ a_DT close_JJ correlation_NN to_TO the_DT expression_NN of_IN thyroid_DT peroxidase_JJ r_NN 0.703_CD ;_JJ P_NN 0.05_NN ,_, thyroglobulin_DT r_NN 0.817_CD ;_JJ P_NN 0.01_NN ,_, and_CC the_DT nuclear_JJ oncogene_NN c-fos_NN r_NN 0.935_CD ;_JJ P_NN 0.001_NN ,_, but_CC not_RB c-myc_NN ._NN
The_DT interaction_NN of_IN the_DT Oct2_NN transcription_NN factor_NN with_IN the_DT cognate_JJ octamer_NN motif_NN ATGCAAAT_NN is_VBZ a_DT critical_JJ determinant_NN of_IN the_DT lymphoid-specific_JJ expression_NN of_IN immunoglobulin_NN genes_NNS ._JJ
A_DT protein_NN of_IN the_DT AP-1_NN family_NN is_VBZ a_DT component_NN of_IN nuclear_JJ factor_NN of_IN activated_VBN T_NN cells_NNS ._JJ
This_DT observation_NNS supports_VBP a_DT model_NN ,_, in_IN which_WDT promoter_NN selectivity_JJ reflects_NN the_DT selectively_NN increased_VBD antiproliferative_VBN effect_NN of_IN VD_NN analogues_NN ._NN
In_IN this_DT study_NN we_PRP investigated_VBN the_DT mechanisms_NNS whereby_IN anti-CD2_NN antibodies_NN stimulate_VBZ viral_JJ production_NN ._NN
The_DT data_NNS are_VBP discussed_RB with_IN regard_NN to_TO potential_JJ clinical_JJ relevance_NN for_IN gastroenterology_NN ._NN
The_DT forms_NNS produced_VBN in_IN B_NN lymphocytes_NNS have_VBP a_DT predominantly_JJ activating_NN effect_NN on_IN gene_NN expression_NN whereas_IN those_DT produced_NN in_IN neuronal_JJ cells_NNS have_VBP a_DT predominantly_JJ inhibitory_JJ effect_NN and_CC can_MD repress_NN the_DT expression_NN of_IN both_CC the_DT herpes_NN simplex_JJ virus_NN immediate-early_NN genes_NNS and_CC the_DT cellular_JJ tyrosine_NN hydroxylase_NN gene_NN ._NN
Retinoic_JJ acid_NN RA_NN and_CC 1,25_NN alpha-dihydroxycholecalciferol_NN VitD3_NN are_VBP potent_JJ regulators_JJ of_IN hematopoletic_NN differentiation_NN ._NN
The_DT glutamine-rich_JJ activation_NN domain_NN present_JJ in_IN the_DT amino-terminal_NN portion_NN of_IN Oct2_NN and_CC the_DT POU_NN domain_NN contribute_VBP only_RB marginally_JJ to_TO the_DT transactivation_NN function_NN from_IN a_DT distal_JJ position_NN ._NN
1,25-dihydroxy_NN vitamin_NN D3_NN and_CC 12-O-tetradecanoyl_NN phorbol-13-acetate_NN TPA_NN interact_VBP synergistically_RB to_TO induce_VB monocytic_JJ differentiation_NN of_IN U937_NN histiocytic_NN lymphoma_NN cells_NNS ._JJ
A_DT serum_NN response_NN element_NN and_CC a_DT binding_NN site_NN for_IN NF-Y_NN mediate_NN the_DT serum_NN response_NN of_IN the_DT human_JJ thrombospondin_NN 1_NN gene_NN ._NN
Enhanced_NN NF-kappa_NN B_NN binding_NN activity_NN is_VBZ followed_VBG by_IN functional_JJ activation_NN in_IN that_DT inducibility_JJ of_IN the_DT IL-2_NN receptor_NN alpha_NN chain_NN is_VBZ mediated_VBN by_IN enhanced_NN NF-kappa_NN B_NN binding_NN and_CC that_IN a_DT heterologous_JJ promoter_NN containing_VBG the_DT NF-kappa_NN B_NN consensus_NN sequence_NN -291_NN to_TO -245_VB of_IN the_DT IL-2_NN receptor_NN alpha_NN chain_NN gene_NN is_VBZ activated_VBN ._NN
Both_NN inhibitors_NNS inhibited_VBD monocyte_NN chemotactic_NN activity_NN in_IN the_DT culture_NN supernatant_NN of_IN P-LPS-treated_JJ cells_NNS ._NN
TPA_NN induction_NN inhibits_VBZ the_DT binding_NN of_IN the_DT lineage_NN limited_NN transcription_NN factor_NN NF-E2_NN to_TO this_DT transcriptional_JJ control_NN element_NN ._NN
lymphocytes_NNS ,_, at_IN both_CC polyclonal_JJ and_CC clonal_JJ level_NN ,_, recognized_NN peptide_NN in_IN an_DT HLA-DR--restricted_NN fashion_NN on_IN presentation_JJ by_IN autologous_JJ antigen-presenting_NN cell_NN APC_NN or_CC by_IN APC_NN expressing_NN the_DT HLA-DR11_NN restricting_NN molecule_NN ._NN
The_DT sequence_NN between_IN -1.7_NN and_CC -0.2_NN kb_NN linked_NNS to_TO a_DT heterologous_JJ thymidine_NN kinase_NN promoter_NN failed_VBD to_TO respond_JJ to_TO PRL_NN stimulation_NN ,_, suggesting_VBG that_IN the_DT activity_NN of_IN upstream_JJ PRL_NN response_NN elements_NNS may_MD require_VB an_DT interaction_NN with_IN promoter-proximal_NN elements_NNS ._JJ
In_IN this_DT study_NN ,_, we_PRP characterize_NN an_DT essential_JJ upstream_JJ IL-2_NN response_NN element_NN that_WDT contains_VBZ both_CC consensus_NN and_CC non-consensus_NN GAS_NN motifs_NNS ,_, two_CD putative_JJ Ets_NN binding_NN sites_NNS EBS_NN ,_, one_CD of_IN which_WDT overlaps_NN the_DT consensus_NN GAS_NN motif_NN ,_, and_CC a_DT GATA_NN motif_NN ,_, which_WDT overlaps_NN the_DT non-consensus_JJ GAS_NN motif_NN ._NN
PU.1_NN is_VBZ expressed_VBN at_IN high_JJ levels_NNS in_IN B_NN cells_NNS ,_, mast_NN cells_NNS ,_, megakaryocytes_JJ ,_, macrophages_JJ ,_, neutrophils_JJ ,_, and_CC immature_JJ erythroid_JJ cells_NNS and_CC at_IN lower_JJR levels_NNS in_IN mature_JJ erythrocytes_JJ ._NN
In_IN previous_JJ studies_NNS ,_, we_PRP identified_VBD calcineurin_NN mutations_NNS that_WDT block_VBD binding_NN by_IN the_DT cyclophilin_NN or_CC complexes_NNS and_CC thereby_RB render_JJ yeast_NN cells_NNS resistant_JJ to_TO the_DT antifungal_NN effects_NNS of_IN CsA_NN or_CC FK506_NN ._NN
Afternoon_NN ACTH_NN and_CC cortisol_NN concentrations_NN did_VBD not_RB differ_VB significantly_RB between_IN the_DT three_CD groups_NNS ._NN
A_DT novel_JJ primer_JJ extension_NN method_NN to_TO detect_VB the_DT number_NN of_IN CAG_NN repeats_NN in_IN the_DT androgen_NN receptor_NN gene_NN in_IN families_NNS with_IN X-linked_NN spinal_NN and_CC bulbar_NN muscular_NN atrophy_NN ._NN
Although_IN the_DT CRE_JJ site_NN is_VBZ necessary_JJ ,_, optimal_JJ induction_NN of_IN bcl-2_NN expression_NN requires_VBZ participation_JJ of_IN the_DT upstream_JJ regulatory_JJ element_NN ,_, suggesting_VBG that_IN phosphorylation_NN of_IN CREB_JJ alters_NNS interaction_NN with_IN the_DT upstream_JJ regulatory_JJ element_NN ._NN
Recombinant_JJ NFAT1_NN can_MD mediate_VB transcription_NN of_IN the_DT interleukin-2_NN ,_, interleukin-4_NN ,_, tumor_NN necrosis_NN factor_NN alpha_NN ,_, and_CC granulocyte-macrophage_JJ colony-stimulating_JJ factor_NN promoters_NNS in_IN T_NN cells_NNS ,_, suggesting_VBG that_IN NFAT1_NN contributes_NN to_TO the_DT CsA-sensitive_NN transcription_NN of_IN these_DT genes_NNS during_IN the_DT immune_JJ response_NN ._NN
The_DT first_JJ results_NNS of_IN continuous_NN blood_NN pressure_JJ measurements_NN with_IN a_DT noninvasive_JJ ,_, real-time_JJ blood_NN pressure_JJ monitor_NN Finapres_NN are_VBP presented_JJ ._JJ
In_IN chloramphenicol_NN acetyltransferase_NN assays_NNS ,_, utilizing_NN the_DT transient_NN transfection_NN of_IN a_DT chloramphenicol_NN acetyltransferase_NN reporter_NN plasmid_NN containing_VBG the_DT IL-6_NN gene_NN promoter_NN ,_, IL-4_NN ,_, but_CC not_RB IL-10_NN ,_, suppressed_VBN the_DT transcriptional_JJ activity_NN of_IN the_DT IL-6_NN gene_NN promoter_NN stimulated_VBZ by_IN PMA_NN and_CC LPS_NN ._NN
When_WRB expressed_VBN in_IN Jurkat_NN T_NN cells_NNS ,_, recombinant_NN NFAT1_NN is_VBZ regulated_VBN ,_, as_IN expected_VBG ,_, by_IN the_DT calmodulin-dependent_NN phosphatase_NN calcineurin_NN ,_, and_CC function_NN is_VBZ inhibited_VBN by_IN the_DT immunosuppressive_JJ agent_NN cyclosporin_NN A_NN CsA_NN ._NN
The_DT partial_JJ cDNA_NN encodes_VBZ a_DT protein_NN which_WDT is_VBZ homologous_NN to_TO the_DT C-terminal_JJ 196_NN amino_NN acids_NN of_IN the_DT 36-kDa_NN transcription_NN factor_NN ,_, YB-1_NN ._NN
We_PRP have_VBP observed_VBN that_IN the_DT R24_NN mAb_NN stimulates_VBZ T_NN cell_NN proliferation_NN ,_, cytotoxicity_NN ,_, and_CC surface_NN marker_RB expression_NN of_IN IL-2R_NN alpha-chain_NN ,_, IL-2R_NN beta-chain_IN ,_, HLA-DR_NN ,_, CD11a_NN ,_, and_CC CD11c_NN ._NN
In_IN the_DT present_JJ study_NN ,_, analysis_NN of_IN the_DT interleukin-2_NN IL-2_NN gene_NN activation_NN shows_VBD that_IN naive_NN human_JJ helper_NN T_NN cells_NNS cord_VBG blood_NN T_NN cells_NNS ,_, adult_NN T_NN cells_NNS regulate_VB IL-2_NN transcription_NN by_IN a_DT mechanism_NN involving_NN both_CC a_DT silencer_NN and_CC an_DT activator_NN acting_NN on_IN the_DT purine-rich_JJ IL-2_NN promoter_NN elements_NNS NF-AT_NN binding_NN sites_NNS ._JJ
PBL_NN constitutively_RB express_VBD c-jun_NN transcripts_NNS ,_, and_CC the_DT level_NN of_IN c-jun_NN mRNA_NN is_VBZ not_RB altered_VBN by_IN PHA_NN activation_NN in_IN the_DT absence_NN or_CC presence_JJ of_IN EC_NN ._NN
The_DT combined_NNS data_NNS lend_NN additional_NN support_NN to_TO the_DT proposal_NN that_IN spirochetal_JJ lipoproteins_NNS and_CC LPS_JJ initiate_NN monocyte_NN activation_NN via_IN different_JJ cell_NN surface_NN events_NNS but_CC that_IN the_DT signaling_NN pathways_NN ultimately_NN converge_NN to_TO produce_NNS qualitatively_JJ similar_JJ cellular_JJ responses_NNS ._NN
Control_JJ peptides_NN corresponding_VBG to_TO the_DT normal_JJ pml_NN and_CC RAR_NN alpha_NN proteins_NNS were_VBD not_RB recognized_VB ._NN
Thus_RB ,_, HTLV-I_NN Tax_NN ,_, HTLV-II_NN Tax_NN ,_, and_CC c-jun_NN transactivate_NN PTHrP_NN and_CC may_MD contribute_VBP to_TO the_DT pathogenesis_NN of_IN hypercalcemia_NN in_IN adult_NN T-cell_NN leukemia_NN ._NN
Moreover_RB ,_, platelet-activating_JJ factor_NN was_VBD capable_JJ of_IN inducing_VBG transcription_NN of_IN the_DT nuclear_JJ proto-oncogenes_NN c-fos_NN and_CC c-jun_NN ._NN
The_DT cDNA_NN clone_NN encodes_VBZ a_DT new_JJ isoform_NN ,_, NFATc.beta_NN ,_, of_IN the_DT NFAT_NN gene_NN family_NN member_NNS NFATc_NN designated_NN here_NN NFATc.alpha_NN ._NN
Additionally_JJ ,_, Nef_JJ expressing_VBG cells_NNS were_VBD transiently_RB transfected_VBN with_IN a_DT plasmid_NN in_IN which_WDT HIV-1_NN AP-1_NN DNA_NN recognition_NN sequences_NNS were_VBD cloned_JJ downstream_JJ of_IN the_DT chloramphenicol_NN acetyltransferase_NN CAT_NN gene_NN ._NN
We_PRP now_RB report_NN that_IN EC_NN costimulation_NN causes_VBZ increased_VBN levels_NNS of_IN IL-2_NN mRNA_NN as_IN a_DT result_NN of_IN increased_VBN IL-2_NN transcription_NN in_IN PBL_NN ._NN
We_PRP have_VBP isolated_VBN cDNA_NN clones_NNS of_IN myeloid_JJ differentiation_NN primary_JJ response_NN MyD_NN genes_NNS ,_, activated_VBN in_IN the_DT absence_NN of_IN de_NN novo_JJ protein_NN synthesis_NN following_VBG induction_NN for_IN differentiation_NN along_NN either_CC the_DT macrophage_JJ or_CC granulocyte_JJ lineage_NN in_IN human_JJ myeloblastic_NN leukemia_NN HL-60_NN cells_NNS ._JJ
Characterization_NN of_IN HB24_NN expression_NN in_IN lymphoid_JJ and_CC select_JJ developing_NN tissues_NNS was_VBD performed_RB by_IN in_IN situ_NN hybridization_NN ._NN
These_DT observations_NNS establish_JJ the_DT importance_NN of_IN different_JJ signal_NN transducing_NN pathways_NNS leading_VBG to_TO CD40_NN activation_NN of_IN B_NN lymphocytes_NNS ._JJ
Cortisone-resistant_NN bronchial_JJ asthma_NN
Moreover_RB ,_, cAMP_NN activators_NN did_VBD not_RB activate_VBN NF-kappa_NN B_NN in_IN Jurkat_NN cells_NNS ._JJ
Positive_NN and_CC negative_JJ regulation_NN of_IN immunoglobulin_NN gene_NN expression_NN by_IN a_DT novel_JJ B-cell-specific_NN enhancer_NN element_NN ._NN
Charybdotoxin-sensitive_NN ,_, membrane_NN potential_JJ changes_NN are_VBP not_RB involved_VBN in_IN human_JJ T_NN or_CC B_NN cell_NN activation_NN and_CC proliferation_NN ._NN
The_DT A_NN site_NN in_IN the_DT 21_NN bp_NN repeat_NN has_VBZ strong_JJ homology_NN with_IN previously_RB described_VBN binding_NN sites_NNS for_IN the_DT transcription_NN factor_NN AP-2_NN ._NN
There_EX was_VBD no_DT detectable_JJ binding_NN of_IN in_IN vitro_FW translated_NN heterodimer_NN AP-1_NN to_TO the_DT NF-AT_NN sequence_NN ,_, and_CC the_DT NF-AT_NN sequence_NN was_VBD unable_JJ to_TO inhibit_VB the_DT binding_NN of_IN to_TO the_DT AP-1_NN sequence_NN ._NN
Nuclear_JJ association_VBN of_IN a_DT T-cell_NN transcription_NN factor_NN blocked_VBD by_IN FK-506_NN and_CC cyclosporin_NN A_NN see_NN comments_NN
Studies_NNS of_IN cell_NN lines_NNS representing_JJ endocrine_JJ ,_, fibroblast_JJ ,_, and_CC lymphoid_JJ lineages_NNS using_VBG polyclonal_NN antisera_NN to_TO detect_VB E2A_NN proteins_NNS have_VBP suggested_VBD that_IN significant_JJ E2A_NN protein_NN expression_NN is_VBZ restricted_JJ to_TO B-lymphocytes_NN ._NN
Both_NN drugs_NN dose-dependently_NN inhibited_VBD LPS-induced_JJ TF_NN and_CC TNF-alpha_NN synthesis_NN at_IN the_DT mRNA_NN and_CC the_DT protein_NN level_NN ,_, and_CC reduced_VBN PGE2_NN production_NN ._NN
Using_NN amino_NN acid_NN sequence_NN information_NN derived_VBN from_IN the_DT DNA_NN affinity-purified_VBG protein_NN ,_, we_PRP have_VBP now_RB isolated_VBN cDNA_NN clones_NNS encoding_VBG TCF-1_NN alpha_NN ._NN
Nonhuman_NN primates_JJ are_VBP naturally_NN infected_NN with_IN a_DT B-lymphotropic_JJ herpesvirus_NN closely_NN related_JJ to_TO Epstein-Barr_JJ virus_NN EBV_NN ._NN
Association_NN with_IN the_DT precursors_JJ is_VBZ sufficient_JJ for_IN cytoplasmic_JJ retention_NN of_IN either_CC p65_NN or_CC c-Rel_NN ,_, both_CC of_IN which_WDT are_VBP otherwise_JJ nuclear_JJ ._NN
Furthermore_RB ,_, P-LPS-induced_JJ expression_NN of_IN the_DT MCP-1_NN gene_NN in_IN the_DT cells_NNS also_RB was_VBD blocked_VBD by_IN inhibitors_NNS of_IN two_CD transcription_NN factors_NNS ,_, i.e._NN ,_, curcumin_RB ,_, an_DT inhibitor_NN of_IN AP-1_NN ,_, and_CC pyrolidine_NN dithiocarbamate_NN ,_, an_DT inhibitor_NN of_IN NF-kappaB_NN ._NN
We_PRP report_NN here_RB that_IN interleukin_NN 2_CD IL-2_NN acts_NNS on_IN human_JJ blood_NN monocytes_NNS by_IN enhancing_NN binding_NN activity_NN of_IN the_DT transcription_NN factor_NN NF-kappa_NN B_NN to_TO consensus_NN sequence_NN in_IN the_DT regulatory_JJ enhancer_NN region_NN of_IN the_DT IL-2_NN receptor_NN alpha_NN chain_NN p55_NN ._NN
Moreover_RB ,_, Elf-1_NN is_VBZ the_DT only_RB factor_NN present_JJ in_IN activated_VBN T-cell_NN nuclear_JJ extracts_NNS that_WDT binds_VBZ to_TO these_DT sites_NNS in_IN electrophoretic_JJ mobility_NN shift_NN assays_NNS ._JJ
We_PRP report_NN two_CD patients_NNS with_IN transient_NN pseudohypoaldosteronism_NN due_JJ to_TO obstructive_NN renal_NN disease_NN ._NN
To_TO study_VB the_DT transcription_NN factor_NN requirement_NN in_IN B-cells_NN ,_, different_JJ U2_NN enhancer_NN constructions_NN were_VBD transfected_VBN into_IN the_DT lymphoid_JJ cell_NN line_NN ,_, BJA-B_NN ._NN
The_DT number_NN of_IN GR_NN in_IN MNL_NN from_IN these_DT patients_NNS was_VBD significantly_RB decreased_VB one_CD month_JJ after_IN the_DT initiation_NN of_IN prednisolone_JJ therapy_NN ._NN
These_DT differences_JJ in_IN expression_NN of_IN FOS_NN and_CC FOSB_NN suggest_VBP different_JJ roles_NNS and_CC regulation_NN ._NN
This_DT factor_NN is_VBZ composed_JJ of_IN a_DT DNA-binding_JJ protein_NN ISGF3_NN gamma_NN ,_, which_WDT normally_RB is_VBZ present_JJ in_IN the_DT cytoplasm_NN ,_, and_CC other_JJ IFN-alpha-activated_NN proteins_NNS which_WDT preexist_JJ as_IN latent_VBG cytoplasmic_JJ precursors_JJ ISGF3_NN alpha_NN ._NN
In_IN human_JJ leukocytes_NNS ,_, the_DT peak_JJ value_NN of_IN GR_NN was_VBD found_VBN to_TO parallel_JJ that_IN of_IN plasma_NN cortisol_NN with_IN high_JJ and_CC low_JJ values_NN detected_NN at_IN 04:00-08:00_NN h_NN and_CC 23:00-24:00_NN h_NN ,_, respectively_RB ._NN
By_IN Northern_NN blot_NN analysis_NN ,_, DM_NN caused_VBN a_DT comparable_JJ decrease_NN in_IN IL-2R_NN alpha_NN and_CC in_IN IL-2R_NN beta_IN mRNA_NN levels_NNS to_TO membrane_NNS receptor_NN expression_NN in_IN mitogen-stimulated_NNS T_NN cells_NNS ._JJ
These_DT inhibitory_JJ effects_NNS of_IN c-Rel_NN correlate_NN with_IN DNA-binding_JJ activity_NN but_CC not_RB with_IN ability_NN to_TO heterodimerize_JJ with_IN p50_NN ,_, suggesting_VBG that_IN c-Rel_NN inhibition_NN involves_VBZ competition_JJ with_IN for_IN occupancy_NN of_IN the_DT kappa_NN B_NN enhancer_NN element_NN ._NN
Northern_NN blot_NN analysis_NN revealed_VBD in_IN these_DT cells_NNS ,_, an_DT increase_NN in_IN the_DT transcription_NN of_IN these_DT two_CD proto-oncogenes_NNS ,_, and_CC this_DT increase_NN was_VBD amplified_VBN after_IN treatment_NN with_IN phorbol_NN myristate_NN acetate_NN ._NN
The_DT results_NNS demonstrate_VBP that_IN physiologic_NN concentrations_NN of_IN all_DT three_CD of_IN these_DT agents_NNS inhibit_VBP the_DT anti-CD3_NN mAb-induced_NN proliferation_NN of_IN T_NN cells_NNS ._JJ
Studies_NNS were_VBD also_RB performed_JJ with_IN an_DT revertant_JJ line_NN that_WDT has_VBZ regained_VBN partial_JJ sensitivity_NN to_TO vincristine_VB ._NN
The_DT BCL6_NN gene_NN encodes_VBZ a_DT 95-kDa_JJ protein_NN containing_VBG six_NN C-terminal_JJ zinc-finger_NN motifs_NNS and_CC an_DT N-terminal_JJ POZ_NN domain_NN ,_, suggesting_VBG that_IN it_PRP may_MD function_NN as_IN a_DT transcription_NN factor_NN ._NN
Using_NN these_DT drugs_NN as_IN probes_NN ,_, chemists_NN and_CC biologists_NN have_VBP uncovered_VBN several_JJ intracellular_JJ signalling_NN molecules_NNS bridging_JJ the_DT generation_NN of_IN second-messenger_JJ ions_NNS and_CC the_DT transcriptional_JJ activation_NN of_IN IL-2_NN ,_, among_IN which_WDT are_VBP calmodulin_NN ,_, calcineurin_NN and_CC the_DT nuclear_JJ factor_NN of_IN activated_VBN T_NN cells_NNS NF-AT_NN ._NN
In_IN this_DT paper_JJ we_PRP have_VBP investigated_VBN the_DT role_NN of_IN Egr-1_NN in_IN B_NN cell_NN growth_NN regulation_NN by_IN examining_NN the_DT gene_NN expression_NN in_IN a_DT panel_JJ of_IN B_NN cell_NN lines_NNS ,_, including_VBG both_CC EBV_NN genome_NN negative_JJ and_CC EBV_NN carrying_NN cell_NN lines_NNS ._JJ
Loss_NN of_IN heterozygosity_JJ in_IN PB_NN granulocytes_NNS would_JJ be_VB masked_NN by_IN the_DT presence_JJ of_IN significant_JJ numbers_NN of_IN normal_JJ granulocytes_NNS not_RB derived_VBN from_IN the_DT malignant_JJ clone_NN ._NN
To_TO further_JJ reduce_NN the_DT size_NN of_IN the_DT common_JJ deleted_NN region_NN we_PRP have_VBP searched_VBN for_IN small_NN deletions_NN or_CC mitotic_NN recombination_NN events_NNS ,_, neither_DT of_IN which_WDT would_NN be_VB detected_VBN by_IN conventional_NN cytogenetics_NN ._NN
In_IN summary_NN ,_, the_DT expression_NN of_IN E1A_NN gene_NN products_NNS inhibited_VBD IFN-MCP_NN independently_VBN of_IN virus_NN infection_NN ._NN
Eicosanoids_NN in_IN breast_JJ cancer_NN patients_NNS before_VBG and_CC after_IN mastectomy_NN ._NN
Interleukin-10_IN IL-10_NN ,_, like_IN IL-4_NN ,_, is_VBZ known_VBN to_TO inhibit_VB cytokine_NN expression_NN in_IN activated_VBN human_JJ monocytes_NNS ._NN
The_DT results_NNS demonstrate_VBP that_IN the_DT simultaneous_JJ activation_NN of_IN PKC_NN and_CC elevation_NN of_IN cAMP_NN leads_NN to_TO an_DT enhanced_NN AP-1_NN transcriptional_JJ activity_NN in_IN a_DT T-leukemia_NN cell_NN line_NN ,_, suggesting_VBG that_IN the_DT previously_RB observed_VBN interaction_NN between_IN the_DT parallel_JJ signal_NN transduction_NN pathways_NNS may_MD have_VB functional_JJ consequences_NN at_IN the_DT level_NN of_IN gene_NN transcription_NN ._NN
We_PRP investigated_VBD the_DT upstream_JJ regulatory_JJ elements_NNS of_IN the_DT human_JJ IL-4_NN promoter_NN ._NN
Improvement_JJ in_IN urinary_NN protein_NN excretion_NN and_CC in_IN disease_NN activity_NN ,_, which_WDT was_VBD scored_NN according_NN to_TO the_DT SLE_NN Disease_NN Activity_NN Index_NN system_NN of_IN the_DT University_NN of_IN Toronto_JJ ,_, closely_JJ related_JJ to_TO the_DT glucocorticoid_NN receptor_NN concentrations_NN in_IN MNL_NN isolated_VBN from_IN the_DT corresponding_JJ patients_NNS ._NN
Retinoic_JJ acid_NN treatment_NN of_IN irradiated_JJ mice_NNS enhanced_VBN granulocyte_NNS recovery_NN ._NN
When_WRB cells_NNS were_VBD treated_NN with_IN IL-4_NN for_IN 5_NN hours_NN before_NN LPS_NN activation_NN ,_, both_CC the_DT c-fos_NN and_CC the_DT c-jun_NN mRNA_NN expression_NN was_VBD decreased_VBN ._NN
Two_CD stable_NN B_NN cell_NN lines_NNS were_VBD established_JJ :_: R59Z_NN activator_NN cells_NNS were_VBD used_VBN to_TO induce_VB lytic_JJ EBV_NN expression_NN in_IN a_DT constitutive_JJ manner_NN by_IN the_DT production_NN of_IN the_DT BZLF_NN 1_CD trans-activator_JJ Zta_NN ._NN
Cloning_NN of_IN a_DT human_JJ homeobox_NN gene_NN that_WDT resembles_VBZ a_DT diverged_JJ Drosophila_NN homeobox_NN gene_NN and_CC is_VBZ expressed_VBN in_IN activated_VBN lymphocytes_NNS ._NN
This_DT inhibition_NN of_IN calcium-activated_NN IE_NN gene_NN induction_NN was_VBD reversed_JJ by_IN treatment_NN with_IN cyclosporin_NN A_NN ,_, suggesting_VBG the_DT involvement_JJ of_IN calcineurin_NN in_IN this_DT regulation_NN ._NN
Analysis_NN of_IN the_DT p50_NN and_CC p65_NN subunits_NNS of_IN the_DT NF-kappa_NN B_NN transcription_NN factor_NN complex_NN has_VBZ revealed_VBD that_IN both_CC proteins_NNS can_MD interact_VBP with_IN related_JJ DNA_NN sequences_NNS through_IN either_CC homo-_NN or_CC heterodimer_NN formation_NN ._NN
The_DT former_NN two_CD substances_NNS interact_VBP with_IN T_NN cells_NNS via_IN the_DT glucocorticoid_NN and_CC beta-adrenergic_NN receptors_NNS respectively_JJ ._NN
Further_RB examination_VBN of_IN this_DT system_NN has_VBZ shown_VBN that_IN the_DT inhibition_NN of_IN HSV-1_NN replication_NN by_IN the_DT antiviral_NN drug_NN acyclovir_NN does_VBZ not_RB inhibit_VB HSV-1-mediated_NN induction_NN of_IN HIV-1_NN provirus_NN ._NN
The_DT p65_NN subunit_NN of_IN NF-kappa_NN B_NN regulates_VBZ I_NN kappa_NN B_NN by_IN two_CD distinct_JJ mechanisms_NNS ._NN
Studies_NNS of_IN pluripotent_NN islet_VBZ cultures_NNS ._NN
Here_RB we_PRP describe_VBP an_DT alternative_NN approach_JJ ,_, based_JJ on_IN in_IN vitro_FW stimulation_NN with_IN epitope_NN peptide-loaded_NN dendritic_NN cells_NNS DCs_JJ ,_, which_WDT allows_VBZ one_CD to_TO probe_NN the_DT CTL_NN repertoire_NN for_IN any_DT individual_JJ reactivity_NN of_IN choice_NN ;_NN this_DT method_JJ proved_NN significantly_NNS more_RBR efficient_JJ than_IN stimulation_NN with_IN peptide_NN alone_NN ._NN
We_PRP now_RB report_NN the_DT identification_NN of_IN a_DT cDNA_NN clone_NN 15B-7_NN ,_, from_IN a_DT Jurkat_NN expression_NN library_NN ,_, that_IN binds_VBZ specifically_RB to_TO the_DT DRE_NN 1_CD regulatory_JJ sequence_NN ._NN
Murine_JJ and_CC human_JJ TCF-1_NN displayed_NN a_DT 95.5_NN overall_NN amino_NN acid_NN homology_NN ._NN
These_DT results_NNS demonstrate_VBP that_IN Rb_NN interacts_NN specifically_RB with_IN a_DT lineage-restricted_JJ Ets_NN transcription_NN factor_NN ._NN
Oct-2_NN mRNA_NN levels_NNS and_CC both_CC Oct-2_NN and_CC NF-kappa_NN B_NN proteins_NNS in_IN nuclear_JJ extracts_NNS were_VBD not_RB altered_VBN by_IN treatment_NN with_IN TGF-beta_NN ._NN
All_DT cell_NN lines_NNS examined_VBD in_IN this_DT group_NN also_RB expressed_VBD 1,25-LRB-OH-RRB-2D3_NN receptors_NNS ._JJ
In_IN patients_NNS infiltration_JJ of_IN c-fos-positive_NN lymphocytes_NNS into_IN tumor_NN tissues_NNS were_VBD moderate_NN or_CC remarkable_NN at_IN 4_NN Gy_NN of_IN radiotherapy_NN ,_, the_DT tumors_NNS responded_VBP significantly_RB well_RB to_TO radiation_NN therapy_NN P_NN 0.025_CD ,_, chi2_NN test_NN ,_, and_CC the_DT patients_NNS took_VBP a_DT significantly_JJ favorable_NN clinical_JJ course_NN P_NN 0.05_CD ,_, chi2_NN test_NN ._NN
On_NN the_DT first_JJ day_NN of_IN the_DT disease_NN ,_, glucocorticoid_NN receptor_NN capacity_NN was_VBD significantly_RB decreased_VB without_IN alteration_IN of_IN the_DT receptor-ligand_NN affinity_NN ,_, whereas_IN on_IN days_NN 4_NN and_CC 12_NN the_DT number_NN of_IN receptor_NN sites_NNS was_VBD normal_JJ again_RB ._NN
The_DT PML_NN gene_NN is_VBZ fused_JJ to_TO the_DT retinoic_NN acid_NN receptor_NN alpha_NN gene_NN RAR_NN alpha_NN in_IN the_DT acute_JJ promyelocytic_NN leukemia_NN APL_NN 15_NN ;_NN 17_NN translocation_NN ._NN
A_DT 2-bp_NN mutation_NN within_IN the_DT CBF_NN site_NN resulted_VBD in_IN a_DT 2-3-fold_NN decrease_NN in_IN the_DT activities_NN of_IN both_CC a_DT 69-bp_NN proximal_NN promoter_NN fragment_NN and_CC a_DT 627-bp_NN full-length_JJ promoter_NN fragment_NN ._NN
Using_NN purified_VBN recombinant_NN p50_NN ,_, p65_NN ,_, and_CC c-Rel_NN proteins_NNS ,_, optimal_JJ DNA-binding_JJ motifs_NNS were_VBD selected_JJ from_IN a_DT pool_JJ of_IN random_NN oligonucleotides_NN ._NN
This_DT absence_NN of_IN binding_NN was_VBD localized_JJ to_TO the_DT NF-kappa_NN B_NN region_NN of_IN the_DT HIV-1_NN enhancer_NN ;_NN the_DT 65-kDa_NN plus_NN 50-kDa_NN NF-kappa_NN B_NN heterodimer_NN was_VBD preferentially_JJ lost_JJ ._NN
E3_NN transcripts_NNS were_VBD RA-inducible_NN in_IN HL60_NN cells_NNS ,_, but_CC not_RB in_IN an_DT RA-resistant_NN subclone_NN ,_, HL60R_NN ,_, that_IN harbors_NN a_DT mutated_NN RAR_NN alpha_NN gene_NN ._NN
Nuclear_JJ factor_NN kappa_NN B_NN activates_VBZ proenkephalin_VBN transcription_NN in_IN T_NN lymphocytes_NNS ._JJ
No_NN correlation_NN between_IN chromosome_NN 1_NN alterations_NNS and_CC nuclear_JJ grade_NNS ,_, age_NNS ,_, size_NN ,_, lymph-node_NN involvement_VBN ,_, hormonal_NN receptor_NN presence_VBZ ,_, proliferation_NN activity_NN or_CC p53_NN protein_NN expression_NN was_VBD detected_VBN ._NN
In_IN vitro_NN translated_NN hGR_NN was_VBD indistinguishable_VBN from_IN native_NN hGR_NN ,_, as_IN determined_VBN by_IN migration_NN on_IN sodium_NN dodecyl_NN sulfate-polyacrylamide_NN gels_NN ,_, sedimentation_NN on_IN sucrose_JJ density_NN gradients_NNS ,_, and_CC reactivity_NN with_IN antipeptide_JJ antibodies_NNS generated_VBN against_IN hGR_NN ._NN
We_PRP investigated_VBD the_DT pattern_NN of_IN tal-1_NN expression_NN in_IN purified_VBN human_JJ hematopoietic_JJ cells_NNS by_IN in_IN situ_NN hybridization_NN and_CC reverse_JJ transcriptase_NN polymerase_NN chain_NN reaction_NN analysis_NN ._NN
Abnormality_NN of_IN Oct-1_NN DNA_NN binding_NN in_IN T_NN cells_NNS from_IN Sjogren_NN syndrome_NN patients_NNS ._JJ
Mammal_NN pyruvate_NN kinases_NN are_VBP encoded_VBN by_IN two_CD genes_NNS ._NN
This_DT phenomenon_NN ,_, which_WDT is_VBZ independent_VBN of_IN tumour_NN necrosis_NN factor_NN ,_, is_VBZ associated_VBN with_IN HIV_NN replication_NN ,_, and_CC is_VBZ thus_RB likely_VBN to_TO explain_VB at_IN least_VBG in_IN part_NNS the_DT perpetuation_JJ of_IN HIV_NN infection_NN in_IN monocytes_NNS ._NN
As_JJ described_NN by_IN Jun_NN Liu_NN ,_, these_DT drugs_NN manifest_NN effects_NNS in_IN an_DT unprecedented_JJ fashion_NN ._NN
Since_JJ APL_NN cells_NNS do_JJ not_RB express_VBP HLA_NN class_NN II_NN molecules_NNS ,_, we_PRP tested_JJ in_IN two_CD donors_NN D.E._NN and_CC C.H.R._NN and_CC in_IN patients_NNS S.R._NN and_CC P.G._NN whether_IN the_DT use_NN of_IN 9-mer_NN peptides_NN would_NN generate_NN a_DT class_NN I-restricted_NN response_NN ._NN
The_DT anti-oxidative_NN effect_NN of_IN BHA_NN was_VBD accompanied_VBN by_IN an_DT increase_NN in_IN thiol_JJ ,_, but_CC not_RB glutathione_JJ ,_, content_NN in_IN stimulated_VBN and_CC unstimulated_JJ T_NN cell_NN ,_, whereas_IN TNF_NN stimulation_NN itself_NN barely_NNS modified_VBP the_DT cellular_JJ thiol_JJ level_NN ._NN
No_NN unifying_JJ hypothesis_NN has_VBZ yet_NN emerged_NN explaining_NN this_DT collection_JJ of_IN data_NNS ._NN
One_CD enigmatic_NN aspect_NNS of_IN GATA_NN factor_NN expression_NN is_VBZ that_IN several_JJ GATA_NN proteins_NNS ,_, which_WDT ostensibly_NN share_NN the_DT same_JJ DNA-binding_JJ site_NN specificity_NNS ,_, are_VBP coexpressed_NN in_IN erythroid_JJ cells_NNS ._NN
Transient_JJ expression_NN of_IN NFATc.beta_NN was_VBD capable_JJ of_IN activating_NN an_DT interleukin-2_NN NFAT-driven_NN reporter_NN gene_NN in_IN stimulated_VBN Jurkat_NN cells_NNS in_IN a_DT CsA-sensitive_NN manner_NN ._NN
We_PRP investigated_VBD the_DT clinical_JJ significance_NN of_IN glucocorticoid_NN receptor_NN determination_NN in_IN 20_CD patients_NNS with_IN systemic_NN lupus_NN erythematosus_JJ SLE_NN who_NN afterwards_IN developed_NN nephrotic_JJ syndrome_NN ._NN
However_RB ,_, the_DT transcription_NN and_CC synthesis_NN of_IN interleukin_NN 2_CD and_CC other_JJ delayed_NN early_JJ cytokines_NN were_VBD markedly_RB attenuated_JJ by_IN BCL-2_NN ._NN
Different_JJ modes_NN ,_, like_IN chemical_NN induction_NN ,_, lytic_JJ superinfection_NN with_IN EBV_NN and_CC single_JJ gene_NN trans-activation_NN converted_NN the_DT recombinant_NN ori_NN Lyt_NN element_NN in_IN R7-57_NN reporter_NN cells_NNS ._JJ
Notably_NN ,_, we_PRP do_JJ not_RB see_JJ particularly_NNS strong_JJ transcription_NN when_WRB the_DT immunoglobulin_NN kappa_NN enhancer_NN or_CC the_DT immunoglobulin_NN heavy_NN chain_NN enhancer_NN is_VBZ used_VBN to_TO activate_VB a_DT kappa_NN gene_NN promoter_NN ._NN
Potent_NN gene_NN regulatory_JJ and_CC antiproliferative_JJ activities_NN of_IN 20-methyl_NN analogues_NN of_IN 1,25_NN dihydroxyvitamin_JJ D3_NN ._NN
Cyclosporin_JJ A_NN and_CC FK506_NN inhibit_VBP T-_NN and_CC B-cell_NN activation_NN and_CC other_JJ processes_NN essential_NN to_TO an_DT effective_JJ immune_NN response_NN ._NN
1,25-LRB-OH-RRB-2D3_NN is_VBZ therefore_RB one_CD of_IN the_DT most_RBS potent_JJ regulators_JJ of_IN HIV-1_NN replication_NN described_NN to_TO date_NNS ._NN
Importantly_JJ ,_, two_CD previously_RB characterized_VBN mutants_NNS with_IN point_JJ mutations_NNS in_IN Tax_NN ,_, M32_NN Y196A_NN ,_, K197S_NN and_CC M41_NN H287A_NN ,_, P288S_NN ,_, which_WDT were_VBD shown_VBN to_TO be_VB defective_JJ in_IN Tax-activated_NN transcription_NN were_VBD unable_JJ to_TO interact_VBP with_IN TFIIA_NN in_IN this_DT assay_NN ._NN
Addition_JJ of_IN KCl_NN resulted_VBD in_IN less_RBR DNA_NN binding_NN either_CC due_JJ to_TO blockage_VB of_IN DNA-receptor_NN complex_NN formation_NN or_CC disruption_NN of_IN the_DT complexes_NNS ._NN
Thus_RB ,_, the_DT 55_NN kd_NN TNFR_NN plays_VBZ a_DT decisive_NN role_NN in_IN the_DT host_NN defense_NN against_IN microorganisms_JJ and_CC pathogenic_JJ factors_NNS
Members_NN of_IN this_DT group_NN have_VBP three_CD tetraproline_JJ repeats_NN ._NN
Ectopic_NN expression_NN of_IN cloned_JJ Oct2_NN cDNA_NN was_VBD shown_VBN to_TO be_VB sufficient_JJ to_TO reconstitute_NN at_IN least_VBG some_DT aspects_JJ of_IN this_DT regulation_NN in_IN non-lymphoid_JJ cells_NNS ._NN
We_PRP used_VBN phenolic_NN ,_, lipid-soluble_NN ,_, chain-breaking_NN antioxidants_NNS butylated_CC hydroxyanisole_NN BHA_NN ,_, nordihydroquairetic_RB acid_NN ,_, or_CC alpha-tocopherol_NN vitamin_NN E_NN to_TO show_VBP that_IN peroxyl_JJ radical_NN scavenging_NN in_IN unstimulated_JJ and_CC PMA-_NN or_CC TNF-stimulated_NN cells_NNS blocks_VBD the_DT functions_JJ depending_NN on_IN NF-kappa_NN B_NN activation_NN ._NN
It_PRP also_RB bound_VBD to_TO the_DT purine-rich_JJ CD3R_NN element_NN from_IN the_DT human_JJ immunodeficiency_NN virus_NN type_NN 2_CD long_JJ terminal_JJ repeat_NN ,_, which_WDT is_VBZ required_VBN for_IN inducible_JJ virus_NN expression_NN in_IN response_NN to_TO signalling_NNS through_IN the_DT T-cell_NN receptor_NN ._NN
We_PRP conclude_VBP that_IN different_JJ domains_NNS of_IN the_DT pp56-LRB-lck-RRB-_NN molecule_NN contribute_VBP to_TO regulate_VB distinct_JJ biologic_NN functions_NN ._NN
Furthermore_RB ,_, GcR_JJ were_VBD unaltered_JJ after_IN these_DT patients_NNS received_NN ketoconazole_NN ,_, in_IN spite_JJ of_IN a_DT marked_JJ reduction_NN in_IN morning_NN plasma_NN cortisol_NN and_CC urinary_NN free_NN cortisol_NN ._NN
The_DT binding_NN protein_NN s_NN that_WDT recognize_VBZ the_DT P_NN sequence_NN of_IN the_DT IL-4_NN gene_NN were_VBD identified_VBN by_IN DNA-mobility-shift_NN assays_NNS ._JJ
In_IN JM_NN T_NN cells_NNS ,_, tax_NN induced_VBN LT-293_NN activity_NN by_IN two-_CD to_TO four-fold_JJ ,_, though_DT there_DT was_VBD no_DT induction_NN of_IN M1-CAT_NN ._NN
Once_NN we_PRP identify_NN the_DT functional_JJ domains_NN of_IN the_DT GATA-binding_NN proteins_NNS ,_, we_PRP hope_NN to_TO learn_NNS what_IN proteins_NNS GATA-1_NN binds_VBZ to_TO in_IN the_DT basic_JJ transcription_NN machinery_NN or_CC in_IN chromatin_NN ._NN
REV_NN LTRs_NN work_NN efficiently_NN in_IN human_JJ lymphoid_JJ cells_NNS ,_, and_CC are_VBP viable_IN alternatives_IN to_TO promoters_NNS commonly_JJ used_VBN for_IN expression_NN of_IN cloned_JJ genes_NNS ._NN
The_DT immunosuppressants_JJ ciclosporin_NN and_CC FK506_NN block_NN the_DT signal-transduction_JJ pathway_NN emanating_NN from_IN the_DT T-cell_NN receptor_NN ,_, thereby_RB inhibiting_VBG the_DT activation_NN of_IN helper_NN T_NN cells_NNS ._JJ
TSC2_JJ messenger_NNS RNA_NN was_VBD widely_JJ expressed_VBN in_IN various_JJ cell_NN types_NNS throughout_IN the_DT body_NN ,_, including_VBG epithelia_NN ,_, lymphocytes_NNS ,_, and_CC cells_NNS with_IN endocrine_JJ functions_NNS ,_, e.g._FW ,_, adrenal_NN cortex_NN and_CC anterior_NN pituitary_NN ._NN
While_NN this_DT expectation_NN may_MD be_VB realized_NN in_IN some_DT cases_NN ,_, we_PRP have_VBP not_RB found_VBN evidence_NN for_IN it_PRP ._NN
We_PRP present_JJ evidence_NN that_WDT induction_NN of_IN neutrophil_JJ binding_NN by_IN LPS_NN is_VBZ actually_VBN suppressed_VBN by_IN agents_NNS that_IN elevated_NN cAMP_NN levels_NNS ._JJ
Interleukin-3_IN expression_NN by_IN activated_VBN T_NN cells_NNS involves_VBZ an_DT inducible_JJ ,_, T-cell-specific_NN factor_NN and_CC an_DT octamer_NN binding_NN protein_NN ._NN
Viruses_NN containing_VBG the_DT human_JJ cytomegalovirus_NN immediate-early_NN enhancer_NN exhibited_NN infectious_NN kinetics_NN similar_JJ to_TO that_DT of_IN wild-type_JJ HIV_NN in_IN activated_VBN human_JJ peripheral_JJ blood_NN lymphocytes_NNS and_CC AA2_NN cells_NNS but_CC replicated_NN less_RBR efficiently_NNS in_IN H9_NN and_CC CEM_NN cells_NNS ._JJ
p52_NN and_CC RelB_NN were_VBD detected_VBN in_IN the_DT nuclei_NNS in_IN both_DT and_CC cells_NNS from_IN the_DT T_NN cell_NN area_VBP ,_, whereas_IN p50_NN was_VBD found_VBN only_RB in_IN CD68-_NN and_CC CD1a-_NN cells_NNS ._JJ
Hydrochlorothiazide_NN therapy_NN resulted_VBD in_IN life-threatening_NN hypokalemia_NN ._NN
Nuclear_JJ factor_NN kappa_NN B_NN ,_, a_DT mediator_NN of_IN lipopolysaccharide_NN effects_NNS ._JJ
Oct-2_NN was_VBD found_VBN in_IN and_CC T_NN cells_NNS prepared_JJ from_IN human_JJ peripheral_JJ blood_NN and_CC in_IN mouse_NN lymph_NN node_NN T_NN cells_NNS ._JJ
Therefore_RB ,_, we_PRP conclude_VBP that_IN IL-4_NN and_CC IL-10_NN inhibit_VBP IL-6_NN production_NN by_IN different_JJ mechanisms_NNS in_IN human_JJ monocytic_JJ cell_NN lines_NNS ._JJ
Northern_NN blot_NN analysis_NN showed_VBD that_IN C3a_NN as_IN well_RB as_IN C3a_NN desArg_NN enhanced_NN LPS-induced_NN mRNA_NN levels_NNS for_IN IL-6_NN ._NN
activators_NN are_VBP required_VBN for_IN HIV-1_NN replication_NN and_CC proviral_NN induction_NN in_IN monocytic_JJ cell_NN lines_NNS ._JJ
IL-2_NN transcription_NN seems_NN to_TO be_VB controlled_NN solely_NN by_IN the_DT transition_NN from_IN inactive_JJ to_TO active_JJ functional_JJ state_NN of_IN a_DT positive_JJ transcription_NN factor_NN binding_NN to_TO these_DT promoter_NN elements_NNS as_IN well_RB as_IN cytoplasmic_JJ or_CC nuclear_JJ location_JJ :_NN in_IN resting_JJ memory_NNS T_NN cells_NNS the_DT activator_NN is_VBZ located_JJ in_IN the_DT cytoplasm_NN and_CC is_VBZ inactive_JJ ,_, whereas_IN in_IN stimulated_VBN cells_NNS it_PRP is_VBZ functional_JJ in_IN promoting_NNS transcription_NN and_CC now_RB resides_JJ in_IN the_DT nucleus_NN ._NN
The_DT v-erb_NN A_NN protein_NN has_VBZ sustained_JJ two_CD amino_NN acid_NN alterations_NNS within_IN DNA-binding_JJ domain_NN relative_JJ to_TO that_IN of_IN c-erb_NN A_NN ,_, one_CD of_IN which_WDT ,_, at_IN serine_NN 61_NN ,_, is_VBZ known_VBN to_TO be_VB important_JJ for_IN v-erb_NN A_NN function_NN in_IN the_DT neoplastic_JJ cell_NN ._NN
In_IN human_JJ monocytes_NNS ,_, interleukin_NN 1beta_NN protein_NN production_NN and_CC steady_NN state_NN mRNA_NN levels_NNS are_VBP increased_VBN in_IN response_NN to_TO lipopolysaccharide_NNS ,_, predominantly_JJ as_IN a_DT result_NN of_IN increased_VBN transcription_NN of_IN the_DT interleukin_NN 1beta_NN gene_NN ._NN
Imbalanced_JJ expression_NN of_IN the_DT glucocorticoid_NN receptor_NN isoforms_NNS in_IN cultured_NNS lymphocytes_NNS from_IN a_DT patient_NN with_IN systemic_NN glucocorticoid_NN resistance_NN and_CC chronic_NN lymphocytic_NN leukemia_NN ._NN
Thymocytes_DT ,_, activated_VBN peripheral_JJ T_NN lymphocytes_NNS ,_, or_CC an_DT activated_VBN T-cell_NN clone_NN were_VBD used_VBN as_IN human_JJ partners_NNS ,_, respectively_RB ,_, in_IN three_CD independent_NN fusions_JJ ._NN
The_DT findings_NN presented_JJ here_NN link_NNS an_DT atheogenic_NN lipoprotein_NN ,_, LDL_NN ,_, with_IN the_DT induction_NN of_IN an_DT adhesion_NN molecule_NN important_JJ in_IN atherogenesis_NN
c-jun_NN mRNA_NN levels_NNS were_VBD superinduced_VBN in_IN cells_NNS treated_NN with_IN both_DT okadaic_NN acid_NN and_CC cycloheximide_NN ,_, whereas_IN inhibition_NN of_IN protein_NN synthesis_NN had_VBD little_JJ ,_, if_IN any_NN ,_, effect_NN on_IN okadaic_NN acid-induced_NN c-jun_NN transcription_NN ._NN
HIV-1_NN harboring_VBZ mutations_NNS within_IN two_CD sites_NNS were_VBD crippled_NNS in_IN ability_NN to_TO replicate_VB in_IN U937_NN promonocytic_NN cells_NNS ,_, indicating_VBG that_IN these_DT sites_NNS are_VBP required_VBN for_IN replication_NN ._NN
The_DT approach_JJ was_VBD further_JJ extended_VBN to_TO cell_NN separation_NN by_IN the_DT efficient_JJ recovery_NN and_CC elution_NN of_IN human_JJ CD37_NN B_NN lymphocytes_NNS from_IN peripheral_JJ blood_NN ._NN
Transient_JJ overexpression_NN of_IN hTAFII105_NN selectively_NN squelches_NN the_DT transcription_NN of_IN some_DT genes_NNS in_IN B_NN cells_NNS ._JJ
Previous_JJ studies_NNS have_VBP suggested_VBD that_IN gangliosides_NN have_VBP an_DT important_JJ role_NN in_IN cell_NN signaling_NN and_CC recognition_NN ._NN
Both_NN NK-_NN and_CC T-cell_NN subtypes_NNS are_VBP closely_RB associated_VBN with_IN Epstein-Barr_JJ virus_NN EBV_NN ._NN
This_DT decrease_NN was_VBD seen_JJ in_IN patients_NNS who_IN responded_JJ to_TO the_DT therapy_NN as_IN well_RB as_IN in_IN those_DT who_NN did_VBD not_RB ._VBN
In_IN the_DT present_JJ study_NN ,_, corticosteroid_NN Type_NN I_NN and_CC Type_NN II_NN receptors_NNS in_IN mononuclear_JJ leukocytes_NNS were_VBD measured_NN in_IN 10_CD elderly_NN subjects_NNS and_CC in_IN 9_NN young_NN adults_NN ,_, before_VBG and_CC after_IN overnight_NN DST_NN 1_CD mg_JJ ._NN
Other_NN studies_NNS have_VBP demonstrated_VBN that_IN TPA-induced_NN monocytic_JJ differentiation_NN and_CC expression_NN of_IN the_DT c-jun_NN and_CC c-fos_NN genes_NNS in_IN myeloid_JJ leukemia_NN cells_NNS are_VBP regulated_VBN by_IN protein_NN kinase_NN C_NN PKC_NN ._NN
Constitutive_JJ nuclear_JJ appearance_NN was_VBD also_RB observed_VBN for_IN ._NN
To_TO determine_VB the_DT E1A_NN domain_NN s_NN responsible_NN for_IN these_DT properties_NNS several_JJ cell_NN lines_NNS were_VBD created_NN by_IN transforming_NN baby_NN rat_NN kidney_NN BRK_NN cells_NNS with_IN a_DT set_JJ of_IN plasmids_NNS expressing_VBG different_JJ hybrid_NN E1A_NN gene_NN products_NN ._NN
Activation_NN of_IN Stat_NN 5b_NN in_IN erythroid_JJ progenitors_NNS correlates_VBG with_IN the_DT ability_NN of_IN ErbB_NN to_TO induce_VB sustained_JJ cell_NN proliferation_NN ._NN
A_DT chimeric_NN type_NN II_NN type_NN I_NN interleukin-1_NN receptor_NN can_MD mediate_VB interleukin-1_NN induction_NN of_IN gene_NN expression_NN in_IN T_NN cells_NNS ._JJ
In_IN contrast_NN to_TO inhibitory_JJ effects_NNS on_IN cytokine_NN expression_NN ,_, GCS_NN up-regulate_NN cytokine_NN receptor_NN expression_NN that_WDT correlates_NN with_IN enhanced_NN cytokine_NN effects_NNS on_IN target_NN cells_NNS ._JJ
The_DT translated_NN protein_NN showed_VBD weak_RB DNA_NN binding_NN with_IN a_DT specificity_JJ for_IN the_DT kappa_NN B_NN binding_NN motif_NN ._NN
Treatment_NN of_IN Jurkat_NN cells_NNS with_IN mAb_NN J393_NN induced_VBD tyrosine_JJ phosphorylation_NN of_IN specific_JJ protein_NN substrates_NNS that_WDT underwent_JJ hyperphosphorylation_NN upon_IN antigen_NN receptor_NN costimulation_NN ._NN
The_DT effect_NN appeared_VBD within_IN 30_CD min_NN and_CC returned_NN to_TO basal_JJ levels_NNS after_IN 2_CD h_NN ._NN
These_DT factors_NNS are_VBP detected_VBN at_IN the_DT time_NN the_DT CD11b_NN promoter_NN is_VBZ activated_VBN ._NN
There_EX were_VBD two_CD main_JJ goals_NN :_: 1_CD to_TO evaluate_VB whether_IN workers_NN with_IN a_DT moderately_NN increased_VBD burden_JJ 25-140_NN ppt_NN TCDD_NN or_CC 104-522_NN ppt_NN I-TE_NN in_IN blood_NN fat_NN exhibit_NN changes_NN in_IN the_DT surface_NN receptors_NNS of_IN white_NN blood_NN cells_NNS ,_, as_IN observed_VBN in_IN previous_JJ studies_NNS in_IN non-human_JJ primates_JJ ,_, and_CC 2_CD to_TO clarify_NN whether_IN persons_JJ at_IN the_DT upper_JJ range_NN 10-23_NN ppt_NN TCDD_NN or_CC 30-90_NN ppt_NN I-TE_NN in_IN blood_NN fat_NN of_IN the_DT body_NN burden_NN reference_NN values_NN of_IN a_DT not_RB particularly_JJ exposed_NN population_NNS show_VBP detectable_JJ deviations_NN in_IN these_DT immunological_JJ variables_NN ,_, when_WRB compared_VBN with_IN persons_JJ at_IN the_DT lower_JJ and_CC medium_JJ range_NN 1-3_NN ppt_NN TCDD_NN or_CC 9-29_NN ppt_NN I-TE_NN of_IN these_DT body_NN burden_NN reference_NN values_NN ._NN
Cyclosporin_JJ A_NN CsA_NN and_CC FK506_NN rescued_NN B104_NN cells_NNS from_IN death_NN induced_VBD by_IN anti-IgM_NN Ab_NN ,_, but_CC did_VBD not_RB affect_VBN the_DT expression_NN of_IN Egr-1_NN and_CC c-fos_NN mRNA_NN ,_, showing_NN that_IN CsA_NN and_CC FK506_NN affect_NN signal_NN transducers_NN differently_VBD from_IN or_CC downstream_JJ to_TO these_DT molecules_JJ ._NN
Signaling_JJ via_IN IL-2_NN and_CC IL-4_NN in_IN JAK3-deficient_NN severe_JJ combined_NN immunodeficiency_NN lymphocytes_NNS :_: JAK3-dependent_NN and_CC independent_NN pathways_NN ._NN
1_CD ._NN The_DT purpose_JJ of_IN these_DT studies_NNS was_VBD to_TO investigate_VBN the_DT modulation_NN of_IN the_DT proliferation_NN of_IN human_JJ T_NN cells_NNS obtained_VBN from_IN peripheral_JJ blood_NN by_IN dexamethasone_NN DEX_NN ,_, isoproterenol_VBN ISO_NN ,_, and_CC prostaglandin_NN E2_NN PGE2_NN ._NN
As_NN the_DT NF-kappa_NN B_NN transcription_NN factor_NN has_VBZ a_DT central_JJ role_NN in_IN the_DT control_NN of_IN transcription_NN of_IN several_JJ genes_NNS involved_VBN in_IN immune_JJ and_CC inflammatory_JJ responses_NNS ,_, the_DT authors_NN have_VBP analysed_VBN the_DT activation_NN of_IN NF-kappa_NN B_NN in_IN human_JJ umbilical_JJ cord_NN T_NN lymphocytes_NNS ._JJ
Bcd_NN mRNA_NN transcripts_NNS of_IN or_CC 2.6_NN kb_NN were_VBD selectively_JJ expressed_VBN in_IN PBL_NN and_CC testis_NN of_IN healthy_NN individuals_NN ._NN
In_IN this_DT review_JJ ,_, we_PRP summarize_VBP the_DT current_NN state_NN of_IN knowledge_JJ of_IN the_DT mechanism_NN of_IN action_NN of_IN GCS_NNS ,_, including_VBG the_DT phenomenon_NN of_IN steroid-induced_JJ rebound_NN ,_, which_WDT ensues_NN upon_IN GCS_NNS withdrawal_IN ._NN
The_DT activity_NN of_IN the_DT CCAAT-box_NN binding_NN factor_NN NF-Y_NN is_VBZ modulated_NN through_IN the_DT regulated_VBN expression_NN of_IN A_NN subunit_NN during_IN monocyte_NN to_TO macrophage_VB differentiation_NN :_: regulation_NN of_IN tissue-specific_NNS genes_NNS through_IN a_DT ubiquitous_JJ transcription_NN factor_NN ._NN
Early_NN buds_NN are_VBP characterized_VBN by_IN a_DT branching_JJ morphogenesis_NN of_IN the_DT ductal_JJ epithelium_NN from_IN which_WDT endocrine_JJ and_CC exocrine_JJ precursor_NN cells_NNS bud_JJ to_TO eventually_VB form_NN the_DT two_CD other_JJ compartments_NNS ._NN
Substantial_NN decreases_NN of_IN IL-2_NN production_NN were_VBD observed_VBN for_IN cell_NN cultures_NNS from_IN 7_NN of_IN 12_JJ elderly_NN individuals_NNS in_IN response_NN to_TO the_DT different_JJ stimuli_NN ,_, whereas_IN the_DT levels_NNS of_IN IL-2_NN produced_NN by_IN stimulated_VBN T_NN cells_NNS from_IN other_JJ elderly_NN individuals_NNS were_VBD equivalent_JJ to_TO those_DT observed_NN for_IN stimulated_VBN T_NN cells_NNS of_IN young_NN subjects_NNS ._JJ
Half-maximal_NN induction_NN of_IN GR_NN mRNA_NN and_CC protein_NN in_IN 6TG1.1_NN cells_NNS was_VBD observed_VBN between_IN 10-100_CD nM_NN dexamethasone_NN ,_, and_CC inclusion_NN of_IN 1_CD microM_NN RU_NN 38486_NN completely_NN blocked_VBD the_DT effects_NNS of_IN 100_NN nM_NN dexamethasone_NN ,_, demonstrating_VBG that_IN positive_JJ autoregulation_NN of_IN GR_NN expression_NN in_IN 6TG1.1_NN cells_NNS is_VBZ a_DT receptor-mediated_NN response_NN ._NN
Taken_VBN together_RB ,_, results_NNS suggest_VBP that_IN OCA-B_NN is_VBZ a_DT tissue-_JJ ,_, promoter-_JJ ,_, and_CC factor-specific_NN coactivator_NN and_CC that_IN OCA-B_NN may_MD be_VB a_DT major_JJ determinant_NN for_IN B_NN cell-specific_JJ activation_NN of_IN immunoglobulin_NN promoters_NNS ._JJ
Constitutive_JJ binding_NN of_IN further_JJ factor_NN proteins_NNS to_TO DNA_NN ,_, such_JJ as_IN JunD_NN ,_, c-Fos_NN and_CC FosB_NN ,_, was_VBD detected_VBN in_IN several_JJ patients_NNS whereas_IN the_DT localisation_JJ and_CC DNA_NN binding_NN of_IN other_JJ factors_NNS such_JJ as_IN c-Jun_NN ,_, and_CC c-Rel_NN was_VBD unaltered_JJ ._NN
A_DT clone_NN of_IN U937_NN cells_NNS was_VBD selected_JJ which_WDT expressed_VBN Fc_NN receptor_NN I_NN Fc_NN gamma_NN RI_NN and_CC which_WDT ,_, after_IN incubation_VBG with_IN IFN-gamma_NN for_IN 72_NN h_NN ,_, was_VBD capable_JJ of_IN generating_NNS high_JJ levels_NNS of_IN lucigenin-enhanced_NN CL_NN ._NN
Different_JJ amounts_NN of_IN the_DT various_JJ isoforms_NN are_VBP present_JJ within_IN the_DT same_JJ B-cell_NN regardless_NN of_IN the_DT developmental_NN stage_NN of_IN B-cell_NN differentiation_NN and_CC at_IN least_JJS some_DT of_IN the_DT isoforms_NNS are_VBP conserved_VBN between_IN mouse_NN and_CC humans_JJ ._NN
These_DT blast_NN cells_NNS express_VBP lineage-specific_NNS transcription_NN factors_NNS such_JJ as_IN GATA-1_NN common_JJ to_TO these_DT lineages_NNS and_CC frequently_JJ express_NN erythroid-specific_JJ mRNAs_NN such_JJ as_IN gamma-globin_NN and_CC erythroid_JJ delta-aminolevulinate_NN synthase_NN ALAS-E_NN ,_, indicating_VBG that_IN most_RBS of_IN the_DT blasts_NNS in_IN M7_NN and_CC TMD_NN cases_NN have_VBP erythroid_JJ and_CC megakaryocytic_JJ phenotypes_NN ._NN
The_DT structural_JJ classes_NN of_IN transcription_NN factors_NNS are_VBP described_VBN and_CC basic_JJ methods_NN for_IN detection_NN and_CC analysis_NN of_IN transcription_NN factors_NNS are_VBP detailed_VBN ._JJ
Overexpression_NN of_IN the_DT p50_NN ,_, p65_NN and_CC Rel_NN proteins_NNS in_IN these_DT cells_NNS showed_VBP that_IN significant_JJ activation_NN of_IN the_DT IL-2R_NN alpha_NN kappa_NN B_NN site_NN was_VBD observed_VBN only_RB with_IN Rel_NN and_CC Rel_NN plus_NN p65_NN ._NN
Three_RB molecular_JJ clones_NNS of_IN HIV-1_NN ,_, derived_VBN from_IN a_DT single_JJ isolate_NN AL1_NN ,_, exhibited_VBG distinct_JJ replicative_JJ and_CC cytopathic_JJ properties_NNS during_IN propagation_NN in_IN a_DT human_JJ T_NN cell_NN line_NN ._NN
Okadaic_NN acid_NN was_VBD found_VBN to_TO be_VB a_DT potent_JJ inducer_NN of_IN AP1_NN ._NN
It_PRP is_VBZ assumed_VBN that_IN pp56-LRB-lck-RRB-_NN acts_NN on_IN these_DT processes_NN by_IN phosphorylating_NN substrates_NN ._NN
Instead_IN ,_, ATF-2_NN and_CC Jun_NN proteins_NNS bind_VBP to_TO the_DT composite_NN kappa_NN site_NN and_CC NFATp_NN binds_VBZ to_TO a_DT newly_JJ identified_NN second_JJ NFAT_NN site_NN centered_NN at_IN -76_NN nucleotides_NN relative_JJ to_TO the_DT TNF-alpha_NN transcription_NN start_NN site_NN ._NN
When_WRB endothelial_JJ cells_NNS are_VBP incubated_VBN with_IN this_DT lipoprotein_NNS in_IN pathophysiologic_NN amounts_NN ,_, the_DT cells_NNS are_VBP activated_VBN ._JJ
LPS_JJ binding_NN to_TO plasma_NN membrane_NNS receptors_NNS and_CC internalization_JJ of_IN LPS_NN into_IN monocytes_NNS were_VBD not_RB affected_VBN by_IN lysoPC_NN ._NN
The_DT kappa_NN B_NN sequence_NN GGGACTTTCC_NN binds_VBZ a_DT factor_NN ,_, NF-kappa_NN B_NN ,_, that_IN is_VBZ constitutively_RB found_VBN in_IN functional_JJ ,_, DNA_NN binding_NN form_NN only_RB in_IN B_NN lymphocytes_NNS ._JJ
We_PRP have_VBP isolated_VBN TFIIH_JJ from_IN cells_NNS derived_VBN from_IN a_DT patient_NN XP11BE_NN who_NN carries_NN this_DT frameshift_NN mutation_NN TFIIHmut_NN and_CC from_IN the_DT mother_NN of_IN this_DT patient_NN TFIIHwt_NN to_TO determine_VB the_DT biochemical_JJ consequences_NN of_IN the_DT mutation_NN ._NN
Activation_NN of_IN T_NN cells_NNS results_NNS in_IN a_DT cascade_NN of_IN gene_NN activation_NN and_CC subsequent_NN proliferation_NN and_CC differentiation_NN into_NN effector_NN phenotypes_NN ._NN
These_DT findings_NN provide_NN direct_JJ in_IN vivo_NN evidence_NN to_TO strongly_RB suggest_VBP that_IN the_DT modulation_NN of_IN X1_NN and_CC X2_NN interactions_NN is_VBZ an_DT important_JJ constituent_NN of_IN the_DT interferon_NN gamma_NN induction_NN pathway_NN ._NN
One_CD of_IN the_DT factors_NNS bound_VBD to_TO a_DT novel_JJ dyad_NN symmetrical_NN sequence_NN ._NN
Recent_JJ work_NN has_VBZ shown_VBN that_IN IL-10_NN induces_VBZ activation_NN of_IN the_DT JAK-STAT_NN signaling_NN pathway_NN ._NN
Subsequently_NN binding_NN sites_NNS have_VBP been_VBN demonstrated_VBN in_IN the_DT plasma_NN membrane_NNS of_IN human_JJ lymphocytes_NNS which_WDT show_VBP pharmacological_NN aldosterone_NN specificity_NN and_CC kinetic_NN high_JJ turnover_NN properties_NNS identical_VBD with_IN those_DT of_IN the_DT rapid_JJ aldosterone_NN effects_NNS in_IN the_DT same_JJ cells_NNS ._NN
TCF-1_NN contained_VBD a_DT single_JJ DNA-binding_JJ HMG_NN box_NN most_RBS closely_JJ related_JJ to_TO similar_JJ boxes_NN in_IN the_DT putative_JJ mammalian_JJ sex-determining_NN gene_NN SRY_NN and_CC in_IN the_DT Schizosaccharomyces_NN pombe_NN Mc_NN mating_NN type_NN gene_NN ._NN
The_DT biochemical_JJ modifications_NN responsible_NN for_IN the_DT defect_NN in_IN transduction_NN and_CC execution_NN of_IN the_DT proliferative_NN signal_NN are_VBP analyzed_VBN as_IN a_DT function_NN of_IN age_NN ._NN
Moreover_RB ,_, using_VBG a_DT heterologous_JJ promoter_NN herpes_NN thymidine_NN kinase_NN construct_NN containing_VBG the_DT NF-kappa_NN B_NN consensus_NN sequence_NN ,_, it_PRP is_VBZ shown_VBN that_IN NF-kappa_NN B_NN binding_NN by_IN an_DT IL-2-induced_NN monocyte-derived_NN nuclear_JJ protein_NN confers_NN reporter_NN gene_NN human_JJ growth_NN hormone_NN activity_NN ._NN
This_DT study_NN determined_NN if_IN the_DT Ad5-induced_JJ inhibition_NN of_IN IFN-MCP_NN was_VBD independent_VBN of_IN adenovirus_NN Ad_NN infection_NN and_CC secondary_JJ only_RB to_TO the_DT expression_NN of_IN the_DT Ad_JJ early_JJ region_NN 1A_NN gene_NN E1A_NN ._NN
Analysis_NN of_IN a_DT series_NN of_IN showed_JJ several_JJ peaks_NN of_IN basal_JJ and_CC PMA_NN induced_VBD activity_NN suggesting_VBG the_DT presence_JJ of_IN several_JJ positive_JJ and_CC negative_JJ regulatory_JJ elements_NNS ._NN
Thus_RB ,_, this_DT work_NN presents_VBZ the_DT first_JJ detailed_NN analysis_NN of_IN a_DT naturally_JJ occurring_NN mutation_NN in_IN a_DT basal_JJ transcription_NN factor_NN and_CC supports_NN the_DT concept_NN that_WDT the_DT combined_JJ clinical_JJ entity_NN is_VBZ actually_VBN the_DT result_JJ of_IN a_DT combined_JJ deficiency_NN ._NN
Cortivazol_NN is_VBZ a_DT phenylpyrazolo_NN glucocorticoid_NN of_IN high_JJ potency_JJ and_CC unusual_JJ structure_NN ._NN
This_DT indicated_JJ that_IN the_DT dUTPase_NN is_VBZ expressed_VBN during_IN EBV_NN replication_NN and_CC reactivation_NN ._NN
We_PRP have_VBP therefore_RB investigated_VBN the_DT changes_NN in_IN protein_NN kinase_NN C_NN PKC_NN activity_NN upon_IN exposure_NN of_IN monocytes_NNS to_TO M-CSF_NN ._NN
These_DT studies_NNS suggest_VBP that_IN ,_, by_IN inhibiting_VBG AP-1_NN activation_NN ,_, Nef_NN may_MD play_VB a_DT role_NN in_IN regulating_VBG HIV-1_NN gene_NN expression_NN in_IN infected_JJ T-cells_NN
As_NN a_DT consequence_NN ,_, the_DT immune_JJ response_NN developed_NN in_IN senescent_JJ organisms_NN is_VBZ usually_NN inappropriate_NN ,_, often_NN inefficient_NN ,_, sometimes_RB aberrant_JJ ,_, and_CC potentially_JJ detrimental_NN ._NN
The_DT regulatory_JJ mechanisms_NNS of_IN the_DT human_JJ and_CC murine_JJ TNF_NN genes_NNS are_VBP discussed_NN ._NN
Furthermore_RB ,_, we_PRP present_JJ a_DT new_JJ principle_NN for_IN searching_JJ Ag_NN for_IN potential_JJ amphipatic_NN alpha-helical_NN protein_NN segments_NN ._NN
Mobility_NN shift_NN assays_NNS showed_VBD that_IN the_DT CLE0_NN sequence_NN has_VBZ an_DT AP1-binding_NN site_NN and_CC is_VBZ associated_VBN with_IN an_DT NF-AT-like_NN factor_NN ,_, termed_VBN NF-CLE0_NN gamma_NN ._NN
Two_CD homologues_NN of_IN the_DT rhombotin_NN gene_NN have_VBP now_RB been_VBN isolated_VBN ._NN
Together_TO ,_, this_DT evidence_NN strongly_RB implicates_JJ BSAP_NN in_IN the_DT regulation_NN of_IN the_DT CD19_NN gene_NN ._NN
The_DT numbers_NN of_IN estrogen_JJ receptor_NN ER_NN in_IN human_JJ peripheral_JJ leucocytes_NN in_IN 22_NN women_NN with_IN climacteric_JJ syndrome_NN were_VBD measured_VBN by_IN radioligand_NN method_NN ._NN
Changes_NN in_IN leucocytic_JJ estrogen_NN receptor_NN levels_NNS in_IN patients_NNS with_IN climacteric_JJ syndrome_NN and_CC therapeutic_DT effect_NN of_IN liuwei_NN dihuang_JJ pills_NN
The_DT 70_NN kDa_NN heat_NN shock_NN protein_NN Hsp70_NN is_VBZ a_DT highly_JJ conserved_NN ,_, ubiquitous_JJ protein_NN involved_VBN in_IN chaperoning_NN proteins_NNS to_TO various_JJ cellular_JJ organelles_NN ._NN
The_DT first_JJ male_NN patient_NN presented_VBZ with_IN mild_JJ hypertension_NN ._NN
The_DT endocrine_JJ events_NNS that_WDT are_VBP rapidly_JJ expressed_VBN seconds_JJ are_VBP due_JJ to_TO a_DT possible_JJ interaction_NN with_IN cellular_JJ membrane_NNS ._NN
Elevated_NN cAMP_NN did_VBD not_RB prevent_VBN nuclear_JJ translocation_NN of_IN and_CC heterodimers_JJ ,_, decrease_NN nuclear_JJ translocation_NN of_IN p65_NN ,_, or_CC significantly_JJ modify_NN TNFalpha-induced_NN phosphorylation_NN of_IN p65_NN ._NN
To_TO analyze_NN the_DT regulatory_JJ mechanisms_NNS controlling_VBG p27Kip1_NN gene_NN expression_NN ,_, we_PRP characterized_NN the_DT region_NN from_IN nt_NN -1609_NN to_TO ._NN
Various_JJ modes_NN of_IN basic_JJ helix-loop-helix_NN protein-mediated_NN regulation_NN of_IN murine_JJ leukemia_NN virus_NN transcription_NN in_IN lymphoid_JJ cell_NN lines_NNS ._JJ
In_IN contrast_NN ,_, Spi-B_NN is_VBZ expressed_VBN exclusively_VBN in_IN lymphoid_JJ cells_NNS and_CC can_MD be_VB detected_VBN in_FW early_JJ fetal_JJ thymus_NN and_CC spleen_NN ._NN
Whereas_IN the_DT hypercalcemic_NN effect_NN for_IN ZK157202_NN is_VBZ also_RB increased_VBN 10-fold_CD ,_, ZK161422_NN has_VBZ the_DT same_JJ calcium-mobilizing_NN potency_NN as_IN VD_NN ._NN
The_DT responses_NNS of_IN lymphocytes_NNS to_TO IL-2_NN and_CC IL-12_NN ,_, involving_VBN proliferation_NN ,_, differentiation_NN ,_, and_CC cytokine_NN production_NN ,_, are_VBP only_RB partially_JJ overlapping_NN ,_, and_CC may_MD depend_NN on_IN induced_VBN differential_JJ expression_NN of_IN specific_JJ sets_NN of_IN genes_NNS ._NN
Serial_JJ sectioning_JJ of_IN 6_CD micrometer_NN was_VBD performed_JJ using_VBG a_DT cryostat_NN ,_, and_CC samples_NN were_VBD immunohistochemically_JJ stained_NN using_VBG the_DT streptoavidin-biotin_JJ peroxidase_NN method_NN and_CC a_DT monoclonal_JJ antibody_NN against_IN c-fos_NN ._NN
Following_NN irradiation_JJ ,_, transgenic_JJ mice_NNS ,_, as_IN compared_VBN with_IN controls_NN ,_, more_RBR rapidly_JJ depressed_NN peripheral_JJ white_NN blood_NN cell_NN and_CC granulocyte_NN counts_NN ._NN
Furthermore_RB ,_, an_DT inverse_VBN relationship_NN was_VBD also_RB observed_VBN between_IN the_DT LDL_NN receptor_NN gene_NN expression_NN at_IN the_DT transcriptional_JJ level_NN and_CC the_DT binding_NN affinity_NN of_IN this_DT 47_NN kDa_NN protein_NN factor_NN to_TO the_DT SRE_NN sequence_NN ._NN
We_PRP studied_VBP the_DT effect_NN of_IN interleukin-4_JJ IL-4_NN on_IN the_DT lipopolysaccharide_NN LPS_NN induction_NN of_IN two_CD immediate_NN early_JJ genes_NNS c-fos_NN and_CC c-jun_NN ._NN
A_DT similar_JJ half-life_NN was_VBD determined_VBN in_IN IM-9_NN cells_NNS and_CC was_VBD also_RB unaffected_VBN by_IN steroid_NN treatment_NN ._NN
Human_NN T-cell_NN leukemia_NN virus_NN type_NN I_NN HTLV-I_NN is_VBZ the_DT etiologic_NN agent_NN of_IN the_DT adult_NN T-cell_NN leukemia_NN ,_, an_DT aggressive_NN and_CC often_NN fatal_NN malignancy_NN of_IN activated_VBN human_JJ CD4_NN T_NN cells_NNS ._JJ
A_DT novel_JJ HIV-1_NN isolate_NNS containing_VBG alterations_NNS affecting_VBG the_DT NF-kappa_NN B_NN element_NN ._NN
TCF-1_NN alpha_NN is_VBZ currently_RB unique_JJ among_IN the_DT newly_JJ emerging_NN family_NN of_IN DNA-binding_JJ regulatory_JJ proteins_NNS that_WDT share_VBP the_DT HMG_NN motif_NN in_IN that_IN it_PRP is_VBZ a_DT highly_JJ tissue-specific_NN RNA_NN polymerase_NN II_NN transcription_NN factor_NN ._NN
DNA-binding_JJ assays_NNS with_IN cotranslated_NN wild-type_JJ and_CC truncated_JJ forms_NNS of_IN EBF_NN indicated_VBZ that_IN the_DT protein_NN interacts_NN with_IN site_NN as_IN a_DT homodimer_NN ._NN
This_DT phenomenon_NN has_VBZ been_VBN termed_VBN tolerance_IN ._NN
Direct_JJ exposure_NN to_TO 2,3,7,8-tetrachlorodibenzo-p-dioxin_NN TCDD_NN increases_NN infectivity_NN of_IN human_JJ erythrocytes_JJ to_TO a_DT malarial_NN parasite_JJ ._NN
Northern_NN analysis_NN using_VBG a_DT probe_NN encompassing_NN a_DT common_JJ region_NN of_IN both_CC isoforms_NNS showed_VBD two_CD mRNA_NN species_NNS of_IN 2.7_NN and_CC 4.5_NN kilobase_NNS pairs_JJ ,_, while_IN an_DT NFATc.beta-specific_NN probe_NN detected_NN only_RB the_DT 4.5-kilobase_NN pair_NN mRNA_NN which_WDT was_VBD preferentially_JJ expressed_VBN in_IN the_DT spleen_JJ ._NN
The_DT rhombotin_NN family_NN of_IN cysteine-rich_NN LIM-domain_NN oncogenes_NN :_: distinct_JJ members_NNS are_VBP involved_VBN in_IN T-cell_NN translocations_NN to_TO human_JJ chromosomes_NN 11p15_NN and_CC 11p13_NN ._NN
c-myc_NN did_VBD not_RB correlate_NN with_IN c-fos_NN and_CC c-jun_NN protein_NN expression_NN ._NN
Fas-mediated_JJ apoptosis_NN plays_VBZ an_DT important_JJ role_NN in_IN regulating_VBG the_DT immune_JJ response_NN in_IN peripheral_JJ T_NN cells_NNS ._JJ
Importantly_JJ ,_, culture_NN of_IN MM_NN cells_NNS with_IN RB_NN antisense_NN ,_, but_CC not_RB RB_JJ sense_NN ,_, oligonucleotide_NN ODN_NN triggered_NN IL-6_NN secretion_NN and_CC proliferation_NN in_IN MM_NN cells_NNS ;_: however_NN ,_, proliferation_NN was_VBD only_RB partially_VB inhibited_VBN by_IN neutralizing_JJ anti-IL-6_NN monoclonal_NN antibody_NN MoAb_NN ._NN
Antigen_NN receptor_NN signals_NNS could_MD be_VB mimicked_JJ by_IN suboptimal_NNS activation_NN of_IN protein_NN kinase_NN C_NN PKC_NN with_IN phorbol_NN esters_NNS in_IN combination_NN with_IN calcium_NN mobilization_NN by_IN an_DT ionophore_NN ._NN
The_DT P_NN sequence_NN does_VBZ not_RB share_NN homology_NN with_IN the_DT upstream_JJ sequence_NN of_IN the_DT IL-2_NN gene_NN ,_, even_RB though_DT surrounding_NN sequences_NNS of_IN the_DT IL-4_NN gene_NN share_NN high_JJ homology_NN with_IN the_DT IL-2_NN gene_NN ._NN
An_DT amino-terminal_NN fragment_NN of_IN OCA-B_NN binds_VBZ the_DT octamer_NN site_NN in_IN the_DT absence_NN of_IN a_DT POU_NN domain_NN with_IN the_DT same_JJ sequence_NN specificity_NN ._NN
The_DT GS_NN strain_NN transactivated_NN the_DT promoter_NN in_IN both_CC stimulated_VBN and_CC resting_JJ T_NN cells_NNS ,_, while_IN the_DT Z29_NN strain_NN increased_VBD HIV_NN promoter_NN activity_NN only_RB in_IN stimulated_VBN T_NN cells_NNS ._JJ
In_IN contrast_NN ,_, the_DT human_JJ T_NN cell_NN line_NN ,_, IARC_NN 301_CD ,_, expresses_NN these_DT two_CD genes_NNS constitutively_RB and_CC we_PRP have_VBP previously_RB demonstrated_VBN that_IN growth_NN depends_NN on_IN the_DT autocrine_JJ production_NN of_IN this_DT T_NN cell_NN growth_NN factor_NN and_CC high_JJ affinity_NN IL-2R_NN ._NN
However_RB ,_, longer_JJ periods_JJ of_IN incubation_VBG were_VBD associated_VBN with_IN a_DT return_NN to_TO the_DT distribution_NN of_IN PKC_NN in_IN control_NN cells_NNS ._JJ
Reticuloendotheliosis_JJ virus_NN long_JJ terminal_JJ repeat_NN elements_NNS are_VBP efficient_NNS promoters_NNS in_IN cells_NNS of_IN various_JJ species_NNS and_CC tissue_NNS origin_CC ,_, including_VBG human_JJ lymphoid_JJ cells_NNS ._NN
Currently_NN it_PRP is_VBZ accepted_VBN the_DT existence_JJ of_IN a_DT cytoplasmic_JJ nuclear_JJ receptor_NN ,_, without_IN explaining_NN satisfactorily_NN how_NN the_DT hormones_NN come_NN to_TO the_DT nucleus_NN ._NN
Infection_IN of_IN target_NN cells_NNS with_IN cytopathic_NN viruses_NN inhibits_VBZ IFN_NN induction_NN of_IN cytolytic_JJ resistance_NN to_TO NK_NN cell-mediated_JJ cytolysis_NN IFN-mediated_NN cytoprotection_NN IFN-MCP_NN ._NN
We_PRP show_VBP that_IN ATRA_NN directly_JJ activates_VBZ IRF-1_NN gene_NN expression_NN ,_, followed_VBG by_IN activation_NN of_IN IRF-2_NN and_CC oligoadenylate_NN synthetase_NN OAS_NN gene_NN expression_NN with_IN slower_NN kinetics_NN ._NN
Here_RB we_PRP demonstrate_VBP that_IN the_DT human_JJ monocytic_JJ M-CSF_NN receptor_NN promoter_NN directs_VBZ reporter_NN gene_NN activity_NN in_IN a_DT tissue-specific_JJ fashion_NN ._NN
Except_IN for_IN PGF2_NN alpha_NN ,_, HHT_NN and_CC 15-HETE_NN no_DT detectable_JJ quantities_NN of_IN eicosanoids_NN were_VBD found_VBN in_IN the_DT non-tumor_JJ material_NN ,_, whereas_IN in_IN the_DT malignant_JJ tumor_NN material_VBP substantial_JJ quantities_JJ of_IN a_DT number_NN of_IN eicosanoid_NN metabolites_NN were_VBD present_JJ ._NN
This_DT study_NN examines_NN the_DT regions_NNS of_IN the_DT HIV_NN promoter_NN required_VBD for_IN HHV-6_NN transactivation_NN in_IN a_DT heterogeneous_JJ population_NN of_IN primary_JJ human_JJ T_NN lymphocytes_NNS with_IN or_CC without_IN antigenic_NN stimulation_NN ._NN
Biomarkers_JJ included_NN DNA_NN ploidy_NN ,_, estrogen_NN receptor_NN ER_NN ,_, and_CC epidermal_NN growth_NN factor_NN receptor_NN EGFR_NN ._NN
Protective_NN effects_NNS of_IN notch-1_RB on_IN TCR-induced_NN apoptosis_NN ._NN
We_PRP previously_RB showed_VBD that_IN granulocyte-macrophage_JJ colony-stimulating_JJ factor_NN GM-CSF_NN and_CC macrophage_NN colony-stimulating_JJ factor_NN M-CSF_NN stimulate_VBZ the_DT differentiation_NN of_IN human_JJ monocytes_NNS into_IN two_CD phenotypically_NN distinct_JJ types_NNS of_IN macrophages_JJ ._NN
For_NN the_DT study_NN of_IN the_DT changes_NN in_IN plasma_NN interleukin-1_NN IL-1_NN and_CC possible_NN relationship_NN with_IN the_DT changes_NN in_IN glucocorticoid_NN receptor_NN GR_NN ,_, plasma_NN IL-1_NN and_CC GR_NN in_IN peripheral_JJ blood_NN leukocytes_NNS in_IN aged_NNS long-distance_JJ runner_JJ were_VBD measured_NN simultaneously_JJ ._NN
Enhanced_NN IL-2_NN transcription_NN correlates_NN with_IN increased_VBN c-fos_NN synthesis_NN and_CC increased_VBD Fos_NN content_NN of_IN AP-1_NN ._NN
In_IN clonogenetic_NN fetal_JJ calf_NN serum-supplemented_NN or_CC -nonsupplemented_NN FCS-_NN culture_NN treated_NN with_IN saturating_NN levels_NNS of_IN interleukin-3_NN IL-3_NN granulocyte-macrophage_NNS colony-stimulating_JJ factor_NN GM-CSF_NN and_CC erythropoietin_JJ Ep_NN combined_NNS with_IN c-kit_NN ligand_NN in_IN FCS-LRB---RRB--culture_NN conditions_NN ,_, RA_NN induces_VBZ a_DT dramatic_NN dose-dependent_NN shift_NN from_IN erythroid_JJ to_TO granulomonocytic_NNS colony_JJ formation_NN ,_, the_DT latter_NN colonies_NNS being_VBG essentially_JJ represented_NN by_IN granulocytic_JJ clones_NNS ._NN
However_RB ,_, simultaneous_JJ incubation_VBD of_IN RU_NN 486_NN with_IN dexamethasone_NN caused_VBN a_DT distinct_JJ interference_NN of_IN RU_NN 486_NN with_IN dexamethasone_NN ._NN
Proliferation_NN index_VBZ as_IN a_DT prognostic_NN marker_NN in_IN breast_JJ cancer_NN ._NN
The_DT differentiating_VBG effects_NNS of_IN the_DT other_JJ C-11_NN analogs_NN on_IN human_JJ promyeloid_NN leukemia_NN cells_NNS HL-60_NN agreed_NN well_RB with_IN bone-resorbing_NN activity_NN and_CC receptor_NN affinity_NN ,_, but_CC they_PRP demonstrated_VBD lower_JJR calcemic_NN effects_NNS in_IN vivo_NN ._NN
These_DT results_NNS can_MD not_RB be_VB explained_VBN by_IN receptor_NN down-regulation_NN due_JJ to_TO higher_JJ level_NN of_IN mineralocorticoids_NN of_IN the_DT zona_NN glomerulosa_NN ._NN
This_DT result_JJ indicates_NN the_DT involvement_VBN of_IN either_CC a_DT B-cell-specific_NN cofactor_NN or_CC a_DT specific_JJ modification_NN of_IN a_DT cofactor_NN or_CC the_DT Oct2_NN protein_NN in_IN Oct2-mediated_NN enhancer_NN activation_NN ._NN
Cyclosporin_JJ A_NN CsA_NN and_CC FK506_NN inhibit_VBP the_DT production_NN of_IN IL-2_NN in_IN T_NN lymphocytes_NNS at_IN the_DT level_NN of_IN gene_NN transcription_NN ._NN
NF-kappa_NN B_NN binding_NN activity_NN was_VBD inducible_JJ by_IN tumor_NN necrosis_NN factor_NN and_CC phorbol_NN myristate_NN acetate_NN in_IN PLB-985_NN ._NN
Defective_NN translocation_NN of_IN protein_NN kinase_NN C_NN in_IN multidrug-resistant_JJ HL-60_NN cells_NNS confers_VBZ a_DT reversible_JJ loss_NN of_IN phorbol_NN ester-induced_JJ monocytic_JJ differentiation_NN ._NN
Furthermore_RB ,_, a_DT significant_JJ decrease_NN in_IN the_DT switch_NN from_IN the_DT membrane_NNS forms_VBP of_IN mu_NN and_CC gamma_NN to_TO respective_NNS secreted_VBN forms_NNS was_VBD noted_RB in_IN the_DT presence_JJ of_IN TGF-beta_NN ._NN
A_DT transcript_NN of_IN the_DT ALAS_NN IRE_NN ,_, mutated_NN in_IN the_DT conserved_VBN loop_NN of_IN the_DT IRE_NN ,_, did_VBD not_RB readily_VBN form_IN this_DT protein-RNA_NN complex_NN ._NN
Binding_NN of_IN HIV-TF1_NN to_TO the_DT HIV_NN long_JJ terminal_JJ repeat_NN LTR_NN activated_VBN transcription_NN from_IN the_DT HIV_NN promoter_NN in_IN vitro_FW ._NN
Here_RB we_PRP examined_VBP the_DT activation_NN of_IN NF-kB_NN in_IN human_JJ T_NN cell_NN thymic_NNS progenitors_NNS ._NN
Because_NN of_IN cell_NN type-specific_JJ alternative_NN messenger_NN RNA_NN splicing_NN ,_, B-cell_NN Fc_NN gamma_NN RII_NN contains_VBZ an_DT insertion_JJ of_IN 47_NN amino_NN acids_NNS that_WDT participates_NNS in_IN determining_NN receptor_NN function_NN in_IN these_DT cells_NNS ._NN
We_PRP have_VBP identified_VBN two_CD adjacent_NN cis-acting_JJ regulatory_JJ elements_NNS ,_, both_CC of_IN which_WDT are_VBP part_JJ of_IN an_DT Alu_NN repeat_NN ._NN
We_PRP then_RB generated_NN new_JJ donor_NN T-cell_NN clones_JJ ._NN
Therefore_RB ,_, the_DT high_JJ radiosensitivity_NN of_IN squamous_NN cell_NN carcinomas_NN in_IN samples_NN could_MD be_VB explained_VBN by_IN an_DT overexpression_NN of_IN c-fos_NN in_IN the_DT tumor-infiltrating_NN lymphocytes_NNS induced_VBD by_IN small_NN doses_NN of_IN radiation_NN therapy_NN ,_, and_CC these_DT activated_VBN lymphocytes_NNS exerted_VBP a_DT cytotoxic_JJ effect_NN against_IN the_DT cancer_JJ cells_NNS ._NN
Analysis_NN of_IN cytosolic_JJ extracts_NNS indicated_VBP that_IN NF-kappa_NN B_NN levels_NNS were_VBD increased_VBN in_IN HIV-infected_NN cells_NNS ._JJ
In_IN human_JJ histiocytic_NN U937_NN cells_NNS mRNA_NN of_IN clone_NN pAT_NN 133_NN was_VBD constitutively_RB expressed_VBN ,_, whereas_IN mRNA_NN of_IN pAT_NN was_VBD induced_VBN upon_IN induction_NN of_IN terminal_JJ differentiation_NN ._NN
The_DT genes_NNS and_CC mechanisms_NNS that_IN control_NN programmed_NN cell_NN death_NN are_VBP currently_RB the_DT subject_NN of_IN intense_JJ study_NN ._NN
Tyrosines_NN 113_NN ,_, 128_NN ,_, and_CC 145_NN of_IN SLP-76_NN are_VBP required_VBN for_IN optimal_JJ augmentation_NN of_IN NFAT_NN promoter_NN activity_NN ._NN
In_IN contrast_NN to_TO the_DT decrease_NN in_IN GR_NN mRNA_NN seen_NN in_IN IM-9_NN cells_NNS after_IN treatment_NN with_IN 1_CD microM_NNS dexamethasone_NN for_IN 16-18_NN h_NN ,_, treatment_NN of_IN 6TG1.1_NN cells_NNS resulted_VBD in_IN an_DT 8-fold_NN increase_NN in_IN GR_NN mRNA_NN ,_, as_IN determined_VBN by_IN Northern_NN blot_NN and_CC RNase_NN protection_NN analysis_NN ,_, with_IN a_DT corresponding_JJ 3-_NN to_TO 4-fold_VB increase_NN in_IN GR_NN protein_NN ._NN
Unlike_NN classical_JJ NFkappaB_NN sites_NNS ,_, neither_DT the_DT SNE_NN nor_CC the_DT SEE_NN motif_NN responded_NN to_TO phosphatase_NN inhibition_NN by_IN okadaic_NN acid_NN ._NN
While_NN one_CD of_IN the_DT twins_NNS was_VBD clinically_JJ affected_VBN ,_, the_DT other_JJ was_VBD asymptomatic_JJ ._NN
Another_NN component_NN of_IN the_DT AP-1_NN transcription_NN complex_NN ,_, JunB_NN ,_, is_VBZ shown_VBN to_TO inhibit_VB activation_NN mediated_VBN by_IN JunD_NN ._NN
Expression_NN of_IN Bcl-xL_NN and_CC adenovirus_NN E1B_NN 19K_NN did_VBD not_RB interfere_VBN with_IN anti-Fas_NN killing_NN ._NN
The_DT promoter_NN of_IN the_DT major_JJ histocompatibility_NN class_NN II_NN gene_NN DRA_NN contains_VBZ an_DT octamer_NN element_NN ATTTGCAT_NN that_WDT is_VBZ required_VBN for_IN efficient_JJ DRA_NN expression_NN in_IN B_NN cells_NNS ._JJ
ABSTRACT_NN TRUNCATED_NN AT_NN 250_NN WORDS_NN
It_PRP is_VBZ becoming_VBN increasingly_VBN apparent_JJ that_IN NF-kappa_NN B_NN plays_VBZ a_DT critical_JJ role_NN in_IN regulating_VBG the_DT inflammatory_JJ response_NN ._NN
S107_NN plasmacytoma_VBZ cells_NNS ,_, which_WDT express_VBP CD40_NN but_CC are_VBP defective_JJ for_IN the_DT nuclear_JJ appearance_NN of_IN ,_, do_NN not_RB express_VBD RelB_JJ after_IN CD40_NN stimulation_NN ._NN
Interleukin_IN 6-induced_NN differentiation_NN of_IN a_DT human_JJ B_NN cell_NN line_NN into_NN IgM-secreting_NN plasma_NN cells_NNS is_VBZ mediated_VBN by_IN c-fos_NN ._NN
Activation_NN of_IN the_DT human_JJ immunodeficiency_NN virus_NN type_NN 1_CD enhancer_NN is_VBZ not_RB dependent_JJ on_IN NFAT-1_NN ._NN
In_IN one_CD patient_NN ,_, transient_NN reduction_NN of_IN aldosterone_NN receptors_NNS could_MD be_VB documented_NN ,_, while_IN in_IN the_DT second_JJ patient_NN the_DT clinical_JJ and_CC biochemical_JJ parameters_NNS were_VBD consistent_RB with_IN transient_NN pseudohypoaldosteronism_NN ._NN
In_IN the_DT human_JJ leukemic_JJ cells_NNS studied_VBN here_RB ,_, the_DT ability_NN to_TO induce_VB CD8_NN antigen_NN expression_NN in_IN a_DT cells_NNS correlates_NN with_IN the_DT ability_NN to_TO induce_VB cell_NN lysis_NN in_IN a_DT glucocorticoid_NN receptor_NN positive_JJ cell_NN population_NN ._NN
Corticosteroids_NN are_VBP the_DT preeminent_JJ antiinflammatory_NN agents_NNS although_IN the_DT molecular_JJ mechanisms_NNS that_WDT impart_JJ efficacy_NNS have_VBP not_RB been_VBN defined_VBN ._NN
Finally_NN ,_, RNA_NN from_IN activated_VBN lymphocytes_NNS was_VBD amplified_VBN by_IN polymerase_NN chain_NN reaction_NN using_VBG oligonucleotide_NN primers_JJ flanking_NN the_DT 196_NN base_JJ pair_NN long_JJ region_NN encoding_VBG the_DT DNA-binding_JJ domain_NN of_IN the_DT human_JJ intestinal_NN receptor_NN ._NN
Concerning_JJ tumor-infiltrating_NN lymphocytes_NNS ,_, the_DT rate_NN of_IN moderate_NN or_CC remarkable_NN grades_NNS of_IN c-fos-positive_JJ lymphocytes_NNS before_VBG radiotherapy_NN and_CC at_IN radiation_NN doses_NN of_IN 4_NN ,_, 10_CD ,_, and_CC 20_NN Gy_NN was_VBD 8.0_VBN ,_, 29.2_NN ,_, 4.8_NN ,_, and_CC 0_NN ,_, respectively_RB ._NN
In_IN each_NN cohort_NN there_EX was_VBD only_RB one_CD case_NN with_IN a_DT negative_JJ reaction_NN of_IN the_DT primary_JJ tumor_NN and_CC a_DT positive_JJ reaction_NN with_IN the_DT isolated_VBN tumor_NN cells_NNS from_IN the_DT pleural_JJ effusions_NN ._NN
When_WRB human_JJ monocytes_NNS were_VBD preincubated_RB with_IN dexamethasone_NN for_IN 1_CD hour_NN and_CC then_RB stimulated_VBN either_CC with_IN bacterial_NN lipopolysaccharide_NN or_CC phorbol_NN myristate_NN ,_, it_PRP was_VBD found_VBN that_IN dexamethasone_NN inhibited_VBD the_DT lipopolysaccharide-induced_NN interleukin-1_NN beta_IN protein_NN production_NN ,_, but_CC the_DT phorbol_NN myristate-induced_NN production_NN was_VBD increased_VBN 3-10_NN fold_VBG ._NN
In_IN GH4C1_NN pituitary_NN cells_NNS ,_, T3SO4_NN failed_NN to_TO displace_VB -LCB-125I-RCB-T3_NN from_IN nuclear_JJ receptors_NNS in_IN intact_JJ cells_NNS or_CC soluble_JJ preparations_JJ ._NN
Signal_JJ transduction_NN through_IN tyrosine_NN kinase_NN activation_NN may_MD lead_VB to_TO altered_NNS gene_NN expression_NN ,_, as_IN ligation_NN prompted_NN decreases_NN in_IN the_DT nuclear_JJ localization_NN of_IN the_DT transcriptional_JJ regulatory_JJ protein_NN NF-kappaB_NN and_CC proteins_NNS binding_NN the_DT interferon-inducible_NN regulatory_JJ element_NN ._NN
Sjogren_NN syndrome_NN SS_NN is_VBZ characterized_VBN by_IN lymphocytic_JJ infiltrates_NN of_IN exocrine_JJ glands_NN ,_, remarkable_RB B_NN cell_NN hyperreactivity_NN and_CC a_DT strong_JJ predisposition_JJ to_TO B_NN cell_NN neoplasia_JJ ._NN
Remarkably_JJ ,_, the_DT expression_NN of_IN both_DT genes_NNS is_VBZ downmodulated_NN during_IN erythroid_JJ and_CC megakaryocytic_JJ terminal_JJ maturation_NN ._NN
Unexpectedly_NN ,_, in_IN vivo_NN studies_NNS also_RB demonstrate_VBP that_IN I_NN kappa_NN binds_VBZ directly_RB to_TO NF-kappa_NN B_NN p50_NN ._NN
Rheumatoid_NN arthritis_JJ is_VBZ a_DT multistep_JJ disorder_NN associated_VBN with_IN autoimmune_NN features_NN of_IN yet_NN unknown_JJ etiology_NN ._NN
Furthermore_RB ,_, a_DT truncated_NN form_NN of_IN NFAT1_NN acts_NN as_IN a_DT dominant-negative_NN ,_, reducing_NN IL-4_NN promoter_NN activity_NN in_IN primed_JJ CD4_NN T_NN cells_NNS and_CC confirming_NNS the_DT importance_NN of_IN endogenous_JJ NFAT_NN to_TO increased_VBN IL-4_NN gene_NN expression_NN by_IN effector_JJ T_NN cells_NNS ._JJ
Few_NN known_VBN genes_NNS IL-2_NN ,_, members_NNS of_IN the_DT IL-8_NN family_NN ,_, interferon-gamma_NN are_VBP induced_VBN in_IN T_NN cells_NNS only_RB through_IN the_DT combined_JJ effect_NN of_IN phorbol_NN myristic_NN acetate_NN PMA_NN and_CC a_DT ,_, and_CC expression_NN of_IN only_RB these_DT genes_NNS can_MD be_VB fully_RB suppressed_VBN by_IN Cyclosporin_NN A_NN CyA_NN ._NN
Activation_NN of_IN T_NN lymphocytes_NNS induces_VBZ an_DT NF-kappa_NN B-like_NN binding_NN activity_NN to_TO the_DT B2_NN site_NN ,_, concomitant_VBG with_IN activation_NN of_IN the_DT proenkephalin_NN promoter_NN ._NN
Gel_NN retardation_NN assays_NNS ,_, using_VBG a_DT 32P-probe_JJ containing_NN the_DT HIV-1_NN NF-kB_NN probe_NN and_CC nuclear_JJ extracts_NNS from_IN PMA-treated_NN cells_NNS ,_, showed_VBD significantly_RB reduced_VBN induction_NN of_IN nuclear_JJ NF-kB_NN binding_NN proteins_NNS in_IN these_DT two_CD subclones_NNS compared_VBN with_IN wild_JJ type_NN CEM_NN and_CC a_DT control_NN subclone_NN ._NN
Severe_JJ combined_NN immunodeficiency_NN due_JJ to_TO defective_JJ binding_NN of_IN the_DT nuclear_JJ factor_NN of_IN activated_VBN T_NN cells_NNS in_IN T_NN lymphocytes_NNS of_IN two_CD male_NN siblings_NN ._NN
In_IN these_DT studies_NNS ,_, we_PRP have_VBP identified_VBN DNA_NN sequences_NNS and_CC specific_JJ protein_NN interactions_NN necessary_JJ for_IN transcriptional_JJ regulation_NN of_IN the_DT human_JJ prointerleukin_NN 1_CD beta_IN proIL-1_JJ beta_NN gene_NN ._NN
The_DT closest_JJ match_NN to_TO the_DT known_VBN SP-1_NN consensus_NN sequence_NN within_IN the_DT respective_JJ region_NN is_VBZ a_DT TCCCCTCCCCT_NN motif_NN ._NN
An_DT attempt_JJ was_VBD also_RB undertaken_VBN to_TO use_VB a_DT cell_NN harvester_NN for_IN the_DT separation_NN of_IN cells_NNS from_IN unbound_JJ ligand_NN ._NN
Hypothetically_NN ,_, switches_NN of_IN lineage-restricted_JJ transactivators_NN may_MD underlie_VB the_DT binary_NN fate_NN decisions_NN of_IN hematopoietic_JJ progenitors_NNS ._NN
However_RB ,_, in_IN either_CC EL-4_NN T_NN cells_NNS or_CC S194_NN cells_NNS ,_, both_CC lower-affinity_JJ sites_NNS can_MD be_VB significantly_RB induced_VBN by_IN the_DT tax_NN gene_NN product_NN of_IN human_JJ T-cell_NN leukemia_NN virus_NN type_NN I_NN ,_, showing_NN that_IN NF-kappa_NN B_NN activity_NN can_MD be_VB modulated_NN even_RB in_IN a_DT B-cell_JJ line_NN that_WDT constitutively_VBZ expresses_VBN this_DT factor_NN ._NN
In_IN contrast_NN ,_, NF-kappa_NN B_NN p50_NN alone_NN fails_NN to_TO stimulate_VB kappa_NN B-directed_JJ transcription_NN ,_, and_CC based_JJ on_IN prior_JJ in_IN vitro_FW studies_NNS ,_, is_VBZ not_RB directly_JJ regulated_NN by_IN I_NN kappa_NN B_NN ._NN
Analogs_NN of_IN 1_CD alpha,25-dihydroxyvitamin_NN D3_NN 1_NN alpha,25--LRB-OH-RRB-_NN 2D3_NN with_IN substitutions_NNS on_IN C-11_JJ were_VBD synthesized_NN ._NN
The_DT lymphocyte-specific_JJ immunoglobulin_NN mu_NN heavy-chain_NN gene_NN intronic_NN enhancer_NN is_VBZ regulated_VBN by_IN multiple_JJ nuclear_JJ factors_NNS ._NN
Specific_JJ nuclear_JJ translocation_NN of_IN was_VBD found_VBN to_TO be_VB time_NN dependent_JJ reaching_NN a_DT maximum_JJ of_IN approximately_RB 2100_NN binding_NN after_IN 3_NN h_NN of_IN incubation_VBG in_IN HL60_NN cells_NNS ,_, whereas_IN a_DT maximum_JJ of_IN approximately_RB 310_NN binding_NN was_VBD found_VBN after_IN 3_NN h_NN in_IN PBL_NN ._NN
Group_NN C_NN ,_, adenovirus_NN serotype_NN 5_NN Ad5_NN infection_NN inhibits_VBZ both_CC IFN-MCP_NN and_CC cellular_JJ protein_NN synthesis_NN ._NN
These_DT results_NNS demonstrate_VBP that_IN CD40_NN ,_, like_IN sIg_JJ ,_, may_MD employ_NN PKC_NN in_IN producing_NN select_NN outcomes_NN ,_, that_IN individual_VBG B_NN cell_NN receptors_NNS may_MD signal_NN downstream_JJ events_NNS via_IN both_DT PKC-dependent_JJ and_CC PKC-independent_JJ pathways_NNS ,_, and_CC that_IN multiple_JJ signal_NN transduction_NN pathways_NNS may_MD be_VB used_VBN to_TO activate_VB the_DT expression_NN of_IN closely_JJ related_JJ genes_NNS ._NN
The_DT c-rel_NN protooncogene_NN product_NN represses_NN NF-kappa_NN B_NN p65-mediated_NN transcriptional_JJ activation_NN of_IN the_DT long_JJ terminal_JJ repeat_NN of_IN type_NN 1_NN human_JJ immunodeficiency_NN virus_NN ._NN
As_NN with_IN egr-3_NN ,_, expression_NN of_IN egr-2_NN was_VBD blocked_VBN by_IN cyclosporin_NN A_NN ._NN
Furthermore_RB ,_, we_PRP discuss_VBD recent_NN advances_NN that_WDT have_VBP led_JJ to_TO a_DT better_NN understanding_NN of_IN how_NN cytokines_NN elicit_NN intracellular_JJ responses_NNS ,_, as_RB well_RB as_IN role_NN in_IN normal_JJ lymphoid_JJ development_NN ._NN
The_DT transcription_NN factor_NN as_IN well_RB as_IN the_DT closely_JJ related_JJ factor_NN Spi-B_NN bound_VBD to_TO the_DT PU-box_NN in_IN B-cells_NN ._NN
T_NN cell_NN priming_JJ enhances_NN IL-4_NN gene_NN expression_NN by_IN increasing_VBG nuclear_JJ factor_NN of_IN activated_VBN T_NN cells_NNS ._JJ
Similarly_RB ,_, interferons_JJ could_MD act_NN on_IN APL_NN cells_NNS ,_, alone_RB or_CC in_IN combination_NN with_IN all-trans_DT retinoic_JJ acid_NN RA_NN ,_, especially_NN if_IN the_DT alpha_NN fusion_NN transcript_NN that_WDT results_VBZ from_IN the_DT t-LRB-15;_NN 17-RRB-_NN is_VBZ induced_VBN by_IN interferon_NN ._NN
The_DT induction_NN of_IN tyrosine_NN phosphorylation_NN of_IN p80c-rel_NN was_VBD unique_JJ to_TO G-CSF_NN in_IN that_IN granulocyte-macrophage_JJ colony_NN stimulating_NN factor_NN which_WDT also_RB stimulates_VBZ neutrophils_NNS and_CC induces_VBZ tyrosine_NN phosphorylation_NN does_VBZ not_RB result_VBN in_IN tyrosine_NN phosphorylation_NN of_IN p80c-rel_NN ._NN
Furthermore_RB ,_, overexpression_NN and_CC constitutive_NN nuclear_JJ localization_NN of_IN NF-AT_NN ,_, but_CC not_RB Jun_NN ,_, Fos_NN ,_, NF-kappaB_NN ,_, Oct_NN or_CC Ets_NN family_NN members_NNS ,_, renders_VBD the_DT interleukin-2_NN enhancer_NN in_IN Jurkat_NN T_NN lymphocytes_NNS resistant_JJ to_TO FK506_NN and_CC cyclosporin_NN A_NN ._NN
The_DT viral_JJ transcriptional_JJ pattern_NN similar_JJ to_TO that_IN of_IN nasopharyngeal_NN carcinoma_NN and_CC Hodgkin_NN disease_NN suggests_VBZ that_IN EBV_NN can_MD exploit_VB common_JJ regulatory_JJ mechanisms_NNS for_IN gene_NN transcription_NN in_IN diverse_JJ host_NN cell_NN types_NNS ._JJ
The_DT type_NN I_NN interleukin-1_NN receptor_NN IL-1R_NN is_VBZ capable_JJ of_IN transducing_NN a_DT signal_NN resulting_NN in_IN promoter_NN activation_NN in_IN T_NN cells_NNS ._JJ
Pleural_NN effusions_NNS from_IN 20_NN patients_NNS with_IN breast_JJ cancer_NN were_VBD tested_VBN ._NN
Productive_NN human_JJ immunodeficiency_NN virus_NN type_NN 1_CD HIV-1_NN infection_NN causes_VBZ sustained_JJ NF-kappaB_NN DNA-binding_JJ activity_NN in_IN chronically_NN infected_NN monocytic_JJ cells_NNS ._NN
Interferon_IN gamma_NN induces_VBZ class_NN II_NN expression_NN in_IN this_DT glioblastoma_JJ cell_NN line_NNS and_CC ,_, in_IN parallel_JJ ,_, up-regulates_JJ X1_NN and_CC X2_NN box_NN protein-DNA_NN interactions_NN ,_, while_IN all_DT other_JJ interactions_NN remain_NN unchanged_NN ._NN
EL-4_NN cells_NNS were_VBD transfected_VBN with_IN a_DT plasmid_NN containing_VBG the_DT IL-2_NN promoter_NN and_CC enhancer_NN region_NN linked_NNS to_TO the_DT chloramphenicol_NN acetyltransferase_NN CAT_NN reporter_NN gene_NN ._NN
Cloning_NN and_CC characterization_NN of_IN NF-ATc_NN and_CC NF-ATp_NN :_: the_DT cytoplasmic_JJ components_NNS of_IN NF-AT_NN ._NN
We_PRP report_NN here_RB a_DT simple_JJ and_CC rapid_JJ strategy_NN to_TO detect_VB the_DT precise_JJ number_NN of_IN the_DT CAGs_NN ._NN
Transfection_JJ of_IN an_DT expression_NN vector_NN containing_VBG ORF2_NN but_CC not_RB full_JJ length_NN cDNA_NN was_VBD able_JJ to_TO transform_NN NIH3T3_NN cells_NNS and_CC induce_VB tumors_NNS in_IN nude_NN mice_NNS ._JJ
Alternative_RB mechanisms_NNS include_VBP the_DT possibility_NN that_WDT NF-ATc_NN operates_JJ on_IN some_DT cytoplasmic_JJ anchor_NN or_CC that_IN other_JJ proteins_NNS that_WDT are_VBP controlled_NN by_IN calcineurin_NN carry_NN out_NN the_DT nuclear_JJ import_NN of_IN NF-ATc_NN ._NN
We_PRP report_NN here_RB that_IN PML_NN is_VBZ expressed_VBN at_IN low_JJ levels_NNS or_CC not_RB expressed_VBN in_IN normal_JJ circulating_JJ human_JJ monocytes_NNS ,_, lymphocytes_NNS ,_, and_CC polymorphonucleate_JJ cells_NNS ,_, but_CC is_VBZ markedly_RB induced_VBN by_IN interferon_NN ;_NN that_WDT PML_NN and_CC alpha_NN expression_NN is_VBZ augmented_JJ by_IN interferon_NN in_IN the_DT NB4_NN APL_NN cell_NN line_NNS ,_, which_WDT carries_NNS the_DT t-LRB-15;_NN 17-RRB-_NN ,_, and_CC in_IN APL_NN blasts_NNS from_IN patients_NNS ;_JJ that_IN interferon_NN inhibits_VBZ growth_NN and_CC survival_NN of_IN NB4_NN APL_NN cells_NNS in_IN cooperation_NN with_IN RA_NN ;_NN that_IN interferons_JJ alone_NN have_VBP minimal_JJ maturation_JJ effect_NN on_IN NB4_NN cells_NNS ;_: and_CC ,_, finally_NN ,_, that_IN interferon_NN gamma_NN ,_, but_CC not_RB alpha_NN or_CC beta_NN ,_, induces_VBZ maturation_JJ and_CC growth_NN suppression_NN of_IN NB4_NN cells_NNS with_IN de_NN novo_JJ retinoid_NN resistance_NN ,_, and_CC partially_RB restores_JJ RA_NN response_NN ._NN
Radiolabeled_NN complexes_NNS of_IN nuclei_NNS isolated_VBN from_IN cells_NNS exposed_VBG for_IN 3_NN h_NN to_TO radiolabeled_VB hormone_NN --_NN in_IN contrast_NN to_TO identical_VBN experiments_NNS with_IN intact_JJ cells_NNS --_NN did_VBD not_RB disappear_VB from_IN the_DT nuclear_JJ compartment_NN upon_IN incubation_VBG of_IN nuclei_NNS with_IN identical_NN concentrations_NN of_IN the_DT unlabeled_JJ compound_NN ._NN
Peptide_NN vaccination_NN can_MD lead_VB to_TO enhanced_VBN tumor_NN growth_NN through_IN specific_JJ T-cell_NN tolerance_NN induction_NN ._NN
In_IN contrast_NN to_TO MEL_VB cells_NNS ,_, however_NN ,_, K562_NN cells_NNS acquired_JJ a_DT macrophage-like_JJ morphology_NN and_CC exhibited_NN a_DT complete_JJ failure_NN to_TO generate_NNS benzidine-positive_VBN cells_NNS ._NN
The_DT loss_NN of_IN proliferative_NN potential_JJ in_IN response_NN to_TO antigenic_NNS challenge_NN is_VBZ a_DT characteristic_NN feature_NN of_IN immune_JJ senescence_NN ._NN
Nuclear_JJ run-on_JJ experiments_NNS demonstrated_VBD decreased_VBN transcription_NN of_IN kappa_NN L_NN chain_NN ._NN
A_DT sequence_NN is_VBZ also_RB present_JJ in_IN the_DT cytoplasmic_JJ domain_NN of_IN the_DT Hodgkin_NN disease_NN marker_NN ,_, CD30_NN ,_, and_CC binds_VBZ TRAF3_NN in_IN vitro_FW ._NN
We_PRP show_VBP that_IN in_IN S194_NN plasma_NN cells_NNS the_DT activity_NN of_IN each_NN element_NN correlates_NN well_RB with_IN the_DT relative_JJ affinity_NN of_IN B-cell-derived_NN NF-kappa_NN B_NN for_IN that_IN element_NN ._NN
CD3-epsilon_NN expression_NN is_VBZ controlled_VBN by_IN a_DT downstream_JJ T_NN lymphocyte-specific_NN enhancer_NN element_NN ._NN
Finally_NN ,_, we_PRP show_VBP that_IN one_CD of_IN the_DT isoforms_NNS encodes_VBP the_DT previously_RB described_VBN lymphoid-specific_JJ Oct2B_NN protein_NN which_WDT has_VBZ been_VBN suggested_VBD to_TO be_VB involved_VBN in_FW the_DT function_NN of_IN the_DT octamer_NN motif_NN in_IN the_DT context_NN of_IN the_DT immunoglobulin_NN heavy-chain_NN IgH_NN enhancer_NN ._NN
Inhibition_IN of_IN HIV-1_NN latency_NN reactivation_NN by_IN dehydroepiandrosterone_NN DHEA_NN and_CC an_DT analog_NN of_IN DHEA_NN ._NN
The_DT SS_NN Oct-1_NN DNA-binding_JJ abnormality_NN correlated_NN significantly_RB with_IN an_DT inability_JJ of_IN cells_NNS to_TO exit_VB the_DT cell_NN cycle_NN phase_NN when_WRB stimulated_VBN in_IN vitro_FW ._NN
Except_IN for_IN a_DT 4-hour_NN advancement_NN of_IN the_DT peak_JJ ,_, a_DT similar_JJ circadian_JJ rhythm_NN of_IN hepatic_NN GR_NN was_VBD detected_VBN in_IN rats_NN reared_NN under_IN a_DT reversed_JJ lighting_NN regimen_NN 12D_NN :_: 12L_NN ;_JJ lights_NN on_IN between_IN 18:30_NN and_CC 06:30_NN h_NN ._NN
Here_RB we_PRP report_NN that_IN this_DT interference_NN is_VBZ cell_NN specific_JJ ,_, as_IN TPA_NN augmented_NN dexamethasone-induced_NN transcriptional_JJ activation_NN of_IN the_DT MMTV_NN LTR_NN in_IN several_JJ T_NN cell_NN lines_NNS but_CC was_VBD inhibitory_JJ in_IN NIH-3T3_NN fibroblasts_NN ._NN
This_DT signal_NN transduction_NN is_VBZ dependent_JJ on_IN the_DT cytoplasmic_JJ domain_NN ,_, which_WDT consists_RB of_IN 213_NN amino_NN acids_NN ._NN
The_DT results_NNS obtained_VBN suggest_VBP that_IN two_CD Ad12_NN E1A_NN domains_NNS are_VBP required_VBN to_TO induce_VB resistance_NN of_IN the_DT cell_NN lines_NNS to_TO NK_NN cells_NNS ._JJ
results_NNS therefore_RB show_VBP that_IN allele_DT loss_NN on_IN chromosome_NN 20q_NN in_IN polycythemia_JJ vera_NN does_VBZ not_RB commonly_VBN involve_IN mitotic_NN recombination_NN or_CC chromosome_NN loss_NN and_CC that_IN microsatellite_NN instability_NN is_VBZ a_DT rare_JJ event_NN in_IN this_DT disorder_JJ ._NN
These_DT data_NNS are_VBP the_DT first_JJ to_TO define_VB the_DT molecular_JJ weight_NN of_IN the_DT membrane_NNS receptor_NN for_IN aldosterone_NN ._NN
Antisera_NN to_TO Fos_NN inhibits_VBZ NF-AT_NN DNA_NN binding_NN as_IN does_VBZ an_DT oligonucleotide_NN containing_VBG a_DT binding_NN site_NN for_IN AP1_NN ._NN
Using_NN reverse-transcription_VBD PCR_JJ differential_JJ display_NN ,_, we_PRP isolated_VBN an_DT mRNA_NN species_NNS expressed_VBN in_IN IL-2-_NN but_CC not_RB IL-12-stimulated_NN NK_NN cells_NNS ._JJ
HIV1_NN infection_NN of_IN human_JJ monocytes_NNS and_CC macrophages_JJ promotes_NN induction_NN or_CC translocation_NN of_IN NF-KB-related_NN factors_NNS ._JJ
Moreover_RB ,_, when_WRB introduced_VBN into_IN murine_JJ pro-B_NN lymphocytes_NNS ,_, the_DT oncogenic_NN E2A-HLF_NN fusion_NN protein_NN reversed_NN both_CC interleukin-3-dependent_NN and_CC p53-mediated_NN apoptosis_NN ._NN
The_DT rules_JJ of_IN assembly_VBG of_IN the_DT cognate_JJ ligands_NN of_IN TF_NN ,_, namely_NN the_DT zymogen_NN plasma_NN factors_NNS VII_JJ and_CC the_DT serine_NN protease_NN factor_NN VIIa_NN ,_, with_IN the_DT soluble_NN surface_NN domain_NN of_IN TF_NN in_IN free_JJ solution_NN ,_, in_IN the_DT presence_JJ of_IN phospholipid_NN surfaces_NN and_CC cell_NN surface_NN and_CC of_IN the_DT anchored_NN TF_NN molecule_NN have_VBP been_VBN described_VBN ._NN
Instead_IN ,_, regulation_NN of_IN activation_NN involved_VBN a_DT region_NN of_IN the_DT cytoplasmic_JJ domain_NN common_JJ to_TO both_DT the_DT lymphocyte_NN and_CC macrophage_NN receptor_NN isoforms_NNS ._JJ
The_DT glucocorticoid_NN receptor_NN levels_NNS in_IN mononuclear_JJ leukocytes_NNS correlated_VBG with_IN those_DT in_IN polymorphonuclear_JJ leukocytes_NNS ,_, and_CC there_DT was_VBD a_DT linear_JJ relationship_NN between_IN the_DT cellular_JJ glucocorticoid_NN receptor_NN levels_NNS and_CC glucocorticoid-mediated_NNS inhibition_NN of_IN the_DT uptake_JJ of_IN 3-O-methyl-D-glucose_NN in_IN mononuclear_JJ leukocytes_NNS ._NN
CsA_NN was_VBD found_VBN not_RB to_TO inhibit_VB lck_NN gene_NN expression_NN ,_, nor_CC the_DT activity_NN of_IN the_DT lck_NN gene_NN product_NN ._NN
Plasma_NN cortisol_NN and_CC aldosterone_NN levels_NNS and_CC number_NN of_IN related_JJ receptors_NNS in_IN mononuclear_JJ leukocytes_NNS were_VBD measured_NN in_IN 49_NN healthy_NN aged_NNS subjects_NNS 62-97_NN yr_NN and_CC in_IN 21_NN adult_NN controls_NN 21-50_NN yr_NN ._NN
No_NN such_JJ increase_NN was_VBD observed_VBN in_IN control_NN U937_NN cells_NNS ._JJ
Pregnancy-induced_JJ hypertension_NN PIH_NN is_VBZ a_DT frequent_JJ cause_NN of_IN maternal_JJ and_CC neonatal_JJ morbidity_NN and_CC mortality_NN ._NN
The_DT functional_JJ significance_NN of_IN c-Rel_NN involvement_VBZ in_IN the_DT CD28-responsive_NN complex_NN is_VBZ demonstrated_VBN by_IN transient_NN transfection_NN analysis_NN ,_, where_WRB cotransfection_NN of_IN c-Rel_NN augments_NN the_DT level_NN of_IN expression_NN of_IN a_DT chloramphenicol_NN acetyltransferase_NN reporter_NN gene_NN linked_NNS to_TO the_DT CD28-responsive_NN element_NN ._NN
The_DT prevalence_JJ of_IN aneuploidy_NN and_CC overexpressed_NN EGFR_NN was_VBD significantly_RB higher_JJ in_IN the_DT high_JJ risk_NN women_NN than_IN in_IN the_DT 25_NN low_JJ risk_NN controls_NN p_NN 0.002_CD ,_, median_NN 10_CD year_JJ Gail_NN risk_NN was_VBD 0.7_CD ._NN
This_DT dispersed_JJ localization_NN of_IN a_DT group_NN of_IN functionally_JJ related_JJ gene_NN provides_NN insights_NN into_IN the_DT molecular_JJ mechanism_NN of_IN human_JJ genome_NN evolution_NN and_CC possible_JJ involvement_NN in_IN human_JJ diseases_NN ._NN
Indomethacin_NN blocked_VBD PGE2_NN release_NN ,_, but_CC had_VBD no_DT influence_JJ on_IN the_DT observed_NN effects_NNS of_IN C3a_NN ,_, suggesting_VBG that_IN the_DT effects_NNS of_IN C3a_NN on_IN IL-6_NN production_NN are_VBP independent_VBN of_IN PGE2_NN formation_NN by_IN monocytes_NNS ._NN
Neither_CC deletion_NN of_IN NF_NN kappa_NN B_NN nor_CC deletion_NN of_IN NFAT-1_NN decreased_NN activation_NN of_IN viral_JJ replication_NN by_IN phorbol_NN ester_NN ._NN
Deletion_NN of_IN the_DT glucocorticoid_NN response_NN elements_NNS located_JJ at_IN ca._NN bp_NN -850_NN upstream_JJ of_IN Cp_NN did_VBD not_RB result_VBN in_IN a_DT significant_JJ loss_NN in_IN activity_NN ._NN
These_DT results_NNS suggest_VBP that_IN CN_NN is_VBZ involved_VBN in_IN the_DT coordinated_NN induction_NN of_IN the_DT GM-CSF_NN and_CC IL-2_NN genes_NNS and_CC that_IN the_DT CLE0_NN sequence_NN of_IN the_DT GM-CSF_NN gene_NN is_VBZ a_DT functional_JJ analogue_NN of_IN the_DT NF-AT-binding_NN site_NN in_IN the_DT IL-2_NN promoter_NN ,_, which_WDT mediates_VBZ signals_NNS downstream_JJ of_IN T_NN cell_NN activation_NN ._NN
Abnormalities_NN of_IN p16_NN ,_, p15_NN and_CC CDK4_NN genes_NNS in_IN recurrent_JJ malignant_NN astrocytomas_NN ._NN
Lymphocytes_NN from_IN patients_NNS who_IN have_VBP received_NN anti-estrogen_NN therapy_NN show_VBP similar_JJ enhancement_NN of_IN Ig-secreting_NN cells_NNS after_IN PWM_NN stimulation_NN ._NN
However_RB ,_, DCoH_JJ did_VBD not_RB confer_VB transcriptional_JJ activation_NN to_TO the_DT GAL4_NN DNA_NN binding_NN domain_NN ._NN
Molecular_NN genetic_JJ characterization_NN of_IN the_DT variant_JJ allele_NN can_MD serve_NN as_IN a_DT primary_JJ tool_NN for_IN diagnosis_JJ and_CC subsequent_JJ therapy_NN ,_, and_CC can_MD provide_NN a_DT basis_JJ for_IN distinguishing_NN heterozygous_NN carriers_NNS in_IN familial_NN androgen_NN resistance_NN ._NN
Treatment_NN of_IN the_DT mature_JJ B-cell_NN line_NN BAL-17_NN with_IN either_CC anti-immunoglobulin_NN M_NN or_CC phorbol_NN 12-myristate_NN 13-acetate_NN leads_NN to_TO an_DT increase_NN in_IN bcl-2_NN expression_NN that_WDT is_VBZ mediated_VBN by_IN the_DT CRE_JJ site_NN ._NN
The_DT apparent_JJ high_JJ frequency_NN of_IN IL-12-nonresponsive_NN Th_NN cells_NNS within_IN the_DT allergen-specific_NN populations_NNS in_IN atopic_NN patients_NNS predicts_VBP a_DT limited_NN skewing_NN potential_JJ of_IN IL-12_NN in_IN the_DT case_NN of_IN established_JJ Th2_NN responses_NNS ,_, but_CC only_RB affecting_VBG newly_JJ recruited_NN naive_NN Th_NN cells_NNS ._JJ
Serum_JJ response_NN factor_NN SRF_NN binds_VBZ to_TO a_DT site_NN adjacent_NN to_TO the_DT NF-kappa_NN B_NN site_NN in_IN the_DT IL-2R_NN enhancer_NN ,_, and_CC both_CC sites_NNS together_RB have_VBP strong_JJ transcriptional_JJ activity_NN specifically_RB in_IN T_NN cells_NNS ._JJ
These_DT ROI-induced_NN effects_NNS can_MD ,_, to_TO a_DT large_RB extent_VBN ,_, be_VB attributed_JJ to_TO the_DT activation_NN of_IN the_DT transcription_NN factor_NN NF-kappaB_NN ._NN
Defective_NN transcription_NN of_IN the_DT IL-2_NN gene_NN is_VBZ associated_VBN with_IN impaired_JJ expression_NN of_IN c-Fos_NN ,_, FosB_NN ,_, and_CC JunB_NN in_IN anergic_JJ T_NN helper_NN 1_CD cells_NNS ._NN
After_NN a_DT 2-day_NN incubation_NN in_IN LDL_NN ,_, the_DT binding_NN of_IN NF-kappa_NN B_NN ,_, which_WDT is_VBZ believed_VBN to_TO be_VB a_DT key_JJ oxidative-stress_NN sensor_NN for_IN VCAM_NN regulation_NN ,_, remains_RB at_IN basal_JJ level_NN ._NN
Looking_NN at_IN highly_JJ purified_VBN gangliosides_NN ,_, GD3_NN ,_, GD1a_NN ,_, GM3_NN ,_, GM2_NN ,_, and_CC GM1_NN were_VBD all_DT effective_JJ in_IN reducing_NN TNF_NN production_NN in_IN PBMC_NN ,_, and_CC in_IN Mono_NN Mac_NN 6_CD by_IN factor_NN 10_CD to_TO 50_NN ._NN
MAbs_NN against_IN the_DT dUTPase_NN reacted_NN with_IN a_DT protein_NN of_IN approximately_JJ 31_NN kDa_NN in_IN 12-O-tetradecanoyl-phorbol-13-acetate_JJ TPA_NN -stimulated_NN B_NN cells_NNS harbouring_VBP either_CC type_NN 1_NN or_CC type_NN 2_CD EBV_NN ._NN
Using_NN this_DT assay_NN system_NN ,_, we_PRP have_VBP evaluated_RB the_DT contributions_NN of_IN ligand_NN binding_NN and_CC heat_NN activation_NN to_TO DNA_NN binding_NN by_IN these_DT glucocorticoid_NN receptors_NNS ._JJ
We_PRP have_VBP defined_VBN the_DT mechanisms_NNS of_IN transactivation_NN by_IN NFAT1_NN ._NN
Nuclear_JJ factor_NN of_IN activated_VBN T_NN cells_NNS contains_VBZ Fos_NN and_CC Jun_NN ._NN
Increased_IN Stat1_NN and_CC Stat3_NN mRNA_NN and_CC protein_NN levels_NNS were_VBD detected_VBN ,_, respectively_JJ 4_NN and_CC 24_NN h_NN after_IN activation_NN ._NN
However_RB ,_, mutation_NN of_IN the_DT AP-1_NN site_NN markedly_RB diminished_VBD both_CC the_DT basal_JJ and_CC PMA-activated_NN promoter_NN activity_NN ._NN
Ductal_NN cells_NNS were_VBD obtained_VBN via_IN random_NN fine_NN needle_JJ aspirations_NN and_CC cytologically_NN classified_NN ._NN
Although_IN identical_NN in_IN composition_JJ and_CC stoichiometry_JJ to_TO TFIIHwt_NN ,_, TFIIHmut_NN shows_NN a_DT reduced_VBN XPB_NN helicase_NN activity_NN ._NN
Functional_JJ studies_NNS in_IN extrarenal_JJ ,_, non-epithelial_JJ cells_NNS such_JJ as_IN smooth_NN muscle_NN cells_NNS and_CC more_RBR recently_NN circulating_JJ human_JJ lymphocytes_NNS have_VBP provided_VBN increasing_VBG evidence_NN that_IN aldosterone_NN produces_NN not_RB only_RB classical_JJ genomic_JJ effects_NNS ,_, but_CC also_RB rapid_JJ ,_, non-genomic_JJ effects_NNS on_IN transmembrane_NN electrolyte_NN movements_NN ._NN
However_RB ,_, while_IN HUVECs_NNS contained_VBG endothelial_JJ NOS_NN protein_NN ,_, no_DT inducible_JJ NOS_NN was_VBD detected_VBN in_IN either_CC tolerant_JJ or_CC nontolerant_JJ cells_NNS ._NN
We_PRP demonstrated_VBD that_IN the_DT virus_NN dUTPase_NN isolated_VBN from_IN EBV-infected_NN cells_NNS is_VBZ a_DT phosphoprotein_NN ._NN
This_DT HIV-mediated_NN mechanism_NN results_NNS in_IN a_DT self-perpetuating_JJ loop_NN of_IN NF-kappa_NN B_NN production_NN ._NN
Kappa_NN B_NN kappa_NN B_NN enhancer_NN binding_NN proteins_NNS isolated_VBN from_IN the_DT nuclei_NNS of_IN activated_VBN human_JJ T_NN cells_NNS produce_VBD two_CD distinct_JJ nucleoprotein_NN complexes_NNS when_WRB incubated_VBP with_IN the_DT kappa_NN B_NN element_NN from_IN the_DT interleukin-2_NN receptor-alpha_NN IL-2R_NN alpha_NN gene_NN ._NN
In_IN addition_NN ,_, analysis_NN of_IN EBV_NN protein_NN expression_NN by_IN IH_NN revealed_VBD a_DT heterogeneous_JJ pattern_NN of_IN EBV_NN gene_NN expression_NN at_IN the_DT single-cell_JJ level_NN consisting_NN of_IN both_DT and_CC LMP1-_NN tumour_NN cells_NNS ,_, suggesting_VBG a_DT mixture_NN of_IN latency_NN I_NN and_CC II_NN ._NN
Thus_RB ,_, select_JJ genetic_JJ aberrations_NN in_IN the_DT apoptotic_NN pathway_NN reveal_VBP a_DT cell_NN autonomous_NN coregulation_NN of_IN activation_NN ._NN
In_IN this_DT study_NN the_DT effect_NN of_IN anti-estrogen_NN toremifene_NN therapy_NN on_IN serum_NN immunoglobulin_NN IgA_NN ,_, IgM_NN ,_, IgG_NN levels_NNS in_IN breast_JJ cancer_NN patients_NNS was_VBD investigated_VBN ._NN
Although_IN absent_NN in_IN nonexpressing_JJ erythroleukemia_NN cell_NN lines_NNS ,_, the_DT DNase_NN I_NN site_NN is_VBZ present_JJ in_IN uninduced_JJ myelomonocytic_NN cell_NN lines_NNS and_CC is_VBZ not_RB changed_VBN after_IN PMA_NN induction_NN ._NN
Mildly_JJ oxLDLs_NNS 50_NN and_CC 100_NN decreased_NN the_DT number_NN of_IN lymphoblasts_JJ and_CC the_DT level_NN of_IN IL-2_NN concentration_NN in_IN the_DT culture_NNS supernatants_VBP after_IN activation_NN of_IN lymphocytes_NNS by_IN phytohaemagglutinin_NN and_CC ._NN
Resting_JJ monocytes_NNS contained_VBD nuclear_JJ factors_NNS binding_VBG to_TO the_DT AP-1_NN element_NN ,_, but_CC stimulation_NN of_IN monocytes_NNS with_IN LTB4_NN induced_VBD greater_JJR AP-1-binding_NN activity_NN of_IN nuclear_JJ proteins_NNS ._NN
The_DT elevation_NN in_IN intracellular_JJ calcium_NN that_WDT is_VBZ induced_VBN by_IN interactions_NN at_IN the_DT antigen_NN receptor_NN leads_NN to_TO the_DT activation_NN of_IN the_DT calcium-dependent_JJ phosphatase_NN calcineurin_NN ._NN
These_DT findings_NN may_MD have_VB important_JJ implications_NNS for_IN the_DT design_NN of_IN alternative_NN treatment_NN approaches_VBZ for_IN recalcitrant_NN asthma_NN ._NN
Increased_IN proliferation_NN ,_, cytotoxicity_NN ,_, and_CC gene_NN expression_NN after_IN stimulation_NN of_IN human_JJ peripheral_JJ blood_NN T_NN lymphocytes_NNS through_IN a_DT surface_NN ganglioside_NN GD3_NN published_NN erratum_NN appears_VBZ in_IN J_NN Immunol_NN 1994_NN Jul_NN 15_NN ;_NN 153_NN 2_CD :_: 910_NN
Analysis_NN of_IN the_DT accumulation_NN of_IN mRNA-encoding_NN members_NNS of_IN the_DT AP-1_NN transcription_NN factor_NN family_NN demonstrated_VBD that_IN c-fos_NN and_CC junB_NN are_VBP also_RB expressed_VBN upon_IN stimulation_NN of_IN NK_NN and_CC T_NN cells_NNS with_IN IL-2_NN ,_, but_CC not_RB IL-12_NN ,_, whereas_IN expression_NN of_IN c-jun_NN and_CC junD_NN is_VBZ not_RB modified_NN by_IN either_CC cytokine_NN ._NN
These_DT findings_NN are_VBP the_DT first_JJ to_TO demonstrate_VB membrane_NNS binding_NN of_IN aldosterone_NN being_NN compatible_NN with_IN major_JJ aspects_NNS of_IN nongenomic_JJ effects_NNS ._NN
Acute_NN promyelocytic_NN leukemia_NN APL_NN is_VBZ a_DT specific_JJ type_NN of_IN acute_NN myeloid_JJ leukemia_NN characterized_NN by_IN the_DT morphology_NN of_IN the_DT blast_NN cells_NNS ,_, a_DT specific_JJ t-LRB-15;17-RRB-_NN translocation_NN ,_, and_CC risks_NN of_IN definite_NN coagulopathy_NN ._NN
We_PRP tested_JJ the_DT necessity_JJ for_IN appropriate_VBG spatial_JJ alignment_NN of_IN these_DT elements_NNS by_IN using_VBG mutated_JJ enhancers_NN with_IN altered_NN spacings_NN ._NN
To_TO examine_VB the_DT mechanisms_NNS by_IN which_WDT salicylates_NN affect_VBN cytokine_NN gene_NN transcription_NN ,_, the_DT amount_NN of_IN active_JJ and_CC inactive_JJ NF-kappa_NN B_NN and_CC NF-kappa_NN B_NN mRNA_NN ,_, in_IN Porphyromonas_NN gingivalis_JJ lipopolysaccharide-stimulated_NN human_JJ monocytic_JJ cells_NNS was_VBD assessed_VBN ._NN
It_PRP is_VBZ directly_JJ implicated_NN in_IN the_DT emergence_NN of_IN the_DT age-related_NN immune_NN deficiency_NN ._NN
Multiple_JJ prolactin-responsive_NN elements_NNS mediate_VBG G1_NN and_CC S_NN phase_NN expression_NN of_IN the_DT interferon_NN regulatory_JJ factor-1_NN gene_NN ._NN
Abnormalities_NN of_IN retinoblastoma_NN protein_NN pRB_NN and_CC mutations_NNS of_IN RB_NN gene_NN have_VBP been_VBN reported_VBN in_IN up_JJ to_TO 70_NN of_IN MM_NN patients_NNS and_CC 80_NN of_IN MM-derived_NN cell_NN lines_NNS ._JJ
In_IN light_NN of_IN the_DT evidence_NN showing_NN physical_NN and_CC functional_JJ interactions_NN between_IN Oct_NN factors_NNS and_CC OCA-B_NN ,_, we_PRP propose_VBD a_DT mechanism_NN of_IN action_NN for_IN OCA-B_NN and_CC discuss_NN the_DT implications_NNS of_IN OCA-B_NN for_IN the_DT transcriptional_JJ regulation_NN of_IN other_JJ tissue-specific_NNS promoters_NNS ._NN
In_IN contrast_NN ,_, neither_DT the_DT RA-stimulated_NN ,_, RARE-mediated_NN transcription_NN nor_CC the_DT induced_VBN RAR-beta_NN expression_NN was_VBD suppressed_VBN by_IN VitD3_NN ,_, suggesting_VBG that_IN VitD3_NN selectively_NN inhibited_VBD the_DT retinoid-induced_NN differentiation_NN program_NN but_CC not_RB the_DT RARE-mediated_NN signal_NN ._NN
Such_NN a_DT diverse_JJ pathway_NN of_IN monocyte_NN differentiation_NN may_MD constitute_VB one_CD of_IN the_DT basic_JJ mechanisms_NNS of_IN immune_JJ regulation_NN ._NN
Role_NN of_IN Egr-2_NN in_IN up-regulation_NN of_IN Fas_NN ligand_NN in_IN normal_JJ T_NN cells_NNS and_CC aberrant_NNS double-negative_JJ lpr_NN and_CC gld_NN T_NN cells_NNS ._JJ
This_DT activation_NN differed_JJ substantially_NN from_IN that_IN mediated_VBN by_IN phorbol_NN 12-myristate_NN 13-acetate_NN PMA_NN and_CC ionophore_NN or_CC produced_VBD by_IN costimulation_NN with_IN antibodies_NNS against_IN the_DT T_NN cell_NN receptor-CD3_NN complex_NN and_CC to_TO CD28_NN ._NN
Electrophoretic_NN mobility_NN shift_NN assays_NNS and_CC Southwestern_JJ blotting_NN experiments_NNS were_VBD used_VBN to_TO detect_VB the_DT binding_NN of_IN cellular_JJ transactivation_NN factor_NN NF-KB_NN to_TO the_DT double_JJ repeat-KB_NN enhancer_NN sequence_NN located_JJ in_IN the_DT long_JJ terminal_JJ repeat_NN ._NN
E3_NN transcripts_NNS are_VBP present_JJ in_IN the_DT myeloid_JJ ,_, B-lymphoid_JJ ,_, and_CC erythroid_JJ lineages_NNS ,_, absent_JJ in_IN nonhematopoietic_JJ cells_NNS ,_, and_CC encode_NN a_DT highly_JJ hydrophobic_NN ,_, potentially_NN phosphorylated_NN polypeptide_NN of_IN unknown_JJ function_NN with_IN significant_JJ homology_NN to_TO a_DT putative_JJ protein_NN expressed_VBN in_IN myeloid_JJ cells_NNS ._NN
Expression_NN of_IN the_DT human_JJ interleukin-2_NN IL-2_NN receptor_NN alpha_NN chain_NN gene_NN is_VBZ potently_RB upregulated_VBN by_IN own_JJ ligand_NN ,_, IL-2_NN ._NN
We_PRP demonstrate_VBP that_IN ,_, in_IN normal_JJ human_JJ T_NN cells_NNS ,_, an_DT AP-1_NN protein_NN is_VBZ a_DT component_NN of_IN the_DT NF-AT_NN protein_NN complex_NN ._NN
These_DT results_NNS demonstrate_VBP a_DT complex_NN role_NN for_IN VitD3_NN in_IN modifying_NN the_DT retinoid_NN differentiation_NN pathway_NN and_CC may_MD have_VBP implications_NNS for_IN differentiation-inducing_JJ therapy_NN of_IN hematopoietic_JJ tumors_NN ._NN
In_IN order_NN to_TO inquire_VB into_IN the_DT functional_JJ state_NN of_IN adrenal_NN cortex_NN in_IN patients_NNS with_IN pulmonary_JJ heart_NN disease_NN ,_, the_DT number_NN of_IN glucocorticoid_NN receptors_NNS GCR_JJ of_IN peripheral_JJ blood_NN leukocytes_NNS in_IN patients_NNS with_IN chronic_NN pulmonary_NN heart_NN disease_NN was_VBD determined_VBN with_IN radioligand-binding_NN assay_NN and_CC the_DT corresponding_VBG plasma_NN cortisol_NN levels_NNS were_VBD assessed_VBN with_IN radioimmune_NN assays_NNS ._JJ
We_PRP propose_VBD that_IN direct_JJ interaction_NN between_IN the_DT glucocorticoid_NN receptor_NN and_CC nuclear_JJ factor-kappa_NN B_NN factors_NNS is_VBZ at_IN least_JJS a_DT partial_JJ explanation_NN for_IN the_DT effects_NNS of_IN this_DT hormone_NN in_IN inflammatory_JJ diseases_NN ._NN
This_DT rise_NN is_VBZ due_JJ to_TO increased_VBN mRNA_NN stability_NN ,_, which_WDT increased_VBN by_IN almost_NN twofold_NN ,_, and_CC to_TO an_DT overall_NN increase_NN in_IN transcription_NN ,_, which_WDT rises_NN by_IN more_NN than_IN sixfold_JJ ._NN
A_DT fragment_NN extending_VBG from_IN -643_NN to_TO is_VBZ capable_JJ of_IN controlling_VBG the_DT tissue-specific_JJ expression_NN of_IN the_DT CAT_NN gene_NN in_IN transfection_NN experiments_NN ._NN
We_PRP studied_VBN glucocorticosteroid_JJ receptor_NN density_NN and_CC affinity_NN on_IN peripheral_JJ blood_NN mononuclear_JJ cells_NNS by_IN the_DT glucocorticosteroid_JJ binding_NN assay_NN in_IN 33_NN patients_NNS with_IN SLE_NN who_NN had_VBD taken_VBN no_DT glucocorticosteroid_JJ for_IN the_DT previous_JJ 6_NN months_NN and_CC in_IN 32_NN healthy_NN controls_NN ._NN
In_IN THP-1_NN cells_NNS ,_, TPA_NN also_RB induced_VBD a_DT new_JJ ,_, faster-migrating_JJ NF_NN kappa_NN B_NN species_NNS not_RB induced_VBN in_IN monocytes_NNS ._NN
Clinical_NN remissions_NN induced_VBD with_IN all-trans_DT retinoic_JJ acid_NN RA_NN treatment_NN in_IN acute_NN promyelocytic_NN leukemia_NN are_VBP linked_NNS to_TO expression_NN in_IN leukemic_JJ cells_NNS ._NN
The_DT results_NNS show_VBP for_IN the_DT first_JJ time_NN that_WDT a_DT DNA-binding_JJ protein_NN can_MD be_VB used_VBN for_IN affinity_NN purification_NN of_IN fusion_JJ proteins_NNS as_IN exemplified_NN by_IN the_DT specific_JJ and_CC gentle_JJ recovery_NN of_IN beta-galactosidase_NN and_CC alkaline_NN phosphatase_NN from_IN bacterial_JJ lysates_NN using_VBG immunomagnetic_NN separation_NN ._NN
I_NN kappa_NN masks_NN the_DT nuclear_JJ localization_NN signal_NN of_IN NF-kappa_NN B_NN p65_NN and_CC requires_VBZ the_DT transactivation_NN domain_NN to_TO inhibit_VB NF-kappa_NN B_NN p65_NN DNA_NN binding_NN ._NN
We_PRP have_VBP shown_VBN that_IN the_DT Z_NN gene_NN product_NN ,_, which_WDT binds_VBZ to_TO AP-1_NN sites_NNS as_IN a_DT homodimer_NN and_CC has_VBZ sequence_NN similarity_NN to_TO c-Fos_NN ,_, can_MD efficiently_NNS activate_NN the_DT EBV_NN early_JJ promoter_NN ,_, BMRF1_NN ,_, in_IN certain_JJ cell_NN types_NNS i.e._JJ ,_, HeLa_NN cells_NNS but_CC not_RB others_JJ i.e._NN ,_, Jurkat_NN cells_NNS ._JJ
The_DT data_NNS indicate_VBP that_IN decrease_NN of_IN ER_NN levels_NNS in_IN cell_NN may_MD involve_VB in_IN the_DT pathogenesis_NN of_IN climacteric_JJ syndrome_NN ._NN
They_PRP are_VBP composed_VBN of_IN different_JJ structural_NN domains_NNS ,_, including_VBG distinct_JJ domains_NNS for_IN DNA_NN and_CC ligand_NN binding_NN ._NN
Mobility_NN shift_NN assays_NNS showed_VBD that_IN addition_NN of_IN anti-AIM_NN mAb_NN to_TO PMA-treated_NN T_NN lymphocytes_NNS markedly_RB enhanced_VBN the_DT binding_NN activity_NN of_IN AP-1_NN to_TO cognate_JJ sequence_NN ,_, the_DT phorbol_NN ester_NN response_NN element_NN ._NN
Chloramphenicol_NN acetyl_NN transferase_NN CAT_NN assays_NNS using_VBG the_DT HIV-1_NN -139_NN long_JJ terminal_JJ repeat-CAT_NN construct_NN showed_VBD no_RB PMA_NN induction_NN of_IN CAT_NN activity_NN in_IN these_DT subclones_NNS unlike_JJ the_DT parental_JJ line_NN and_CC other_JJ subclones_NNS ._NN
Stimulation_NN of_IN human_JJ peripheral_JJ blood_NN mononuclear_JJ cells_NNS by_IN zinc_NN and_CC related_JJ cations_NNS ._NN
Nevertheless_JJ ,_, the_DT molecular_JJ mechanisms_NNS involved_VBN in_IN BA-induced_JJ differentiation_NN remain_NN largely_RB unknown_JJ ._NN
Both_JJ canrenone_NN and_CC cortisol_NN were_VBD inactive_JJ as_IN ligands_NN up_NN to_TO concentrations_NNS of_IN 0.1_NN microM_NN ._NN
Gel_NN shift_NN mobility_NN assay_NN showed_VBD stimulation_VBN of_IN the_DT AP-1_NN and_CC NF-kappaB_NN contents_NN in_IN P-LPS-treated_JJ cells_NNS ._NN
However_RB ,_, this_DT apparent_JJ lack_NN of_IN response_NN to_TO the_DT secosterol_NN can_MD be_VB overcome_NN by_IN stimulation_NN of_IN B_NN lymphocytes_NNS with_IN a_DT combination_NN of_IN these_DT cellular_JJ activation_NN signals_NNS ,_, which_WDT are_VBP sufficient_JJ to_TO lead_VBG to_TO G1_NN cell_NN cycle_NN progression_NN ._NN
The_DT proximal_JJ sequence_NN element_NN PSE_NN -binding_NN transcription_NN factor_NN PTF_NN ,_, which_WDT binds_VBZ the_DT PSE_JJ of_IN both_CC RNA_NN polymerase_NN II-_NN and_CC RNA_NN polymerase_NN III-transcribed_NN mammalian_JJ small_NN nuclear_JJ RNA_NN snRNA_NN genes_NNS ,_, is_VBZ essential_JJ for_IN transcription_NN ._NN
Stimulation_NN of_IN T_NN cells_NNS with_IN antigen_NN results_VBZ in_IN activation_NN of_IN several_JJ kinases_NN ,_, including_VBG protein_NN kinase_NN C_NN PKC_NN ,_, that_IN may_MD mediate_VBN the_DT later_JJ induction_NN of_IN activation-related_NN genes_NNS ._JJ
The_DT use_NN of_IN the_DT protein_NN tyrosine_NN kinase_NN PTK_NN -specific_NN inhibitor_NN herbimycin_NN A_NN dramatically_NN decreased_NN cellular_JJ proliferation_NN without_IN altering_NNS the_DT activity_NN of_IN the_DT human_JJ immunodeficiency_NN virus-1_NN long_JJ terminal_JJ repeat_NN HIV-1_NN LTR_NN ,_, a_DT promoter_NN largely_RB dependent_JJ on_IN the_DT binding_NN of_IN nuclear_JJ factor_NN kappa_NN B_NN NF-_NN kappa_NN B_NN ._NN
PMA_NN induction_NN increases_NN the_DT level_NN of_IN a_DT number_NN of_IN specific_JJ binding_NN complexes_NNS relative_JJ to_TO the_DT resting_JJ cells_NNS ._NN
Problems_NN of_IN antihypertensive_NN therapy_NN are_VBP discussed_JJ and_CC the_DT first_JJ results_NNS of_IN a_DT pilot_NN study_NN with_IN Urapidil_NN are_VBP presented_JJ ._JJ
Several_JJ methods_NN for_IN specific_JJ down-regulation_NN of_IN transcription_NN factors_NNS are_VBP shown_VBN that_IN may_MD be_VB relevant_JJ to_TO treatment_NN of_IN human_JJ disease_NN ._NN
Proliferation_NN in_IN response_NN to_TO TG_NN was_VBD observed_VBN in_IN T_NN cells_NNS from_IN only_RB 1_CD of_IN 5_NN Hashimoto_NN patients_NNS ._JJ
The_DT B_NN family_NN of_IN transcription_NN factors_NNS is_VBZ composed_VBN of_IN two_CD distinct_JJ subgroups_NNS ,_, proteins_NNS that_IN undergo_JJ proteolytic_NN processing_NN and_CC contain_NN repeats_NN in_IN carboxyl_NN termini_JJ p105_NN ,_, p98_NN ,_, and_CC those_DT without_IN such_JJ repeats_NN that_WDT do_VBZ not_RB require_VB processing_VBN p65_NN ,_, c-Rel_NN ,_, RelB_NN ,_, and_CC Dorsal_NN ._NN
Class_NN II_NN antigen_NN expressing_NN T-cell_NN lines_NNS maintained_VBG contacts_NN identical_NN to_TO B-cell_NN lines_NNS ,_, while_IN class_NN II-negative_NN T-cell_NN lines_NNS exhibited_VBP no_DT interactions_NN ._NN
In_IN particular_JJ ,_, a_DT high-affinity_JJ BSAP-binding_NN site_NN instead_NN of_IN a_DT TATA_NN sequence_NN is_VBZ located_JJ in_IN the_DT -30_NN promoter_NN region_NN upstream_JJ of_IN a_DT cluster_JJ of_IN heterogeneous_NN transcription_NN start_NN sites_NNS ._JJ
This_DT event_NNS is_VBZ associated_VBN with_IN induction_NN of_IN the_DT c-jun_NN early_JJ response_NN gene_NN and_CC appearance_NN of_IN a_DT monocytic_JJ phenotype_NN ._NN
Endothelial_JJ cells_NNS EC_NN act_NN as_IN APC_NN for_IN resting_JJ PBL_NN in_IN vitro_FW ,_, and_CC may_MD have_VBP important_JJ roles_NNS in_IN vivo_NN in_IN the_DT pathogenesis_NN of_IN allograft_DT rejection_NN and_CC delayed_NN hypersensitivity_NN ._NN
The_DT results_NNS define_VB the_DT rhombotin_NN gene_NN family_NN as_IN a_DT class_NN of_IN T-cell_NN oncogenes_NN with_IN duplicated_JJ cysteine-rich_NN LIM_NN domains_NN ._NN
Thus_RB ,_, p65_NN and_CC I_NN kappa_NN B_NN are_VBP linked_NNS in_IN an_DT autoregulatory_JJ loop_JJ ,_, ensuring_JJ that_IN NF-kappa_NN B_NN is_VBZ held_JJ in_IN the_DT cytoplasm_NN until_NN cells_NNS are_VBP specifically_RB induced_VBN to_TO translocate_VB it_PRP to_TO the_DT nucleus_NN ._NN
Agonist_NN dexamethasone_NN was_VBD slightly_RB more_RBR effective_JJ in_IN supporting_NN specific_JJ DNA_NN binding_NN than_IN antagonist_NN RU486_NN ._NN
For_NN these_DT reasons_NN ,_, the_DT region_NN of_IN the_DT GPIIb_NN gene_NN was_VBD used_VBN to_TO identify_VBN the_DT regions_NNS that_IN interact_VBP with_IN DNA-binding_JJ nuclear_JJ factors_NNS ._NN
This_DT defect_NN was_VBD localized_JJ to_TO T_NN cells_NNS and_CC reverted_VBD to_TO normal_JJ after_IN 48_NN h_NN in_IN culture_NN media_NN ._NN
The_DT protein_NN Bcl-3_NN contains_VBZ seven_JJ so-called_NN ankyrin_NN repeats_NN ._NN
Previous_JJ reports_NN have_VBP shown_VBN that_IN BA-induced_JJ overexpression_NN of_IN erythroid_JJ genes_NNS occurred_VBZ at_IN the_DT transcriptional_JJ level_NN ,_, suggesting_VBG the_DT involvement_JJ of_IN erythroid_JJ transcription_NN factors_NNS ._JJ
In_IN contrast_NN ,_, mutations_NNS in_IN the_DT AP-1_NN site_NN located_JJ at_IN -150_NN bp_NN almost_NN completely_NN abrogate_NN induction_NN of_IN the_DT IL-2_NN promoter_NN ,_, and_CC appearance_JJ of_IN an_DT inducible_JJ nuclear_JJ factor_NN binding_NN to_TO this_DT site_NN is_VBZ sensitive_JJ to_TO PKC_NN depletion_NN ._NN
Finally_NN ,_, TFIIA_NN facilitates_NN Tax_NN transactivation_NN in_IN vitro_FW and_CC in_FW vivo_FW ._NN
In_IN each_NN case_NN the_DT allele_NN loss_NN was_VBD caused_VBN by_IN an_DT interstitial_JJ deletion_NN because_IN heterozygosity_JJ at_IN distal_JJ markers_NNS was_VBD retained_VBN and_CC because_IN quantitative_JJ Southern_NN blotting_NN demonstrated_VBD hemizygosity_JJ ._NN
TF_NN antigen_NN expression_NN as_IN elicited_NN by_IN LPS_NN was_VBD also_RB lowered_JJ by_IN lysoPC_NN ._NN
Interestingly_IN ,_, T3_NN strongly_RB enhanced_VBN the_DT action_JJ of_IN RA_NN ,_, suggesting_VBG cooperative_NN action_NN of_IN the_DT two_CD receptors_NNS in_IN modulating_NN erythroid_JJ differentiation_NN ._NN
However_RB ,_, compared_VBN to_TO VD_NN ,_, antiproliferative_NN effect_NN is_VBZ up_JJ to_TO 30-fold_CD higher_JJ on_IN human_JJ peripheral_JJ blood_NN mononuclear_JJ cells_NNS and_CC even_RB up_JJ to_TO 300-fold_CD higher_JJ on_IN human_JJ breast_JJ cancer_NN MCF-7_NN cells_NNS ._JJ
A_DT 21.4-kb_NN DNA_NN clone_NN ,_, pZVB70_NN ,_, showed_VBD the_DT highest_JJ transactivating_NN ability_NN ,_, while_IN two_CD other_JJ DNA_NN fragments_NN ,_, pZVB10_NN 6.2_NN kb_NN and_CC pZVH14_NN 8.7_NN kb_NN ,_, showed_VBD lower_JJR activity_NN ._NN
Inhibition_IN of_IN transcription_NN factor_NN Stat1_NN activity_NN in_IN mononuclear_JJ cell_NN cultures_NNS and_CC T_NN cells_NNS by_IN the_DT cyclic_NN AMP_NN signaling_NN pathway_NN ._NN
The_DT active_JJ nuclear_JJ form_NN of_IN the_DT NF-kappa_NN B_NN transcription_NN factor_NN complex_NN is_VBZ composed_JJ of_IN two_CD DNA_NN binding_NN subunits_NNS ,_, NF-kappa_NN B_NN p65_NN and_CC NF-kappa_NN B_NN p50_NN ,_, both_CC of_IN which_WDT share_VBP extensive_JJ N-terminal_JJ sequence_NN homology_NN with_IN the_DT v-rel_NN oncogene_NN product_NN ._NN
Using_NN Western_NN blot_NN analysis_NN with_IN a_DT monoclonal_JJ antibody_NN recognizing_NN a_DT 17-amino_NN acid_NN epitope_NN of_IN the_DT 1,25-dihydroxyvitamin_NN D3_NN 1,25-LRB-OH-RRB-2D3_NN receptor_NN ,_, we_PRP have_VBP detected_VBN two_CD crossreacting_NN proteins_NNS in_IN activated_VBN normal_JJ human_JJ lymphocytes_NNS ._NN
The_DT number_NN of_IN glucocorticoid_NN receptors_NNS was_VBD 63_NN greater_NN in_IN the_DT morning_NN and_CC 26_NN greater_NN in_IN the_DT afternoon_NN in_IN the_DT patients_NNS with_IN PTSD_NN than_IN in_IN the_DT normal_JJ subjects_NNS ._NN
However_RB ,_, Nef_JJ does_VBZ not_RB affect_VBN the_DT DNA-binding_JJ activity_NN of_IN other_JJ transcription_NN factors_NNS implicated_JJ in_IN HIV-1_NN regulation_NN ,_, including_VBG SP-1_NN ,_, USF_NN ,_, URS_NN ,_, and_CC NF-AT_NN ._NN
Pentoxifylline_NN for_IN the_DT treatment_NN of_IN infection_NN with_IN human_JJ immunodeficiency_NN virus_NN ._NN
Here_RB ,_, Stuart_JJ Schreiber_NN and_CC Gerald_NN Crabtree_NN review_NN recent_NN findings_NN that_WDT indicate_VBZ CsA_NN and_CC FK506_NN operate_NN as_IN prodrugs_NN :_: they_DT bind_VBP endogenous_JJ intracellular_JJ receptors_NNS ,_, the_DT immunophilins_JJ ,_, and_CC the_DT resulting_JJ complex_NN targets_NN the_DT protein_NN phosphatase_NN ,_, calcineurin_NN ,_, to_TO exert_VB the_DT immunosuppressive_JJ effect_NN ._NN
IL-4_NN did_VBD not_RB affect_VBN the_DT stability_NN of_IN the_DT c-fos_NN and_CC c-jun_NN transcripts_NNS ._JJ
Since_JJ LPS_NN and_CC anti-IgM_NN were_VBD unable_VBN to_TO activate_VB RelB_NN ,_, CD40_NN appears_VBZ to_TO trigger_VB a_DT special_JJ program_NN of_IN gene_NN expression_NN involved_VBN in_IN the_DT proliferation_NN differentiation_NN of_IN B_NN lymphocytes_NNS ._JJ
We_PRP further_JJ show_VBP that_IN subdominant_NN latent_NN cycle_NN reactivities_NN to_TO epitopes_NN in_IN the_DT latent_NN membrane_NN protein_NN LMP2_NN ,_, though_DT rarely_NN undetectable_NN in_IN LCL-stimulated_NN populations_NNS ,_, can_MD be_VB reactivated_NN by_IN DC_NN stimulation_NN and_CC selectively_NN expanded_NN as_IN polyclonal_JJ CTL_NN lines_NNS ;_: the_DT adoptive_NN transfer_NN of_IN such_JJ preparations_NN may_MD be_VB of_IN value_NN in_IN targeting_NN certain_NNS EBV-positive_NN malignancies_NN ._NN
SCL_NN protein_NN production_NN was_VBD examined_VBN in_IN a_DT variety_NN of_IN hemopoietic_JJ cell_NN lines_NNS by_IN immunoblotting_JJ using_VBG specific_JJ polyclonal_NN antisera_NN ._NN
Epithelial_JJ cells_NNS are_VBP the_DT major_JJ site_NN of_IN lytic_JJ EBV_NN replication_NN within_IN the_DT human_JJ host_NN ,_, and_CC viral_JJ reactivation_NN occurs_VBZ in_IN EBV-associated_NN nasopharyngeal_NN carcinomas_NN ._NN
Unstimulated_NN and_CC T_NN cells_NNS constitutively_RB contained_VBD high_JJ levels_NNS of_IN two_CD proteins_NNS that_IN bound_VBD to_TO the_DT FLRE_NN ._NN
Characterization_NN of_IN the_DT murine_JJ cyclin-dependent_NN kinase_NN inhibitor_NN gene_NN p27Kip1_NN ._NN
Preincubation_NN of_IN endothelial_JJ cells_NNS with_IN endotoxin_JJ lipopolysaccharide_NN LPS_NN ,_, 1_NN led_NN to_TO a_DT 4-fold_NN increase_NN in_IN subsequent_JJ adherence_NN of_IN polymorphonuclear_JJ leukocytes_NNS P_NN 0.0001_NN ,_, n_NN 10_CD to_TO endothelial_JJ cells_NNS ,_, an_DT increase_NN that_WDT was_VBD markedly_RB attenuated_JJ when_WRB endothelial_JJ cells_NNS were_VBD treated_NN with_IN dexamethasone_NN IC50_NN 1_NN nM_NN ,_, P_NN 0.0001_CD ,_, n_NN 6_CD or_CC 7_CD during_IN preincubation_JJ with_IN LPS_NN ._NN
Circular_JJ permutation_JJ and_CC phasing_NN analyses_NNS demonstrated_VBD that_IN PU.1_NN binding_NN but_CC not_RB TFE3_NN or_CC Ets-1_NN bends_NN mu_NN enhancer_NN DNA_NN toward_IN the_DT major_JJ groove_NN ._NN
We_PRP find_VBP that_IN in_IN the_DT absence_NN of_IN EKLF_NN ,_, while_IN human_JJ beta-globin_NN expression_NN is_VBZ dramatically_NN reduced_NN ,_, gamma-globin_NN transcripts_NNS are_VBP elevated_VBN approximately_RB 5-fold_NN ._NN
In_IN the_DT cell_NN types_NNS tested_JJ ,_, the_DT LS_NN mutations_NNS indicated_VBP an_DT apparent_JJ requirement_NN not_RB only_RB for_IN the_DT intact_JJ NF-kappa_NN B_NN and_CC SP1-binding_NN sites_NNS but_CC also_RB for_IN several_JJ regions_NNS between_IN -201_NN and_CC -130_NN not_RB previously_RB associated_VBN with_IN viral_JJ infectivity_NN ._NN
binds_VBZ to_TO the_DT response_NN element_NN by_IN monomer_JJ or_CC heterodimer_JJ with_IN retinoid_NN X_NN receptor_NN RXR_NN ._NN
The_DT data_NNS presented_VBP below_VBN indicate_VBP that_IN Notch-1_NN expression_NN provides_NN significant_JJ protection_NN to_TO T_NN cell_NN lines_NNS from_IN TCR-mediated_JJ apoptosis_NN ._NN
This_DT protein-DNA_NN complex_NN comigrated_NN with_IN the_DT complex_NN obtained_NN with_IN the_DT purified_VBN human_JJ p65_NN NF-kappa_NN B_NN subunit_NN and_CC binding_NN was_VBD inhibited_VBN by_IN I_NN kappa_NN B-alpha_NN and_CC -beta_NN proteins_NNS ._JJ
Gangliosides_NN appear_VBZ to_TO act_VB at_IN an_DT early_JJ step_NN of_IN activation_NN in_IN that_IN TNF_NN transcripts_NNS were_VBD reduced_VBN and_CC the_DT mobilization_NN of_IN the_DT nuclear_JJ factor_NN kappa_NN B_NN was_VBD blocked_VBN ._NN
Surprisingly_NN ,_, although_IN stimulation_NN of_IN Jurkat_NN T_NN cells_NNS with_IN either_CC CHO-CD80_NN or_CC anti-CD28_NN mAb_NN resulted_VBD in_IN robust_NN tyrosine_NN phosphorylation_NN of_IN CD28_NN itself_NN ,_, ligation_NN with_IN CHO-CD86_NN was_VBD unable_JJ to_TO induce_VB detectable_JJ CD28_NN tyrosyl_NN phosphorylation_NN over_NN a_DT range_NN of_IN stimulation_NN conditions_NN ._NN
Later_NN ,_, the_DT expression_NN of_IN the_DT BSAP_NN gene_NN shifts_NN to_TO the_DT fetal_JJ liver_NN where_WRB it_PRP correlates_NN with_IN the_DT onset_JJ of_IN B_NN lymphopoiesis_NN ._NN
Within_NN this_DT region_NN ,_, single_JJ AP-2-_NN and_CC AP-1-like_NN consensus_NN sequences_NNS were_VBD noted_RB ._VBN
The_DT effect_NN is_VBZ mediated_VBN by_IN the_DT NF-kappa_NN B_NN transcription_NN factor_NN which_WDT is_VBZ potently_RB and_CC rapidly_NN activated_VBN by_IN an_DT H2O2_NN treatment_NN of_IN cells_NNS from_IN inactive_JJ cytoplasmic_JJ form_NN ._NN
However_RB ,_, neither_DT TNF_NN or_CC LPS_NN stimulated_VBN VCAM-1_NN expression_NN in_IN HUAECs_NNS ._NN
Terminal_NN differentiation_NN of_IN the_DT leukemic_JJ cell_NN lines_NNS U-937_NN and_CC HL-60_NN by_IN 12-O-tetradecanoylphorbol-13-acetate_JJ is_VBZ accompanied_VBN by_IN marked_NN changes_NN in_IN gene_NN expression_NN ._NN
The_DT transcriptional_JJ activity_NN of_IN the_DT NFAT_NN binding_NN site_NN is_VBZ mediated_VBN by_IN a_DT complex_NN comprising_NN a_DT member_NNS of_IN the_DT NFAT_NN group_NN and_CC AP-1_NN family_NN proteins_NNS ._JJ
Thus_RB ,_, each_DT factor_NN may_MD function_VB as_IN a_DT novel_JJ negative_JJ regulator_NN of_IN transcription_NN ._NN
Therapy_DT with_IN dexamethasone_NN was_VBD successful_JJ in_IN female_NN patients_NNS with_IN acne_JJ and_CC hirsutism_JJ ,_, as_IN the_DT secondary_JJ increase_NN in_IN the_DT production_NN of_IN adrenal_NN androgens_NN was_VBD effectively_JJ controlled_NN ._NN
The_DT use_NN of_IN interferon-gamma-treated_JJ U937_NN cells_NNS in_IN chemiluminescence_NN assays_NNS to_TO detect_VB red_JJ cell_NN ,_, platelet_NN and_CC granulocyte_NN antibodies_NNS of_IN potential_JJ clinical_JJ significance_NN ._NN
Taken_VBN together_RB ,_, data_NNS demonstrate_VBP that_IN TNF_NN gene_NN expression_NN in_IN monocytes_NNS induced_VBN by_IN different_JJ types_NNS of_IN stimuli_NNS can_MD be_VB blocked_VBD by_IN gangliosides_NN at_IN an_DT early_JJ step_NN of_IN signal_NN transduction_NN ._NN
This_DT effect_NN required_NN surface_NN expression_NN of_IN the_DT CD45_NN PTPase_NN and_CC was_VBD not_RB observed_VBN in_IN CD45-deficient_NN variants_NN of_IN Jurkat_NN cells_NNS ._JJ
The_DT transcription_NN and_CC transformation_NN activity_NN of_IN c-Jun_NN is_VBZ governed_NN by_IN a_DT 27-amino_NN acid_NN regulatory_JJ motif_NN ,_, labeled_NN the_DT delta-domain_NN ,_, which_WDT is_VBZ deleted_VBN in_IN v-Jun_NN ._NN
Together_TO ,_, these_DT data_NNS suggest_VBP that_IN EBF_NN represents_NN a_DT novel_JJ regulator_NN of_IN B_NN lymphocyte-specific_NN gene_NN expression_NN ._NN
Similar_RB DNA_NN binding_NN activity_NN was_VBD detected_VBN in_IN a_DT variety_NN of_IN virus-uninfected_JJ human_JJ T_NN cell_NN lines_NNS and_CC HeLa_NN cells_NNS by_IN means_NN of_IN a_DT gel_NN mobility_NN shift_NN assay_NN ._NN
Optimal_NN activation_NN of_IN T_NN cells_NNS requires_VBZ at_IN least_JJS two_CD signals_JJ ._NN
However_RB ,_, a_DT minority_NN of_IN LYSP100_NN nuclear_JJ dots_NN exactly_NN colocalized_NN with_IN PML_NN and_CC SP100_NN ._NN
and_CC related_JJ genes_NNS constitute_VBG a_DT family_NN and_CC the_DT family_NN consists_NN of_IN three_CD subtypes_NNS ,_, named_JJ nur77_NN alpha_NN ,_, nur77_NN beta_IN ,_, nur77_NN gamma_NN ._NN
We_PRP term_VBN the_DT LYSP100_JJ structures_NN LANDs_NN ,_, for_IN LYSP100-associated_NN nuclear_JJ domains_NN ._NN
Cell_NN cycle_NN analysis_NN of_IN E2F_NN in_IN primary_JJ human_JJ T_NN cells_NNS reveals_VBD novel_JJ E2F_NN complexes_NNS and_CC biochemically_JJ distinct_JJ forms_NNS of_IN free_JJ E2F_NN ._NN
Human_NN peripheral_JJ blood_NN monocytes_NNS Mo_VBP constitutively_RB display_JJ the_DT beta-chain_IN of_IN the_DT receptor_NN for_IN IL-2_NN ,_, whereas_IN expression_NN of_IN the_DT IL-2R_NN alpha-chain_NN is_VBZ not_RB constitutive_JJ but_CC inducible_JJ with_IN IL-2_NN ._NN
Suppression_NN of_IN c-jun_NN by_IN antisense_NN oligonucleotides_NN inhibits_VBZ cell_NN adhesion_NN but_CC not_RB respiratory_JJ burst_NN during_IN phorbol_NN ester-induced_JJ differentiation_NN of_IN U937_NN human_JJ monoblastic_NN cells_NNS ._JJ
LTB4_NN increased_VBD the_DT expression_NN of_IN the_DT c-fos_NN gene_NN in_IN a_DT time-_JJ and_CC concentration-dependent_JJ manner_NN ._NN
As_JJ expected_NN ,_, nearly_JJ all_DT control_NN mice_NN 94.4_NN survived_NN irradiation_JJ ,_, yet_JJ this_DT irradiation_JJ was_VBD lethal_NN to_TO 45.8_VB of_IN transgenic_JJ mice_NNS ._NN
Because_NN the_DT GATA-1_NN gene_NN is_VBZ known_VBN to_TO transactivate_VB several_JJ genes_NNS specific_JJ for_IN the_DT erythroid_JJ ,_, megakaryocytic_JJ ,_, and_CC lineages_NNS ,_, we_PRP studied_VBN GATA-1_NN expression_NN in_IN these_DT purified_VBN hematopoietic_NN cells_NNS ._JJ
Reduced_JJ susceptibility_JJ to_TO HIV-1_NN infection_NN of_IN ethyl-methanesulfonate-treated_NN CEM_NN subclones_NNS correlates_VBG with_IN a_DT blockade_NN in_IN protein_NN kinase_NN C_NN signaling_NN pathway_NN ._NN
METHOD_NN :_: They_PRP measured_NN the_DT number_NN of_IN lymphocyte_NN cytosolic_NN glucocorticoid_NN receptors_NNS and_CC plasma_NN cortisol_NN concentrations_NN in_IN 15_NN consecutively_NN admitted_NN male_NN combat_NN Vietnam_NN veterans_NN with_IN PTSD_NN and_CC in_IN a_DT normal_JJ comparison_NN group_NN of_IN 11_NN subjects_NNS ._JJ
The_DT SCMV_NN SNE_NN sites_NNS contain_VBP potential_JJ overlapping_NN core_NN recognition_NN binding_NN motifs_NNS for_IN SRF_NN ,_, ,_, ETS_NN ,_, and_CC YY1_NN class_NN transcription_NN factors_NNS but_CC fail_NNS to_TO respond_VB to_TO either_CC serum_NN or_CC tumor_NN necrosis_NN factor_NN alpha_NN ._NN
Here_RB we_PRP show_VBP that_IN the_DT response_NN of_IN the_DT HIV-1_NN LTR_NN may_MD be_VB governed_NN by_IN two_CD independent_NN sequences_NNS located_JJ to_TO the_DT site_NN of_IN transcription_NN initiation_NN sequences_NNS that_WDT bind_VBP either_CC NFAT-1_NN or_CC NF_NN kappa_NN B_NN ._NN
METHOD_NN ._NN
The_DT expression_NN of_IN tissue_NNS factor_NN TF_NN ,_, the_DT principal_JJ initiator_NN of_IN coagulation_NN ,_, is_VBZ increased_VBN during_IN inflammation_NN and_CC atherosclerosis_NN ._NN
These_DT data_NNS suggest_VBP that_IN NF-kappa_NN B_NN may_MD be_VB an_DT important_JJ molecular_JJ mediator_NN of_IN Pb-induced_NN immunotoxicity_NN ._NN
Aldosterone-specific_RB membrane_NNS receptors_NNS and_CC rapid_JJ non-genomic_JJ actions_NNS of_IN mineralocorticoids_NN ._NN
Cells_NN with_IN nuclear_JJ p50_NN were_VBD negative_JJ for_IN the_DT CD38_NN ,_, CD20_NN and_CC CD2_NN markers_NNS ._JJ
The_DT constitutive_JJ transcription_NN factor_NN SP1_NN was_VBD unaffected_JJ by_IN addition_NN of_IN TPA_NN ._NN
In_IN agreement_NN with_IN this_DT finding_NN ,_, both_CC the_DT IL-2_NN and_CC IL-2-R_NN alpha_NN promoters_NNS are_VBP active_JJ in_IN transient_NN transfection_NN assays_NNS in_IN IARC_NN 301_CD cells_NNS ._NN
External_NN stimuli_NNS ,_, including_VBG those_DT that_IN activate_NN T_NN cells_NNS ,_, result_JJ in_IN nuclear_JJ translocation_NN of_IN active_JJ NF-kappa_NN B_NN ._NN
The_DT development_NN of_IN functionally_JJ responsive_JJ T_NN cells_NNS ._JJ
Stronger_RB c-myc_NN mRNA_NN expression_NN was_VBD detected_VBN in_IN labial_NN salivary_NN glands_NN of_IN patients_NNS with_IN longer_JJ disease_NN duration_IN p_NN less_RBR than_IN or_CC equal_JJ to_TO 0.002_CD and_CC more_RBR intense_JJ T_NN lymphocyte_NN infiltrates_NN p_NN less_RBR than_IN 0.05_NN although_IN these_DT patients_NNS revealed_VBD no_RB hypergammaglobulinemia_NN ._NN
We_PRP observed_VBD no_DT change_NN in_IN membrane_NN structural_NN order_NN with_IN RU_NN 486_NN up_NN to_TO a_DT concentration_NN of_IN 10-LRB--4-RRB-_CD M_NN ._NN
Moreover_RB ,_, kappa_NN 1_CD -_JJ kappa_NN 3_NN can_MD each_VB be_VB deleted_NN from_IN the_DT TNF-alpha_NN promoter_NN with_IN little_JJ effect_NN on_IN the_DT gene_NN inducibility_VBG by_IN PMA_NN ._NN
DNA_NN sequence_NN homology_NN of_IN E1A_NN genes_NNS between_IN different_JJ Ad_NN groups_NNS group_NN A_NN ,_, Ad12_NN ;_NN group_NN C_NN ,_, Ad5_NN is_VBZ limited_NN almost_NN entirely_NN to_TO three_CD conserved_VBN regions_NNS located_JJ within_IN the_DT first_JJ exon_NN of_IN E1A_NN ._NN
The_DT positive_JJ region_NN can_MD be_VB divided_JJ into_IN an_DT upstream_JJ and_CC a_DT downstream_JJ regulatory_JJ region_NN ._NN
DNA_NN from_IN peripheral_JJ blood_NN leukocytes_NNS of_IN six_JJ patients_NNS from_IN five_JJ families_NNS with_IN various_JJ degrees_NN of_IN androgen_NN insensitivity_NN was_VBD studied_VBN ._NN
These_DT species_NNS showed_VBD different_JJ cell_NN cycle_NN kinetics_NN ._NN
The_DT NB4_NN cell_NN line_NNS ,_, which_WDT is_VBZ derived_VBN from_IN the_DT bone_JJ marrow_NN of_IN a_DT patient_NN with_IN APL_NN during_IN relapse_JJ ,_, can_MD be_VB used_VBN as_IN a_DT model_NN system_NN to_TO study_VB the_DT growth_NN and_CC differentiation_NN of_IN APL_NN cells_NNS ._JJ
Resting_JJ T-cell_NN nuclear_JJ extracts_NNS contained_VBG homodimer_NN ._NN
A_DT region_NN upstream_JJ to_TO the_DT first_RB exon_VBN ,_, and_CC highly_RB conserved_VBN between_IN mouse_NN and_CC man_NN ,_, acts_NN as_IN an_DT erythroid_JJ specific_JJ enhancer_NN in_IN transient_NN assays_NNS ,_, if_IN linked_JJ to_TO the_DT GATA-1_NN or_CC to_TO the_DT SV40_NN promoter_NN ._NN
We_PRP show_VBP that_IN JAK2_NN kinase_NN is_VBZ rapidly_JJ phosphorylated_NN and_CC activated_VBN in_IN response_NN to_TO IL-13_NN ._NN
Human_NN tumor_NN necrosis_NN factor_NN alpha_NN gene_NN regulation_NN in_IN phorbol_NN ester_NN stimulated_VBZ T_NN and_CC B_NN cell_NN lines_NNS ._JJ
Further_RB studies_NNS indicated_VBN that_IN inhibition_NN of_IN GTP-cyclohydrolase_NN I_NN an_DT enzyme_NN involved_VBN in_IN de_NN novo_JJ synthesis_NN of_IN an_DT important_JJ cofactor_NN for_IN NOS_NN activity_NN ,_, tetrahydrobiopterin_JJ prevented_VBD the_DT generation_JJ of_IN NO_NN in_IN cells_NNS ._NN
Changes_NN in_IN plasma_NN interleukin-1_NN and_CC possible_NN relationship_NN with_IN the_DT changes_NN in_IN glucocorticoid_NN receptor_NN in_IN aged_NN long-distance_JJ runner_NN
These_DT studies_NNS have_VBP been_VBN extended_VBN to_TO show_VBP that_IN i_NN a_DT mutant_JJ EBV_NN strain_NN lacking_NN the_DT gene_NN encoding_VBG EBNA_NN 2_CD fails_JJ to_TO switch_NN from_IN Wp_NN to_TO Cp_NN usage_NN in_IN primary_JJ B_NN lymphocytes_NNS ,_, although_IN the_DT virus_NN contains_VBZ a_DT functional_JJ Cp_NN ;_NN ii_NN a_DT region_NN from_IN -429_NN to_TO -245_VB base_JJ pairs_NNS upstream_JJ of_IN Cp_NN is_VBZ essential_JJ for_IN Cp_NN activity_NN in_IN B_NN lymphocytes_NNS ,_, but_CC only_RB in_IN the_DT context_NN of_IN upstream_JJ and_CC downstream_JJ sequences_NNS ;_: iii_NN this_DT region_NN contains_VBZ an_DT EBNA_NN 2-dependent_NN enhancer_NN ;_NN and_CC iv_NN DNase_NN I_NN protection_NN employing_NN nuclear_JJ extracts_NNS from_IN B_NN and_CC T_NN lymphocytes_NNS revealed_VBD a_DT B-cell-specific_JJ footprint_NN in_IN the_DT region_NN of_IN the_DT EBNA_NN 2-dependent_NN enhancer_NN ._NN
Human_NN immunodeficiency_NN virus_NN type_NN 1_CD Nef_JJ protein_NN inhibits_VBZ NF-kappa_NN B_NN induction_NN in_IN human_JJ T_NN cells_NNS ._JJ
Purified_NN human_JJ peripheral_JJ T_NN cells_NNS or_CC Jurkat_NN T_NN cells_NNS were_VBD stimulated_VBN with_IN Chinese_NN hamster_NN ovary_NN CHO_NN cells_NNS expressing_VBG either_CC human_JJ CD80_NN CHO-CD80_NN or_CC human_JJ CD86_NN CHO-CD86_NN or_CC with_IN anti-CD28_NN monoclonal_NN antibody_NN mAb_NN ._NN
The_DT three_CD compartments_NNS are_VBP thought_VBN to_TO be_VB of_IN common_JJ endodermal_JJ origin_NN ;_NN in_IN contrast_NN to_TO earlier_JJ hypotheses_NN ,_, which_WDT suggested_VBD that_IN the_DT endocrine_JJ compartment_NN was_VBD of_IN neuroectodermal_JJ origin_NN ._NN
Thus_RB these_DT data_NNS suggest_VBP that_IN the_DT phorbol_NN myristate-induced_NN signal_NN prolonged_NN protein_NN kinase_NN C_NN activation_NN can_MD not_RB be_VB inhibited_VBN by_IN prior_JJ incubation_NN with_IN dexamethasone_NN and_CC it_PRP also_RB protects_NN the_DT induced_VBN mRNA_NN for_IN the_DT degradative_NN action_NN of_IN dexamethasone_NN ._NN
The_DT loss_NN of_IN conventional_NN responsiveness_NN is_VBZ probably_RB caused_VBN by_IN alterations_NNS at_IN the_DT level_NN of_IN signaling_NN ,_, and_CC may_MD be_VB a_DT manifestation_NN of_IN the_DT physiological_JJ state_NN that_WDT is_VBZ a_DT precondition_JJ for_IN selection_NN ._NN
A_DT thymus-specific_JJ member_NN of_IN the_DT HMG_NN protein_NN family_NN regulates_VBZ the_DT human_JJ T_NN cell_NN receptor_NN C_NN alpha_NN enhancer_NN ._NN
Both_JJ conditions_NN are_VBP promoted_VBN by_IN lysophosphatidylcholine_NN lysoPC_NN ._NN
Over_NN end_JJ ,_, it_PRP binds_VBZ a_DT factor_NN that_WDT is_VBZ ubiquitously_JJ and_CC constitutively_RB expressed_VBN ._NN
We_PRP show_VBP that_IN the_DT constitutive_JJ expression_NN of_IN the_DT T24_NN Ha-ras_NN oncogene_NN in_IN EBV-immortalized_NN B_NN lymphoblasts_NN was_VBD associated_VBN with_IN the_DT induction_NN of_IN the_DT interleukin_NN 2_CD receptor_NN alpha_NN subunit_NN ,_, with_IN an_DT impaired_JJ immunoglobulin_NN gene_NN expression_NN ,_, altered_NN adhesion_NN properties_NNS and_CC increased_VBN survival_NN in_IN serum-free_NN medium_NN ._NN
The_DT signaling_NN events_NNS mediating_VBG this_DT effect_NN appeared_VBD to_TO involve_VB the_DT release_NN of_IN H2O2_NN ,_, since_JJ LTB4_NN failed_NN to_TO induce_VB NF-chi_NN B_NN or_CC NF-IL6_NN in_IN the_DT presence_JJ of_IN the_DT scavenger_NN of_IN H2O2_NN ,_, N-acetyl-L-cysteine_NN ._NN
These_DT data_NNS indicate_VBP specific_JJ modulation_NN of_IN the_DT family_NN of_IN transcription_NN factors_NNS by_IN the_DT CD2_NN signalling_NN pathway_NN and_CC suggest_VBP CD2_NN receptor_NN modulation_NN of_IN CRE-mediated_JJ transcription_NN following_VBG ligand_NN engagement_NN e.g._NN cell-to-cell_JJ contact_NN ._NN
These_DT results_NNS are_VBP consistent_RB with_IN the_DT interpretation_JJ that_IN glucocorticoid-mediated_NNS autoregulation_NN of_IN GR_NN expression_NN is_VBZ a_DT tissue-specific_JJ primary_JJ transcriptional_JJ response_NN ._NN
To_TO this_DT aim_NN ,_, allergen-specific_NN T_NN cell_NN clones_NNS TCC_NN were_VBD generated_VBN from_IN the_DT peripheral_JJ blood_NN of_IN three_CD atopic_NN patients_NNS ,_, and_CC cytokine_NN profiles_NN were_VBD analyzed_VBN ._NN
The_DT mechanism_NN of_IN inhibition_NN is_VBZ related_JJ to_TO the_DT surface_NN expression_NN of_IN several_JJ cell_NN adhesion_NN molecules_NN ._NN
The_DT chemiluminescent_NN CL_NN response_NN of_IN interferon-gamma-treated_JJ U937_NN IFN-U937_NN cells_NNS to_TO sensitized_JJ target_NN cells_NNS has_VBZ been_VBN used_VBN to_TO detect_VB red_JJ cell_NN ,_, platelet_NN and_CC granulocyte_NN antibodies_NN ._NN
Treatment_NN of_IN SKW_NN 6.4_NN cells_NNS with_IN IL_NN 6_NN induced_VBD a_DT transient_JJ and_CC early_JJ stimulation_NN of_IN c-fos_NN sense_NN mRNA_NN expression_NN ._NN
LPS_JJ stimulation_NN did_VBD not_RB give_JJ rise_NN to_TO a_DT persistent_JJ nuclear_JJ accumulation_NN of_IN RelB_NN and_CC c-Rel_NN ,_, whereas_IN nuclear_JJ c-Rel_NN ,_, but_CC not_RB RelB_JJ ,_, accumulated_JJ after_IN B_NN cell_NN receptor_NN stimulation_NN ._NN
The_DT concentration_NN of_IN corticosteroid_NN producing_NN 50_NN inhibition_NN IC50_NN was_VBD 600_JJ nM_NN ,_, 70_NN nM_NN ,_, and_CC 0.5_NN nM_NN for_IN hydrocortisone_NN ,_, methylprednisolone_NN ,_, and_CC dexamethasone_NN ,_, respectively_RB ,_, in_IN monocytes_NNS from_IN CS_JJ individuals_NNS ._NN
The_DT algorithm_NN was_VBD constructed_VBN with_IN the_DT aim_NN of_IN identifying_NN segments_NNS in_IN Ag_NN which_WDT are_VBP resistant_JJ to_TO proteolytic_NN degradation_NN by_IN the_DT enzymes_NN cathepsin_NN B_NN ,_, L_NN ,_, and_CC D_NN ._NN
The_DT candidate_JJ oncogene_NN bcl-3_NN was_VBD discovered_JJ as_IN a_DT translocation_NN into_IN the_DT immunoglobulin_NN alpha-locus_NN in_IN some_DT cases_JJ of_IN B-cell_NN chronic_NN lymphocytic_NN leukaemias_NN ._NN
Site-directed_JJ mutagenesis_NN of_IN the_DT wild-type_JJ IL-2R_NN alpha_NN kappa_NN B_NN enhancer_NN GGGGAATCTCCC_NN has_VBZ revealed_VBD that_IN the_DT binding_NN of_IN p50_NN and_CC p55_NN B2_NN complex_NN is_VBZ particularly_RB sensitive_JJ to_TO alteration_VB of_IN the_DT triplet_NN of_IN deoxyguanosine_NN residues_NN ._NN
Dendritic_NN cells_NNS DC_JJ are_VBP potent_JJ APC_NN during_IN primary_JJ and_CC secondary_JJ immune_NN responses_NNS ._JJ
Epstein-Barr_JJ virus_NN EBV_NN ,_, the_DT causative_JJ agent_NN of_IN infectious_JJ mononucleosis_NN ,_, is_VBZ a_DT human_JJ herpesvirus_NN associated_VBN with_IN epithelial_NN cell_NN malignancies_NN nasopharyngeal_NN carcinoma_NN as_IN well_RB as_IN B-cell_NN malignancies_NN ._NN
Demonstration_NN of_IN a_DT 1,25-dihydroxyvitamin_NN D3-responsive_NN protein_NN in_IN human_JJ lymphocytes_NNS :_: immunologic_JJ crossreactivity_NN and_CC inverse_NN regulation_NN with_IN the_DT vitamin_NN D_NN receptor_NN ._NN
FK506_NN and_CC ciclosporin_NN :_: molecular_JJ probes_NN for_IN studying_NN intracellular_JJ signal_NN transduction_NN ._NN
Cells_NN need_JJ to_TO distinguish_VB between_IN transient_NN signals_NN that_WDT induce_VBZ events_NNS such_JJ as_IN muscle_NN contraction_NN ,_, secretion_NN ,_, adhesion_NN and_CC synaptic_NN transmission_NN ,_, and_CC sustained_JJ signals_NNS that_WDT are_VBP involved_VBN in_IN cell_NN proliferation_NN and_CC differentiation_NN ._NN
This_DT multiple_JJ cytokine_NN production_NN deficiency_NN could_MD not_RB be_VB restored_VBN by_IN IL-2_NN or_CC co-stimulatory_NN signals_NNS provided_VBN by_IN antigen-presenting_NN cells_NNS APC_NN ._NN
Although_IN the_DT -20_NN GATA_NN binding_NN site_NN AGATAA_NN is_VBZ also_RB a_DT potential_JJ TFIID_NN binding_NN site_NN ,_, it_PRP does_VBZ not_RB bind_VB TFIID_NN ._NN
The_DT factor_NN responsible_NN for_IN this_DT activity_NN was_VBD designated_VBN Oct_NN coactivator_NN from_IN B_NN cells_NNS OCA-B_NN ._NN
The_DT biological_JJ activity_NN of_IN 11_NN alpha-methyl-1_NN alpha,25--LRB-OH-RRB-2D3_NN closely_JJ resembled_NN that_WDT of_IN the_DT natural_NN hormone_NN on_IN normal_JJ and_CC leukemic_JJ cell_NN proliferation_NN and_CC bone_NN resorption_NN ,_, whereas_IN in_IN vivo_NN effect_NN on_IN calcium_NN metabolism_NN of_IN the_DT rachitic_NN chick_NN was_VBD about_JJ 50_NN of_IN that_IN of_IN 1_NN alpha,25--LRB-OH-RRB-2D3_NN ._NN
Second_NN ,_, T_NN cells_NNS ,_, which_WDT lack_NN CD45_NN and_CC can_MD not_RB signal_NN via_IN the_DT TCR_JJ ,_, supported_JJ higher_JJ levels_NNS of_IN viral_JJ replication_NN and_CC gene_NN expression_NN ._NN
Thus_RB ,_, stable_NN expression_NN of_IN HB24_NN confers_VBZ an_DT activation_NN phenotype_NN on_IN a_DT human_JJ T_NN cell_NN line_NNS ,_, implicating_JJ this_DT gene_NN as_IN an_DT important_JJ transcriptional_JJ factor_NN during_IN T_NN cell_NN activation_NN and_CC growth_NN ._NN
This_DT result_NN fits_NN well_RB into_IN the_DT general_JJ observation_NN of_IN stress-induced_JJ down-regulation_NN of_IN immune_JJ responses_NNS ._NN
4_NN ._NN It_NN is_VBZ suggested_VBD that_IN danazol_NN has_VBZ an_DT anti-estrogenic_JJ action_NN to_TO the_DT monocytes_NNS through_IN the_DT competition_NN and_CC suppression_NN of_IN estrogen_JJ binding_NN sites_NNS as_IN seen_JJ in_IN the_DT estrogen_JJ target_NN organ_NN ._NN
These_DT transcripts_NNS initiate_VBP from_IN one_CD of_IN two_CD promoters_NNS ,_, Cp_NN or_CC Wp_NN ,_, that_IN function_NN in_IN a_DT mutually_JJ exclusive_NN fashion_NN ._NN
All_DT groups_NNS contain_VBP cysteine-_NN and_CC histidine-rich_NN putative_JJ zinc_NN finger_NN domains_NNS and_CC a_DT serine-phenylalanine_NN SFS_NN domain_NN similar_JJ to_TO part_VB of_IN the_DT large_NN subunit_NN of_IN eukaryotic_JJ RNA_NN polymerase_NN II_NN ._NN
Cotransfection_JJ of_IN an_DT hGATA-3_NN expression_NN plasmid_NN with_IN a_DT reporter_NN plasmid_NN transcription_NN is_VBZ directed_JJ by_IN the_DT HIV-1_NN LTR_NN resulted_VBD in_IN 6-_NN to_TO 10-fold_CD stimulation_NN of_IN LTR-mediated_NN transcription_NN ,_, whereas_IN site_NN specific_JJ mutation_NN of_IN these_DT GATA_NN sites_NNS resulted_VBD in_IN virtual_NN abrogation_NN of_IN the_DT activation_NN by_IN hGATA-3_NN ._NN
Involvement_IN of_IN NF-chi_NN B_NN and_CC NF-IL6_NN in_IN induction_NN of_IN IL-6_NN transcription_NN by_IN monocytes_NNS was_VBD demonstrated_VBN using_VBG deleted_NN forms_NNS of_IN the_DT IL-6_NN promoter_NN ._NN
p27Kip1_NN directly_JJ inhibits_VBZ the_DT catalytic_JJ activity_NN of_IN cyclin-dependent_JJ kinase_NN complexes_NNS interferes_JJ physically_NN with_IN activation_NN by_IN CAK_NN ._NN
A_DT human_JJ putative_JJ lymphocyte_NN switch_NN gene_NN containing_VBG a_DT CpG-rich_NN island_NN encodes_VBZ a_DT small_JJ basic_JJ protein_NN with_IN the_DT potential_JJ to_TO be_VB phosphorylated_NN ._NN
The_DT promoter_NN region_NN lacked_NN a_DT TATA_NN box_NN but_CC contained_VBD potential_JJ binding_NN sites_NNS for_IN the_DT transcriptional_JJ factors_NNS including_VBG two_CD Sp1_NN ,_, CRE_NN ,_, Myb_NN and_CC NFkB_NN located_JJ at_IN positions_JJ -153_NN ,_, -178_NN ,_, -286_NN ,_, -875_NN ,_, and_CC -1011_NN ,_, respectively_RB ._NN
However_RB ,_, the_DT molecular_JJ mechanisms_NNS involved_VBN in_IN ATRA-dependent_NN growth_NN inhibition_NN and_CC cellular_JJ differentiation_NN are_VBP not_RB presently_JJ understood_NN ._NN
We_PRP have_VBP previously_RB reported_VBN that_IN the_DT T_NN lymphocytes_NNS of_IN a_DT child_NN with_IN severe_JJ combined_NNS immunodeficiency_NN are_VBP defective_JJ in_IN the_DT transcription_NN of_IN several_JJ lymphokine_NN genes_NNS that_WDT include_VBP IL2_NN ,_, IL3_NN ,_, IL4_NN ,_, and_CC IL5_NN ,_, which_WDT encode_VBZ interleukins_NN 2_CD ,_, 3_NN ,_, 4_NN ,_, and_CC 5_NN IL-2_NN ,_, -3_NN ,_, -4_NN ,_, and_CC -5_NN ._NN
CONCLUSIONS_NN :_: These_DT results_NNS provide_VBP further_RB evidence_NN for_IN a_DT dysregulation_NN of_IN the_DT HPA_NN axis_NN in_IN PTSD_NN ._NN
Female_NN family_NN members_NNS were_VBD also_RB studied_VBN to_TO identify_VB heterozygote_JJ carriers_NNS ._NN
ABSTRACT_NN TRUNCATED_NN AT_NN 250_NN WORDS_NN
The_DT recent_NN definition_NN of_IN a_DT consensus_NN DNA_NN binding_NN sequence_NN for_IN the_DT Ets_NN family_NN of_IN transcription_NN factors_NNS has_VBZ allowed_RB the_DT identification_NN of_IN potential_JJ Ets_NN binding_NN sites_NNS in_IN the_DT promoters_NNS and_CC enhancers_NN of_IN many_JJ inducible_JJ T-cell_NN genes_NNS ._JJ
Other_NN studies_NNS further_JJ demonstrate_VBP that_IN the_DT jun-B_NN and_CC fra-1_NN genes_NNS are_VBP induced_VBN by_IN TPA_NN in_IN both_DT and_CC cells_NNS ,_, whereas_IN c-fos_NN expression_NN is_VBZ attenuated_JJ in_IN the_DT line_JJ ._NN
The_DT log10Kd_JJ increased_VBN 0.304_NN 0.139_NN p_NN 0.04_CD and_CC the_DT log10MBC_JJ increased_VBN 0.49_NN 0.10_NN p_NN 0.001_CD in_IN the_DT subjects_NNS compared_VBN to_TO baseline_JJ ._NN
As_NN a_DT bioassay_JJ for_IN glucocorticoid_NN action_NN we_PRP also_RB measured_NN dexamethasone_NN suppressibility_NN of_IN mitogen-stimulated_NNS incorporation_VBG of_IN -LCB-3H-RCB-thymidine_NN in_IN mononuclear_JJ leukocytes_NNS ._NN
Sequence_NN analysis_NN of_IN nine_NN different_JJ 2.3-kb_NN cDNA_NN clones_NNS obtained_VBN from_IN NK-derived_NN RNA_NN confirmed_NN that_WDT they_PRP corresponded_NN to_TO an_DT unrearranged_JJ TcR_NN delta_NN gene_NN ._NN
Constitutive_JJ expression_NN of_IN 1,25-LRB-OH-RRB-2D3_NN receptor_NN RNA_NN was_VBD detected_VBN in_IN various_JJ kinds_NN of_IN hematopoietic_JJ cells_NNS ,_, including_VBG macrophages_NN and_CC activated_VBN T_NN lymphocytes_NNS ,_, as_RB well_RB as_IN in_IN cell_NN lines_NNS KG-1_JJ myeloblasts_NN ,_, HL-60_NN promyelocytes_NN ,_, ML-3_NN myelomonoblasts_NN ,_, U937_NN ,_, THP-1_NN monoblasts_NN ,_, K562_NN erythroblasts_NNS ,_, and_CC S-LB1_NN HTLV-1-transfected_NN T_NN lymphocytes_NNS ._JJ
After_JJ appropriate_JJ stimulation_NN ,_, both_CC NF-AT_NN and_CC AP-1_NN are_VBP peculiarly_JJ sensitive_JJ to_TO the_DT protein_NN synthesis_NN inhibitor_NN anisomycin_NN ._NN
We_PRP have_VBP previously_RB shown_VBN that_IN a_DT human_JJ B_NN lymphoma_NN cell_NN line_NN ,_, B104_NN ,_, expressed_VBN surface_NN IgM_NN sIgM_NN and_CC surface_NN IgD_NN sIgD_NN ,_, and_CC that_IN crosslinking_NN of_IN sIgM_JJ and_CC sIgD_JJ by_IN anti-IgM_NN antibody_NN Ab_NN and_CC anti-IgD_NN Ab_NN ,_, respectively_RB ,_, induced_VBN influx_NN to_TO almost_VB the_DT same_JJ degree_NN ,_, whereas_IN only_RB sIgM-crosslinking_JJ caused_VBN B104_NN cell_NN death_NN ._NN
We_PRP have_VBP established_JJ the_DT essential_JJ nature_NN of_IN GATA-1_NN during_IN both_DT primitive_JJ and_CC definitive_JJ erythropoiesis_JJ ._NN
Moreover_RB ,_, antisense_JJ oligodeoxynucleotides_NN targeting_NN either_CC GATA-1_NN or_CC p45_NN NF-E2_NN proteins_NNS inhibited_VBD both_CC protein_NN expression_NN and_CC BA-induced_NN differentiation_NN ._NN
3_NN ._NN Although_IN DEX_NN and_CC PGE2_NN were_VBD equipotent_JJ in_IN suppressing_NN T-cell_NN proliferation_NN ,_, ISO_NN was_VBD much_RB less_RBR effective_JJ ._NN
Dexamethasone_NN markedly_RB inhibited_VBD LPS-stimulated_JJ accumulation_NN of_IN mRNA_NN for_IN ELAM-1_NN and_CC expression_NN of_IN ELAM-1_NN and_CC ICAM-1_NN IC50_NN 10_CD nM_JJ ,_, both_CC P_NN 0.001_NN ,_, n_NN 4-9_NN ;_NN inhibition_NN of_IN expression_NN by_IN dexamethasone_NN was_VBD reversed_VBN by_IN RU-486_NN both_CC P_NN 0.005_NN ,_, n_NN 4-6_NN ._NN
Furthermore_RB ,_, the_DT ability_NN of_IN these_DT complexes_NNS to_TO regulate_VB gene_NN expression_NN is_VBZ demonstrated_VBN by_IN increased_VBN transcription_NN from_IN an_DT AP-1_NN driven_NN reporter_NN construct_NN and_CC marked_NN increases_VBP in_IN the_DT expression_NN of_IN endogenous_JJ AP-1_NN regulated_VBN genes_NNS ._NN
We_PRP found_VBN that_IN GIG18_NN was_VBD rapidly_JJ induced_VBN to_TO comparable_VB levels_NNS by_IN both_DT AR_NN and_CC GR_NN ,_, demonstrating_VBG that_IN AR_NN can_MD indeed_VB function_NN as_IN a_DT transcriptional_JJ activator_NN in_IN S49_NN cells_NNS and_CC ,_, moreover_NN ,_, that_IN GIG18_NN induction_NN may_MD be_VB a_DT marker_NN of_IN early_JJ apoptotic_NN events_NNS in_IN steroid-treated_JJ cells_NNS ._NN
LDP_NN not_RB only_RB increases_VBP plasma_NN estradiol_NN levels_NNS ,_, but_CC also_RB increases_VBN the_DT leucocytic_JJ ER_NN levels_NNS ._JJ
These_DT data_NNS show_VBP that_IN this_DT technique_JJ is_VBZ useful_VBN for_IN the_DT identification_NN of_IN minimal_JJ residual_NN disease_NN in_IN patients_NNS with_IN APL_NN and_CC that_IN cytotoxic_JJ chemotherapy_NN following_VBG ATRA_NN therapy_NN is_VBZ required_VBN for_IN the_DT elimination_NN of_IN APL_NN cells_NNS ._JJ
The_DT HIV-TF1-binding_NN site_NN in_IN HIV_NN LTR_NN was_VBD similar_JJ to_TO the_DT site_NN recognized_NN by_IN upstream_JJ stimulatory_NNS factor_NN USF_NN in_IN the_DT adenovirus_NN major_JJ late_NN promoter_NN ._NN
Here_RB we_PRP show_VBP that_IN priming_JJ of_IN CD4_NN T_NN cells_NNS selectively_JJ enhances_NN IL-4_NN expression_NN relative_JJ to_TO IL-2_NN expression_NN by_IN a_DT transcriptional_JJ mechanism_NN involving_VBN nuclear_JJ factor_NN of_IN activated_VBN T_NN cells_NNS NFAT_NN proteins_NNS ._JJ
Recently_JJ it_PRP has_VBZ become_VBN clear_JJ that_IN these_DT cytokines_JJ activate_NN a_DT number_NN of_IN important_JJ intracellular_JJ signaling_NN molecules_NNS ,_, including_VBG the_DT Janus_NN kinases_NN JAK1_NN and_CC JAK3_NN and_CC members_NNS of_IN the_DT transcription_NN factor_NN family_NN of_IN signal_NN transducers_NN and_CC activators_NN of_IN transcription_NN STATs_NN ._NN
